{"meta":{"query_hash":"a991ddcdd147","filters":{"venue":"Drug Design Development and Therapy"},"cohort_total":97,"direct_labels_cover":0,"predictions_cover":97,"exported":97,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/a991ddcdd147","api":"https://metacan.xera.ac/api/v1/cohort?venue=Drug+Design+Development+and+Therapy"},"results":[{"id":"W1658626856","doi":"10.2147/dddt.s81891","title":"Apparent Km of mitochondria for oxygen computed from Vmax measured in permeabilized muscle fibers is lower in water enriched in oxygen by electrolysis than injection","year":2015,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Cardiovascular and exercise physiology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Chemistry; Antimycin A; Oxygen; Mitochondrion; Respiration; Electrolysis; Biophysics; Diffusion; Biochemistry; Electrolyte; Nuclear chemistry; Biology; Anatomy; Electrode; Organic chemistry","score_opus":0.029357815527885495,"score_gpt":0.24383602422610964,"score_spread":0.21447820869822415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1658626856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867517,0.0014007979,0.010632695,0.000067305045,0.000021267933,0.000019668252,0.0002338198,0.00008406489,0.000788628],"genre_scores_gemma":[0.9939825,0.00048075448,0.004133268,0.000023845316,0.000005703974,0.000036031935,0.00050160516,0.000033602377,0.0008026303],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997969,0.000019228013,0.00002339229,0.000081506616,0.00004098058,0.000038008344],"domain_scores_gemma":[0.9997893,0.000048471844,0.00006993992,0.00001920267,0.00003855251,0.000034580105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025114202,0.00058963714,0.00031831014,0.00023344459,0.00019177457,0.00040282472,0.0004901715,0.00042971713,0.0013382458],"category_scores_gemma":[0.00036610654,0.00021164387,0.00026381572,0.00019239692,0.00037530443,0.0008247862,0.000318052,0.00052923855,0.0003339575],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016399872,0.000012533541,0.0013664409,0.000057746238,0.000012691615,0.000035655736,0.00003982004,0.000058034042,0.9974299,0.000069186004,0.000011593598,0.00074244407],"study_design_scores_gemma":[0.000014315519,0.0002760735,0.026391808,0.000012194532,0.000050816805,0.00027031708,0.0001288752,0.0020408232,0.9695022,0.00016889672,0.0011333541,0.000010289118],"about_ca_topic_score_codex":0.000570144,"about_ca_topic_score_gemma":0.000577943,"teacher_disagreement_score":0.0013382458,"about_ca_system_score_codex":0.0002773093,"about_ca_system_score_gemma":0.0002153521,"threshold_uncertainty_score":0.0044768453},"labels":[],"label_agreement":null},{"id":"W1692190376","doi":"10.2147/dddt.s84850","title":"Dolutegravir – a review of the pharmacology, efficacy, and safety in the treatment of HIV","year":2015,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Dolutegravir; Elvitegravir; Raltegravir; Integrase inhibitor; Tolerability; Medicine; Pharmacology; Adverse effect; Integrase; Drug; Human immunodeficiency virus (HIV); Virology; Antiretroviral therapy; Viral load","score_opus":0.09921393294740355,"score_gpt":0.36567768045984955,"score_spread":0.266463747512446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1692190376","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016589487,0.99861026,0.000085956686,0.00012771419,0.0000744517,0.0000073437614,0.000030736817,0.0000064287933,0.00089116447],"genre_scores_gemma":[0.00066794024,0.99853194,0.00019261379,0.00009516541,0.000053912485,0.0000054494617,0.00003456749,0.0000011335086,0.0004172923],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99982953,0.000030706102,0.000032281518,0.00002487519,0.00006954213,0.000013034321],"domain_scores_gemma":[0.9997886,0.000096808224,0.000041957657,0.000004982583,0.000050939918,0.000016819027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044053257,0.00065650145,0.0011870255,0.002231823,0.0002606977,0.0008173399,0.00056066853,0.00060052954,0.0042964863],"category_scores_gemma":[0.0005612361,0.00026575147,0.00062511547,0.0022244896,0.00024206152,0.0007970265,0.00044327378,0.0011102279,0.0016183539],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007041933,0.00008759281,0.00011822814,0.031561516,0.0001347374,0.00014733191,0.000054428914,0.00027316128,0.0017306062,0.0015388089,0.020685839,0.94359726],"study_design_scores_gemma":[0.00002960726,0.00017355742,0.00085550576,0.0057930434,0.00029494124,0.0014531127,0.000046166635,0.00012458241,0.00064566615,0.0008459454,0.98971575,0.00002217513],"about_ca_topic_score_codex":0.0012512124,"about_ca_topic_score_gemma":0.0026082688,"teacher_disagreement_score":0.0042964863,"about_ca_system_score_codex":0.00035776646,"about_ca_system_score_gemma":0.0009386234,"threshold_uncertainty_score":0.014373183},"labels":[],"label_agreement":null},{"id":"W1703213295","doi":"10.2147/dddt.s78036","title":"Spotlight on pembrolizumab in the treatment of advanced melanoma","year":2015,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Pembrolizumab; Medicine; Melanoma; Metastatic melanoma; Food and drug administration; Immune system; Immunotherapy; Disease; Cancer; Drug; Immune checkpoint; Oncology; Immunology; Cancer research; Internal medicine; Pharmacology","score_opus":0.08665092685978829,"score_gpt":0.3368170679676156,"score_spread":0.2501661411078273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1703213295","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008828957,0.99772614,0.00008356283,0.00071812427,0.00042375518,0.000003976221,0.000014831965,0.0000061976243,0.0009351554],"genre_scores_gemma":[0.00052449916,0.99756926,0.00014106496,0.0006215978,0.00038677498,0.000003907034,0.00002362978,0.0000015217756,0.0007276496],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998253,0.000034421537,0.00002334201,0.000025599878,0.00007433741,0.000016929072],"domain_scores_gemma":[0.99972206,0.00011957529,0.000036724407,0.000006784403,0.000079039724,0.000035813246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059015583,0.00048052508,0.000905575,0.0015248196,0.00022068882,0.0007190233,0.0006051427,0.000986974,0.004556014],"category_scores_gemma":[0.0006463009,0.00021039945,0.0004913723,0.0013719016,0.00032949084,0.0014289832,0.0005132914,0.0025079981,0.0019873362],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000914713,0.000062086845,0.00009741379,0.010455292,0.00007532711,0.00016457032,0.000050891107,0.00023112388,0.001838472,0.0035191132,0.065129705,0.91828454],"study_design_scores_gemma":[0.000022182832,0.00008990047,0.00046922985,0.0031316031,0.0000797472,0.00082757,0.000027808253,0.000072041876,0.000230877,0.0015467576,0.99349195,0.000010357013],"about_ca_topic_score_codex":0.000736564,"about_ca_topic_score_gemma":0.0019626748,"teacher_disagreement_score":0.004556014,"about_ca_system_score_codex":0.00043906018,"about_ca_system_score_gemma":0.0006764518,"threshold_uncertainty_score":0.015241325},"labels":[],"label_agreement":null},{"id":"W1805190643","doi":"10.2147/dddt.s91116","title":"Hydrogen sulfide-releasing naproxen suppresses colon cancer cell growth and inhibits NF-κB signaling","year":2015,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute on Drug Abuse; National Institutes of Health","keywords":"Hydrogen sulfide; Naproxen; NFKB1; Cancer research; Chemistry; Kappa; NF-κB; Colorectal cancer; Signal transduction; Cell growth; Caco-2; Cancer; Pharmacology; Medicine; Biochemistry; Internal medicine; Cell; Pathology; Gene","score_opus":0.043780844002484984,"score_gpt":0.2624685227081209,"score_spread":0.21868767870563588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1805190643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98837614,0.007849756,0.0012495441,0.0001611235,0.00003814139,0.000042710504,0.00027849048,0.00007598317,0.0019280531],"genre_scores_gemma":[0.9909095,0.0043584732,0.0013297355,0.000065949396,0.000016162148,0.00003338336,0.0003767143,0.00000839555,0.0029016335],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999651,0.0000062969357,0.0000030043534,0.000005456049,0.000011007446,0.000009261786],"domain_scores_gemma":[0.9999788,0.000002756362,0.000006224194,0.0000021700994,0.0000032207654,0.00000686792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005847137,0.00023124502,0.00016052285,0.00013108004,0.000093232215,0.000102352446,0.00013370007,0.000117502095,0.0011633415],"category_scores_gemma":[0.000041041087,0.000051031733,0.0001565938,0.00008551677,0.00011444692,0.00011848288,0.00007796465,0.00031135822,0.0001889217],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004757787,0.000108414235,0.0001444263,0.00012264375,0.000008212897,0.000056701916,0.000011753667,0.00010048369,0.99307925,0.00005225728,0.000108797256,0.0057313894],"study_design_scores_gemma":[0.00012968041,0.003085928,0.004704064,0.000011065395,0.000024687704,0.0002234079,0.000043777927,0.00087797,0.98452467,0.000044215423,0.0063244416,0.0000061395144],"about_ca_topic_score_codex":0.0005763628,"about_ca_topic_score_gemma":0.0016695451,"teacher_disagreement_score":0.0011633415,"about_ca_system_score_codex":0.000117741896,"about_ca_system_score_gemma":0.00015869598,"threshold_uncertainty_score":0.003891766},"labels":[],"label_agreement":null},{"id":"W1856761374","doi":"10.2147/dddt.s88845","title":"Paget’s disease of bone: an osteoimmunological disorder?","year":2015,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Bone health and treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec","funders":"Amgen Canada; Université Laval; Arthritis Society; Eli Lilly and Company; Amgen","keywords":"Osteoimmunology; RANKL; Osteoprotegerin; Medicine; Immunology; Proinflammatory cytokine; Osteoclast; Bone disease; Osteoporosis; Bone resorption; Cancer research; Pathology; Internal medicine; Inflammation; Receptor; Activator (genetics)","score_opus":0.1686114903308565,"score_gpt":0.37739820737697866,"score_spread":0.20878671704612214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1856761374","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18780462,0.691036,0.0067946846,0.051837865,0.00467758,0.00015226287,0.00047180086,0.00034105833,0.056884225],"genre_scores_gemma":[0.7167,0.23180254,0.004625227,0.0111680785,0.008808907,0.000090245536,0.00037241005,0.000055063443,0.026377508],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.99986243,0.000015276953,0.000021859847,0.000031766936,0.000033775374,0.000035013716],"domain_scores_gemma":[0.99982786,0.000028577164,0.00006385778,0.000008890035,0.000027852391,0.000042922893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017237997,0.0006044973,0.0011489262,0.000877648,0.0006766755,0.0011111139,0.00044056427,0.0021499628,0.0055539683],"category_scores_gemma":[0.0005648367,0.00016375986,0.00023845302,0.0010861533,0.0016760838,0.0010905152,0.000471986,0.0007990112,0.0013692726],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006742565,0.000291469,0.03627069,0.004901035,0.00016274674,0.43532512,0.0010377563,0.00018209266,0.023580229,0.032939654,0.044261433,0.42037347],"study_design_scores_gemma":[0.000080392456,0.00020858026,0.015421081,0.001006008,0.00014177541,0.80894065,0.0010073809,0.000501286,0.0033985071,0.012916173,0.15632279,0.00005539438],"about_ca_topic_score_codex":0.0010796223,"about_ca_topic_score_gemma":0.0012984482,"teacher_disagreement_score":0.0055539683,"about_ca_system_score_codex":0.00042701434,"about_ca_system_score_gemma":0.0004772732,"threshold_uncertainty_score":0.01857984},"labels":[],"label_agreement":null},{"id":"W1891914108","doi":"10.2147/dddt.s84177","title":"Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues","year":2015,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":208,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre","funders":"American Society of Clinical Oncology","keywords":"Pasireotide; Octreotide; Medicine; Gastroenterology; Internal medicine; Somatostatin; Adverse effect; Neuroendocrine tumors; Carcinoid syndrome; Refractory (planetary science); Acromegaly; Hormone","score_opus":0.04525629135987289,"score_gpt":0.30482834823620364,"score_spread":0.2595720568763307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1891914108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878461,0.0036289825,0.0014108864,0.00060858316,0.0003157383,0.0043638623,0.00059232436,0.00010591694,0.0011276945],"genre_scores_gemma":[0.983648,0.0024183523,0.0032961182,0.0013924934,0.0003403209,0.0058706114,0.0013520921,0.000038015845,0.0016440819],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993643,0.00036777052,0.000035404104,0.0000874742,0.000050413426,0.000094670155],"domain_scores_gemma":[0.9988661,0.00030467365,0.000161215,0.000099831734,0.000081229366,0.0004870403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028828103,0.0012357314,0.0030252954,0.0003505891,0.00040716515,0.0008711212,0.00091473747,0.0014561352,0.0020812666],"category_scores_gemma":[0.0014681233,0.000612088,0.0017537903,0.00037701507,0.0010347787,0.00088382995,0.00026296917,0.0026591239,0.0005972252],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8938539,0.03474438,0.0023414192,0.0007437527,0.0014190201,0.00022304346,0.00019592422,0.0015523194,0.023870632,0.00030459446,0.0016325096,0.03911851],"study_design_scores_gemma":[0.8022869,0.19299069,0.0019370363,0.000018765126,0.00022563821,0.000093080824,0.000025365302,0.0007444907,0.0009053321,0.000109715555,0.0006493511,0.000013621409],"about_ca_topic_score_codex":0.0007631308,"about_ca_topic_score_gemma":0.0016145271,"teacher_disagreement_score":0.0030252954,"about_ca_system_score_codex":0.00059629924,"about_ca_system_score_gemma":0.0016739905,"threshold_uncertainty_score":0.015245914},"labels":[],"label_agreement":null},{"id":"W1971992666","doi":"10.2147/dddt.s66236","title":"Effect of administration of water enriched in O2 by injection or electrolysis on transcutaneous oxygen pressure in anesthetized pigs","year":2014,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Hydrogen's biological and therapeutic effects","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Danone","keywords":"Anesthesia; Oxygen; Medicine; Oxygen pressure; Blood pressure; Chemistry; Internal medicine","score_opus":0.01048036583788475,"score_gpt":0.2480426046725239,"score_spread":0.23756223883463914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971992666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989936,0.0002471474,0.00040343354,0.00003649692,0.00002332784,0.000051370636,0.000053054922,0.000018453331,0.0001732062],"genre_scores_gemma":[0.9955218,0.0008711236,0.0020712945,0.00011369972,0.000055036206,0.00020258887,0.00018099761,0.000020200843,0.00096320506],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99976236,0.000039680504,0.000016972783,0.00005840806,0.00003902886,0.00008365331],"domain_scores_gemma":[0.9996112,0.00008837939,0.00015614812,0.000026896829,0.000025148953,0.00009234897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027811553,0.000571108,0.0005271329,0.0002570611,0.00016821189,0.0003265488,0.00029680453,0.00039357127,0.0012072134],"category_scores_gemma":[0.00035682585,0.000223944,0.00030231383,0.00014364904,0.00074425124,0.0004160346,0.00027237163,0.00071573496,0.0001581443],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026624922,0.0016782677,0.00095771014,0.00023563197,0.000060704304,0.00015244985,0.00009939818,0.00012440151,0.9619517,0.000046811005,0.000086194406,0.0079819225],"study_design_scores_gemma":[0.0014622415,0.15956716,0.01769745,0.00003620066,0.0003077112,0.0002525191,0.0002750092,0.0008406787,0.8175393,0.00007659303,0.0019077347,0.000037349797],"about_ca_topic_score_codex":0.0003731032,"about_ca_topic_score_gemma":0.0006284943,"teacher_disagreement_score":0.0012072134,"about_ca_system_score_codex":0.00020284651,"about_ca_system_score_gemma":0.00033754422,"threshold_uncertainty_score":0.0040385127},"labels":[],"label_agreement":null},{"id":"W1981220884","doi":"10.2147/dddt.s34976","title":"Cholesteryl ester transfer protein inhibitors for dyslipidemia: focus on dalcetrapib","year":2012,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Cholesterylester transfer protein; Dyslipidemia; Medicine; Cholesterol; Pharmacology; Lipoprotein; Bioinformatics; Internal medicine; Disease; Biology","score_opus":0.09489177903714113,"score_gpt":0.3135815514196455,"score_spread":0.21868977238250437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981220884","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000973487,0.9990355,0.000074907315,0.00027722993,0.00011328393,0.0000028558914,0.00000660653,0.0000056610047,0.00038673388],"genre_scores_gemma":[0.00046393555,0.9986388,0.00015648168,0.0002171147,0.00011296196,0.000003926014,0.000011480647,0.0000015182409,0.00039372346],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998381,0.000031155192,0.00002623548,0.000029071478,0.00006173154,0.000013623683],"domain_scores_gemma":[0.9997421,0.00012284984,0.000035050623,0.000008904323,0.000066484085,0.000024608546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065006147,0.0008679619,0.0016469638,0.0021517372,0.00021570269,0.00080783066,0.0007475027,0.0008821994,0.002775436],"category_scores_gemma":[0.00064607087,0.00029419604,0.0006085603,0.0024783562,0.00050215743,0.0015901141,0.0006039905,0.0025516818,0.0018328906],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015079354,0.00011510299,0.00012633117,0.015375039,0.00013896005,0.0002127414,0.00006207848,0.0003189308,0.0017945052,0.004059455,0.03371516,0.943931],"study_design_scores_gemma":[0.000080220176,0.0001240399,0.0007717212,0.0037194586,0.00017811784,0.0012347674,0.000046210276,0.00013559916,0.00049434847,0.0018871792,0.9913101,0.00001832655],"about_ca_topic_score_codex":0.0010350839,"about_ca_topic_score_gemma":0.0020099175,"teacher_disagreement_score":0.002775436,"about_ca_system_score_codex":0.00053219986,"about_ca_system_score_gemma":0.0008765629,"threshold_uncertainty_score":0.009284735},"labels":[],"label_agreement":null},{"id":"W1982595853","doi":"10.2147/dddt.s73891","title":"Apparent histological changes of adipocytes after treatment with CL 316,243, a ß-3-adrenergic receptor agonist","year":2015,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Adipose Tissue and Metabolism","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Agonist; Adipose tissue; Internal medicine; Endocrinology; Receptor; White adipose tissue; Thermogenin; Adrenergic agonist; Saline; Body weight; Medicine; Immunohistochemistry; Obesity; Chemistry; Adrenergic","score_opus":0.07728343598737959,"score_gpt":0.2750052235637691,"score_spread":0.19772178757638953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982595853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966228,0.0010208111,0.0012138408,0.000045083012,0.000031963096,0.000032891025,0.00027069007,0.000040447314,0.0007214995],"genre_scores_gemma":[0.99159145,0.0014755678,0.0022105987,0.00012640611,0.0000311742,0.00014234643,0.00066594355,0.000024098243,0.0037323663],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988914,0.000011805454,0.000011938452,0.000027545317,0.000030944822,0.000028538767],"domain_scores_gemma":[0.9998417,0.000023303357,0.000048725127,0.000017449864,0.000021765927,0.000046965113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015206667,0.00038174965,0.00028804815,0.0002716574,0.00015395679,0.00016438754,0.00018972918,0.00039074486,0.0022610312],"category_scores_gemma":[0.00008466091,0.00015221101,0.00027908452,0.00016271144,0.00023732892,0.00021012056,0.00015203057,0.0007485596,0.00043471067],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010198018,0.00008837963,0.00046614272,0.000033745277,0.000006013174,0.00012537366,0.000015785956,0.00001881632,0.9973456,0.000019081997,0.000015997754,0.0008452325],"study_design_scores_gemma":[0.00012814636,0.006206994,0.022189278,0.000014541304,0.00005383257,0.0008035719,0.00018098128,0.0002817883,0.9688599,0.00005289517,0.0012160941,0.00001188707],"about_ca_topic_score_codex":0.00030875695,"about_ca_topic_score_gemma":0.00047620232,"teacher_disagreement_score":0.0022610312,"about_ca_system_score_codex":0.00010046433,"about_ca_system_score_gemma":0.00017923875,"threshold_uncertainty_score":0.0075639486},"labels":[],"label_agreement":null},{"id":"W1991311930","doi":"10.2147/dddt.s40215","title":"Aflibercept in wet AMD: specific role and optimal use","year":2013,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Aflibercept; Medicine; Computer science; Ophthalmology; Bevacizumab; Surgery; Chemotherapy","score_opus":0.09628446476675699,"score_gpt":0.3128199846076987,"score_spread":0.21653551984094171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991311930","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024623628,0.9984072,0.000052794196,0.00051721197,0.00009954929,0.000010835615,0.00003009167,0.0000030377253,0.0006331411],"genre_scores_gemma":[0.0026906596,0.9957237,0.00048644477,0.000559902,0.00019876986,0.000025982135,0.000052307765,0.0000020138425,0.00026018673],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992111,0.000191177,0.0002961846,0.00008488364,0.00017553513,0.000040988765],"domain_scores_gemma":[0.9990608,0.00043564988,0.00028118608,0.000017782286,0.00016759575,0.000037029426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013293473,0.00054375647,0.0020576457,0.003156967,0.00025245087,0.0012552005,0.0007261352,0.0013573096,0.0035416046],"category_scores_gemma":[0.0024006767,0.00025386165,0.0010615971,0.0028534513,0.0004956786,0.0021160317,0.00053512346,0.00092700514,0.00087501196],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027144057,0.000047215657,0.0005287905,0.12694576,0.00022829311,0.0007055003,0.00018621709,0.00013705315,0.001766108,0.0027925612,0.015057119,0.85133404],"study_design_scores_gemma":[0.00028390842,0.0004329002,0.0052000694,0.13685405,0.0017631975,0.00800404,0.00051010353,0.00020919617,0.0010424248,0.004097019,0.84154534,0.000057733898],"about_ca_topic_score_codex":0.0010669926,"about_ca_topic_score_gemma":0.0026634801,"teacher_disagreement_score":0.0035416046,"about_ca_system_score_codex":0.0009430598,"about_ca_system_score_gemma":0.002722809,"threshold_uncertainty_score":0.011847913},"labels":[],"label_agreement":null},{"id":"W1993998711","doi":"10.2147/dddt.s19931","title":"Flavonoids targeting of IκB phosphorylation abrogates carcinogen-induced MMP-9 and COX-2 expression in human brain endothelial cells","year":2011,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Flavonoids in Medical Research","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Fonds Québécois de la Recherche sur la Nature et les Technologies","keywords":"Neuroinflammation; Phosphorylation; Signal transduction; Luteolin; Matrix metalloproteinase; Blood–brain barrier; Downregulation and upregulation; Chemistry; Cell biology; Pharmacology; Apigenin; Cancer research; Biochemistry; Biology; Inflammation; Immunology; Endocrinology; Flavonoid; Central nervous system","score_opus":0.07462496248851534,"score_gpt":0.3088408561781034,"score_spread":0.23421589368958806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993998711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99435824,0.0021507908,0.0018191882,0.00012783015,0.000046872687,0.000039407194,0.0002890119,0.00004917868,0.0011196326],"genre_scores_gemma":[0.9958098,0.0011156438,0.0010477974,0.000049763967,0.000015039653,0.00004528538,0.00034093097,0.000007532175,0.0015681747],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999348,0.000009225117,0.000006834179,0.000013381707,0.0000115398125,0.00002418739],"domain_scores_gemma":[0.99995697,0.00000692697,0.00001223164,0.000006446285,0.000005160403,0.000012315023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000101171114,0.0002933731,0.00019285941,0.00015397528,0.00010609569,0.00013655866,0.00013756593,0.00016144647,0.0016423607],"category_scores_gemma":[0.00008376496,0.000096024545,0.00022881452,0.000090427035,0.00015896115,0.00014747985,0.0000982863,0.00052017136,0.00026512437],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002599156,0.00009197473,0.00004911357,0.000037877722,0.0000048561083,0.00002101911,0.000009332833,0.000030530693,0.99840504,0.000029537061,0.00003613349,0.0010246007],"study_design_scores_gemma":[0.00006428095,0.0012182251,0.003965123,0.000010019929,0.000024094188,0.00017418951,0.000031124906,0.0005126049,0.9921142,0.000040526993,0.0018419306,0.0000036244778],"about_ca_topic_score_codex":0.00070692314,"about_ca_topic_score_gemma":0.0010037969,"teacher_disagreement_score":0.0016423607,"about_ca_system_score_codex":0.00014150159,"about_ca_system_score_gemma":0.00019813092,"threshold_uncertainty_score":0.0054941773},"labels":[],"label_agreement":null},{"id":"W1996090165","doi":"10.2147/dddt.s3255","title":"Surface activity of surfactant spiked with vitamin A","year":2008,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Neonatal Respiratory Health Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Pulmonary surfactant; Vitamin; Retinol; Retinyl acetate; Retinoic acid; Retinyl palmitate; Chemistry; Miscibility; Chromatography; Pharmacology; Medicine; Biochemistry; Organic chemistry","score_opus":0.08727916174307818,"score_gpt":0.3201511810938398,"score_spread":0.2328720193507616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996090165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946444,0.0012893202,0.0023508251,0.000039061157,0.000028327684,0.000025588854,0.00030239602,0.000038861406,0.0012811895],"genre_scores_gemma":[0.99487334,0.0005602193,0.0019592224,0.000025379537,0.000008895997,0.000021178697,0.00073545746,0.00001884596,0.0017975268],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996164,0.00008791498,0.000036741712,0.000069688685,0.00012816965,0.00006107665],"domain_scores_gemma":[0.9995177,0.00018101391,0.00005650555,0.000037799087,0.00017520777,0.000031899555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027490957,0.00034313786,0.00018803986,0.00037043073,0.00014605715,0.0003269936,0.00025087924,0.0004270499,0.0014137452],"category_scores_gemma":[0.0009718821,0.00010975415,0.00022774976,0.00029288293,0.00014954094,0.00023061245,0.00019127713,0.0002924577,0.0004425048],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035929907,0.000048742128,0.0012673485,0.0000480716,0.000019187048,0.000047333768,0.00004774379,0.00022644928,0.99445903,0.000041031915,0.000042966236,0.0033927008],"study_design_scores_gemma":[0.0000063484918,0.0005250009,0.0014978821,0.0000083346595,0.000015262753,0.000057784964,0.000043086904,0.0017133754,0.9955729,0.00002612598,0.0005298196,0.000004033554],"about_ca_topic_score_codex":0.0015284045,"about_ca_topic_score_gemma":0.0008276894,"teacher_disagreement_score":0.0015284045,"about_ca_system_score_codex":0.00020579675,"about_ca_system_score_gemma":0.00019642542,"threshold_uncertainty_score":0.00472939},"labels":[],"label_agreement":null},{"id":"W1999772350","doi":"10.2147/dddt.s32328","title":"New and emerging treatments for symptomatic tardive dyskinesia","year":2013,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Parks Canada; The Scarborough Hospital; Parkinson's Clinic of Eastern Toronto & Movement Disorders Centre; World Wildlife Fund Canada","funders":"","keywords":"Tardive dyskinesia; Tetrabenazine; Medicine; Levetiracetam; Pharmacology; Bioinformatics; Psychiatry; Dopamine; Internal medicine; Biology; Schizophrenia (object-oriented programming); Epilepsy","score_opus":0.06372742804327497,"score_gpt":0.32002404832385223,"score_spread":0.25629662028057726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999772350","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000111679634,0.9993349,0.00005484515,0.00006458444,0.000049614995,0.000006904582,0.000012551348,0.000003432526,0.00036152382],"genre_scores_gemma":[0.0006098035,0.99880445,0.00020615866,0.00010220456,0.000054160988,0.000011112662,0.000020106163,8.362258e-7,0.00019128519],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99973303,0.0000445213,0.000071850896,0.000042495492,0.00008815798,0.000019898915],"domain_scores_gemma":[0.999713,0.0001473093,0.00006314858,0.0000074693835,0.00005349082,0.00001555397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000540702,0.0010241083,0.0017075074,0.0040005823,0.0003352715,0.00078183605,0.0007170588,0.000944233,0.0048188404],"category_scores_gemma":[0.0006690115,0.0003029994,0.00093799405,0.0021569529,0.00034678067,0.0011331803,0.00052952237,0.0011162567,0.0012419228],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009098692,0.00011321001,0.00017799786,0.081618845,0.00022458118,0.00036612645,0.000085413594,0.00017545381,0.0019956501,0.0014046972,0.008912825,0.90483415],"study_design_scores_gemma":[0.00015384982,0.000493058,0.0036462834,0.04346753,0.0013989095,0.0067075333,0.0003147012,0.00020286207,0.0015979271,0.0028332146,0.9391298,0.00005430074],"about_ca_topic_score_codex":0.001022304,"about_ca_topic_score_gemma":0.002842361,"teacher_disagreement_score":0.0048188404,"about_ca_system_score_codex":0.0005233091,"about_ca_system_score_gemma":0.0010613878,"threshold_uncertainty_score":0.016120553},"labels":[],"label_agreement":null},{"id":"W2007084442","doi":"10.2147/dddt.s14071","title":"A Phase I study of an intravesically administered immunotoxin targeting EpCAM for the treatment of nonmuscle-invasive bladder cancer in BCG-refractory and BCG-intolerant patients","year":2010,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Viventia Bio (Canada)","funders":"","keywords":"Medicine; Tolerability; Refractory (planetary science); Adverse effect; Bladder cancer; Urology; Toxicity; Pharmacokinetics; Internal medicine; Maximum tolerated dose; Clinical endpoint; Gastroenterology; Surgery; Clinical trial; Cancer","score_opus":0.031168867441170423,"score_gpt":0.31676000066883975,"score_spread":0.2855911332276693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007084442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979032,0.00056577014,0.0003493338,0.00007848183,0.000024194136,0.00067157473,0.00010308994,0.000022965365,0.00028148424],"genre_scores_gemma":[0.9956802,0.0005341629,0.0013253476,0.00029400754,0.000055809724,0.00088890526,0.00050655904,0.000008940446,0.00070595666],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997546,0.00010242744,0.000013899256,0.000041487365,0.000024445235,0.00006308012],"domain_scores_gemma":[0.9995933,0.000056637797,0.00010107975,0.000037117985,0.00002448263,0.00018747698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008278279,0.00088197074,0.0011539991,0.00027755898,0.0002734006,0.0004951353,0.000690976,0.0008702231,0.0014791756],"category_scores_gemma":[0.00040377147,0.00036423415,0.00069694297,0.0002287591,0.00059565454,0.0003652467,0.00024320478,0.0017546229,0.00033954822],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3425482,0.11948181,0.018861951,0.0012809852,0.001211312,0.0007149052,0.000638657,0.004699083,0.34410393,0.00040261657,0.0019364208,0.16412014],"study_design_scores_gemma":[0.20307766,0.7559076,0.021056114,0.00003529758,0.00032473696,0.0005475279,0.000053235985,0.0013965184,0.015741218,0.000100245044,0.001736164,0.000023708613],"about_ca_topic_score_codex":0.00042275604,"about_ca_topic_score_gemma":0.0009065031,"teacher_disagreement_score":0.0014791756,"about_ca_system_score_codex":0.00051715045,"about_ca_system_score_gemma":0.000880608,"threshold_uncertainty_score":0.004948318},"labels":[],"label_agreement":null},{"id":"W2009241154","doi":"10.2147/dddt.s39100","title":"Clinical effectiveness and safety of montelukast in asthma. What are the conclusions from clinical trials and meta-analyses?","year":2014,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Montelukast; Asthma; Clinical trial; Meta-analysis; Medicine; MEDLINE; Intensive care medicine; Internal medicine","score_opus":0.40565417235875295,"score_gpt":0.5102049939172079,"score_spread":0.10455082155845491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009241154","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042846604,0.9988869,0.000115849456,0.00017719244,0.000114880284,0.000038672595,0.00008459528,0.0000045843776,0.00014883425],"genre_scores_gemma":[0.04008652,0.9564645,0.0011371481,0.0010922889,0.000467799,0.00022423656,0.00031175124,0.000016713493,0.00019900542],"study_design_codex":"meta_analysis","study_design_gemma":"systematic_review","domain_scores_codex":[0.98722446,0.0065734945,0.0035654495,0.0011406512,0.0012674439,0.0002285396],"domain_scores_gemma":[0.96174806,0.032320898,0.003511202,0.00073879986,0.0014199018,0.00026102035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01846908,0.002304849,0.01733922,0.003846576,0.00045750407,0.0037250146,0.002237854,0.0025701283,0.004980294],"category_scores_gemma":[0.041108828,0.0011511862,0.027036747,0.0042334925,0.0007417306,0.002438081,0.0012326743,0.0027132328,0.000400541],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004056737,0.00003998717,0.0026499112,0.44738993,0.4616207,0.00009881303,0.00007033331,0.0005518316,0.0002225373,0.000506546,0.0020666304,0.080726065],"study_design_scores_gemma":[0.001981988,0.00046660463,0.004748405,0.061469458,0.9182692,0.0002000795,0.00008067069,0.00033899397,0.00023692037,0.0014756689,0.010689639,0.000042349824],"about_ca_topic_score_codex":0.0023793527,"about_ca_topic_score_gemma":0.0046850923,"teacher_disagreement_score":0.01846908,"about_ca_system_score_codex":0.0018561321,"about_ca_system_score_gemma":0.001966815,"threshold_uncertainty_score":0.097675025},"labels":[],"label_agreement":null},{"id":"W2017282092","doi":"10.2147/dddt.s30342","title":"Potential role of rivaroxaban in patients with acute coronary syndrome","year":2012,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Rivaroxaban; Medicine; Dabigatran; Acute coronary syndrome; Apixaban; Clopidogrel; Warfarin; Aspirin; Myocardial infarction; Stroke (engine); Internal medicine; Ticagrelor; Cardiology; Atrial fibrillation","score_opus":0.047886802797551586,"score_gpt":0.28971310068247824,"score_spread":0.24182629788492666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017282092","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023437052,0.9915468,0.00011702097,0.0031372604,0.00039969964,0.000009194524,0.00006112506,0.0000064164383,0.0023787396],"genre_scores_gemma":[0.037927944,0.9563253,0.00052101584,0.0021275799,0.002179469,0.000043690652,0.00022839756,0.0000052586793,0.0006413548],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992618,0.00029017602,0.00015990433,0.00006763716,0.00018310494,0.000037434733],"domain_scores_gemma":[0.998941,0.00044613617,0.00032458507,0.000018884055,0.0001957154,0.000073597446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011347866,0.00034280372,0.0010614586,0.00068465597,0.00017642978,0.00095716177,0.00040907756,0.0006943945,0.0020824734],"category_scores_gemma":[0.004085021,0.00010841543,0.00089705683,0.00083392096,0.00017970592,0.0006381777,0.0003242253,0.0009812813,0.00051438215],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001328603,0.00017085228,0.01880709,0.014898854,0.0013046332,0.0015849533,0.00025718333,0.00023262114,0.0008380581,0.002314509,0.027363813,0.93089885],"study_design_scores_gemma":[0.0022767156,0.002496135,0.13764024,0.033765644,0.006952116,0.018466337,0.0008638624,0.00088088174,0.001351883,0.010158021,0.784944,0.0002041482],"about_ca_topic_score_codex":0.00061228464,"about_ca_topic_score_gemma":0.00089958654,"teacher_disagreement_score":0.0020824734,"about_ca_system_score_codex":0.000273207,"about_ca_system_score_gemma":0.000848206,"threshold_uncertainty_score":0.0069665313},"labels":[],"label_agreement":null},{"id":"W2020239218","doi":"10.2147/dddt.s3314","title":"Troglitazone reverses the multiple drug resistance phenotype in cancer cells","year":2009,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Troglitazone; Vorinostat; Doxorubicin; Downregulation and upregulation; Cancer research; Cancer cell; P-glycoprotein; Pharmacology; Multiple drug resistance; Histone deacetylase inhibitor; K562 cells; Cancer; Biology; Drug resistance; Medicine; Peroxisome proliferator-activated receptor; Histone deacetylase; Immunology; Receptor; Internal medicine; Histone; Chemotherapy; Leukemia; Biochemistry","score_opus":0.02539059993474002,"score_gpt":0.24942950304144082,"score_spread":0.2240389031067008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020239218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9675167,0.014328263,0.0064564124,0.001115593,0.00037621814,0.00021514416,0.0017740426,0.0017266164,0.0064909486],"genre_scores_gemma":[0.9775335,0.0076177623,0.004104436,0.0003625236,0.00005595863,0.00017746782,0.0020221213,0.00009327705,0.008033052],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983644,0.000027059952,0.000017963692,0.000033236636,0.000048002097,0.00003714571],"domain_scores_gemma":[0.9999038,0.00001399623,0.000024260704,0.00002315997,0.000016769916,0.000017868806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013788519,0.00048172983,0.0005951084,0.00042535772,0.00015880028,0.00027581822,0.0002776085,0.00034462017,0.0015682306],"category_scores_gemma":[0.00013071993,0.00019759135,0.00031418775,0.00036813522,0.00021486252,0.00017271856,0.0002298367,0.0013859445,0.000637095],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016526767,0.0000954048,0.00016831174,0.00011187926,0.00001405665,0.00007087807,0.000026435895,0.00010197297,0.99313897,0.00014894795,0.0004310338,0.005526701],"study_design_scores_gemma":[0.0001104822,0.0012432248,0.0042721773,0.000019747877,0.00002866167,0.00037584855,0.000037304228,0.0006155096,0.9772485,0.00008026499,0.015960041,0.000008301866],"about_ca_topic_score_codex":0.001274438,"about_ca_topic_score_gemma":0.0032372477,"teacher_disagreement_score":0.0015682306,"about_ca_system_score_codex":0.00030623577,"about_ca_system_score_gemma":0.0003692767,"threshold_uncertainty_score":0.005246222},"labels":[],"label_agreement":null},{"id":"W2028427382","doi":"10.2147/dddt.s10812","title":"Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease – a perspective","year":2010,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rosuvastatin; Medicine; C-reactive protein; Dyslipidemia; Rosuvastatin Calcium; Internal medicine; Statin; Risk factor; Disease; Inflammation; Asymptomatic; Cardiology","score_opus":0.045768458980056353,"score_gpt":0.300191932783629,"score_spread":0.25442347380357266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028427382","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024938988,0.9006672,0.00021309976,0.07799662,0.0151014775,0.000008810024,0.00009441358,0.000030839965,0.005638139],"genre_scores_gemma":[0.0036510315,0.9143484,0.0006068819,0.04021997,0.03214273,0.000022018125,0.00011721948,0.000009830704,0.008881852],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99945706,0.00015886147,0.0000469818,0.00008496635,0.00016986423,0.00008230596],"domain_scores_gemma":[0.9979665,0.0006766357,0.00014730403,0.000041180483,0.0007191723,0.000449268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013894273,0.00063894293,0.000865277,0.0013469901,0.0006310443,0.0023423957,0.000759549,0.003888063,0.009911236],"category_scores_gemma":[0.0022100643,0.00022211183,0.00083200657,0.00089109194,0.00080901355,0.00232782,0.000880947,0.007754844,0.0025757123],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031833103,0.00018274706,0.00067952607,0.003349106,0.000120606564,0.00021896565,0.00010533607,0.00017115456,0.0006447738,0.019992067,0.4944575,0.47976],"study_design_scores_gemma":[0.00007812247,0.00021948805,0.0013073623,0.0024143087,0.000073120726,0.00030166944,0.00013140909,0.00010344366,0.000085981774,0.005733491,0.98953396,0.00001760642],"about_ca_topic_score_codex":0.004685953,"about_ca_topic_score_gemma":0.013160142,"teacher_disagreement_score":0.009911236,"about_ca_system_score_codex":0.001911197,"about_ca_system_score_gemma":0.0029667825,"threshold_uncertainty_score":0.033156395},"labels":[],"label_agreement":null},{"id":"W2034838201","doi":"10.2147/dddt.s77597","title":"Noncoding RNAs as potential biomarkers to predict the outcome in pancreatic cancer","year":2015,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"","keywords":"microRNA; Pancreatic cancer; Long non-coding RNA; Non-coding RNA; Pancreatic ductal adenocarcinoma; Bioinformatics; RNA; Biology; Computational biology; Biomarker; Cancer; Gene; Genetics","score_opus":0.06433265195639923,"score_gpt":0.35616491162870595,"score_spread":0.29183225967230675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034838201","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016111824,0.9987503,0.00015403406,0.00026244493,0.00012408422,0.0000036628312,0.00001770712,0.000005847385,0.00052077154],"genre_scores_gemma":[0.0010345904,0.99819654,0.00021025496,0.0001443714,0.00009247174,0.0000059833606,0.00002889315,0.0000011029485,0.00028575427],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999783,0.000045919598,0.00003561213,0.00004012205,0.00007677058,0.000018589184],"domain_scores_gemma":[0.99966574,0.00018422716,0.00004094114,0.0000082137085,0.00008126068,0.000019546786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064984435,0.00070201315,0.0013316821,0.0019067117,0.00019966229,0.0008101803,0.00070402375,0.0009684653,0.0017510017],"category_scores_gemma":[0.00094495347,0.00023079349,0.0006055364,0.001306126,0.00038685772,0.0009074918,0.0005242887,0.0016255791,0.0010079214],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000096208714,0.000078526864,0.0007517694,0.012803257,0.00018301295,0.00023978607,0.000058569414,0.00040566426,0.002281086,0.0031100495,0.014785511,0.9652065],"study_design_scores_gemma":[0.00003106437,0.00025613082,0.0031705473,0.006085143,0.00039320553,0.002481879,0.00009940324,0.00031688166,0.0018523345,0.0037265215,0.9815377,0.000049084294],"about_ca_topic_score_codex":0.00065929093,"about_ca_topic_score_gemma":0.0012007819,"teacher_disagreement_score":0.0019067117,"about_ca_system_score_codex":0.00058469054,"about_ca_system_score_gemma":0.00077191636,"threshold_uncertainty_score":0.005857706},"labels":[],"label_agreement":null},{"id":"W2043889318","doi":"10.2147/dddt.s49778","title":"Profile of epratuzumab and its potential in the treatment of systemic lupus erythematosus","year":2014,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"University of Toronto; University Health Network","keywords":"Medicine; Lupus erythematosus; Systemic disease; Immunology; Dermatology; Immunopathology; Antibody","score_opus":0.06197174375582932,"score_gpt":0.3249779138467009,"score_spread":0.26300617009087157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043889318","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014972963,0.9991026,0.00004252251,0.00008188718,0.00004232568,0.0000039745805,0.000010292421,0.0000028136708,0.00056400325],"genre_scores_gemma":[0.00070641993,0.9988248,0.000096203345,0.00008214869,0.000042057156,0.000004697234,0.000015961954,5.991767e-7,0.00022718003],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99979717,0.00003816068,0.00003436399,0.00003062807,0.00008388071,0.000015805996],"domain_scores_gemma":[0.9998005,0.00009427909,0.000036512884,0.00000456353,0.000046584864,0.000017590713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005283157,0.0006444114,0.001446286,0.0028039627,0.00022305262,0.0007965117,0.0006937449,0.00084456353,0.0031994146],"category_scores_gemma":[0.00054581376,0.00025035665,0.000682205,0.0024824277,0.00026431796,0.0007784038,0.0004922135,0.0012627208,0.0012187231],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013960934,0.00007944807,0.00015784788,0.041267317,0.00019217975,0.00031630407,0.00008098029,0.0003825205,0.002320393,0.0023289805,0.014045048,0.9386894],"study_design_scores_gemma":[0.000069624395,0.00020690223,0.0015323256,0.010165081,0.000415799,0.0028063303,0.00006972952,0.00013655293,0.0009515515,0.0014894005,0.9821322,0.000024440345],"about_ca_topic_score_codex":0.0009019828,"about_ca_topic_score_gemma":0.0016600736,"teacher_disagreement_score":0.0031994146,"about_ca_system_score_codex":0.0005092783,"about_ca_system_score_gemma":0.0008432384,"threshold_uncertainty_score":0.010703146},"labels":[],"label_agreement":null},{"id":"W2050653904","doi":"10.2147/dddt.s46289","title":"Open-source approaches for the repurposing of existing or failed candidate drugs: learning from and applying the lessons across diseases","year":2013,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Repurposing; Drug repositioning; Drug development; Intellectual property; Data sharing; Drug discovery; Computer science; Variety (cybernetics); Knowledge management; Data science; Business; Medicine; Drug; Pharmacology; Bioinformatics; Engineering; Biology; Alternative medicine; Artificial intelligence","score_opus":0.23991502315300325,"score_gpt":0.3708165682158213,"score_spread":0.13090154506281806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050653904","genre_codex":"methods","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009288814,0.16669184,0.6321673,0.058247745,0.003317945,0.0010229059,0.00071630883,0.002636317,0.12591091],"genre_scores_gemma":[0.13752571,0.27344853,0.5433602,0.012619355,0.002032777,0.0019244893,0.0019350632,0.0011918304,0.025962166],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9898149,0.0050377008,0.0007099535,0.0008668326,0.0030287101,0.00054191897],"domain_scores_gemma":[0.96569866,0.02203537,0.002689272,0.0046666074,0.0034075256,0.0015025175],"candidate_categories":["open_science"],"consensus_categories":[],"category_scores_codex":[0.024433397,0.0013235927,0.0014312562,0.0036571212,0.0018703234,0.009269366,0.0040993765,0.0036220741,0.009708082],"category_scores_gemma":[0.027256357,0.00067617884,0.0021342826,0.0035025894,0.0069139707,0.0116914725,0.011227995,0.007881948,0.0037180893],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018876788,0.00024987978,0.0012973043,0.008598376,0.00023982591,0.00097299996,0.002916302,0.0047168983,0.00688272,0.40942374,0.021572372,0.54294074],"study_design_scores_gemma":[0.00006250382,0.00024049307,0.00062482693,0.0046062297,0.00013476216,0.0010764659,0.0013759689,0.002833131,0.007033189,0.27619165,0.70573145,0.000089272115],"about_ca_topic_score_codex":0.001017548,"about_ca_topic_score_gemma":0.001964296,"teacher_disagreement_score":0.99590063,"about_ca_system_score_codex":0.002699105,"about_ca_system_score_gemma":0.009665892,"threshold_uncertainty_score":0.12921768},"labels":[],"label_agreement":null},{"id":"W2054633103","doi":"10.2147/dddt.s81524","title":"Efficacy and safety of cross-linked hyaluronic acid single injection on osteoarthritis of the knee: a post-marketing phase IV study","year":2015,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Viscosupplementation; Osteoarthritis; Hyaluronic acid; Confidence interval; Physical therapy; Orthopedic surgery; Surgery; Internal medicine; Alternative medicine; Intra articular","score_opus":0.0388719649710327,"score_gpt":0.2907197675178046,"score_spread":0.2518478025467719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054633103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963748,0.0010876613,0.00039698163,0.000059668473,0.00003591141,0.0013298786,0.0002475252,0.00003070828,0.0004370335],"genre_scores_gemma":[0.99273384,0.0014276495,0.0013359501,0.00021741937,0.00015266713,0.0015680306,0.00059014827,0.000016293752,0.001958042],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99907434,0.0004699636,0.0000643565,0.00009309287,0.00015633985,0.0001418755],"domain_scores_gemma":[0.9983209,0.00045005584,0.0005942154,0.00012445552,0.00023028995,0.0002800618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020138007,0.0008935009,0.0014838976,0.00040444254,0.0003474566,0.00064478064,0.00074024353,0.00091258856,0.002816936],"category_scores_gemma":[0.0015087359,0.000300918,0.0009854471,0.00034306754,0.0005618862,0.0005394418,0.00023026597,0.0013892376,0.00048306194],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5414248,0.21013549,0.01193209,0.0025098668,0.0018405368,0.00041049108,0.0005869349,0.0011302354,0.083999805,0.00014099608,0.0013084168,0.14458023],"study_design_scores_gemma":[0.09152102,0.87706524,0.01849995,0.000056863846,0.00036338327,0.00017710747,0.00007398896,0.0004003721,0.0104914,0.000042644573,0.0012855614,0.000022476506],"about_ca_topic_score_codex":0.00031991315,"about_ca_topic_score_gemma":0.0005249795,"teacher_disagreement_score":0.002816936,"about_ca_system_score_codex":0.00045212643,"about_ca_system_score_gemma":0.0008563477,"threshold_uncertainty_score":0.010650158},"labels":[],"label_agreement":null},{"id":"W2055943571","doi":"10.2147/dddt.s40032","title":"Does fesoterodine have a role in the treatment of poorly managed patients with overactive bladder?","year":2014,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Overactive bladder; Tolterodine; Nocturia; Medicine; Polypharmacy; Urinary urgency; Urology; Urinary incontinence; Quality of life (healthcare); Urinary system; Intensive care medicine; Internal medicine; Alternative medicine; Nursing","score_opus":0.04019319151786374,"score_gpt":0.3116987007777201,"score_spread":0.2715055092598564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055943571","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011813639,0.9992403,0.0000303856,0.00020528882,0.00006788281,0.0000023350108,0.000008052381,0.0000018175547,0.0003257079],"genre_scores_gemma":[0.0008596348,0.99858814,0.00009060721,0.00018404172,0.00008327012,0.0000036960248,0.000013472237,6.3610145e-7,0.00017656568],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998405,0.00003659802,0.000033944223,0.000025594798,0.000051637227,0.000011695355],"domain_scores_gemma":[0.99966145,0.00020663367,0.000055011293,0.0000060604393,0.000051206574,0.000019569457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060945074,0.00038210757,0.0013249007,0.0012957131,0.00018764778,0.0007074747,0.0006477343,0.0010208382,0.0033466425],"category_scores_gemma":[0.0010423631,0.00017696184,0.000549248,0.0011116549,0.0003197284,0.0008434738,0.0003556006,0.001178535,0.0010474505],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015283746,0.000056784407,0.00020010884,0.02748802,0.00017393452,0.00019216658,0.000063606065,0.00013962695,0.00076400297,0.001386934,0.009942934,0.9594391],"study_design_scores_gemma":[0.00018482408,0.0004355148,0.0025663134,0.022317315,0.000675807,0.0036317017,0.00019763935,0.00015958044,0.0005758244,0.0018595553,0.9673601,0.000035935525],"about_ca_topic_score_codex":0.00089305505,"about_ca_topic_score_gemma":0.0022120513,"teacher_disagreement_score":0.0033466425,"about_ca_system_score_codex":0.0002806441,"about_ca_system_score_gemma":0.0006765669,"threshold_uncertainty_score":0.01119566},"labels":[],"label_agreement":null},{"id":"W2059050231","doi":"10.2147/dddt.s71352","title":"Development of polyether urethane intravaginal rings for the sustained delivery of hydroxychloroquine","year":2014,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Canadian Institutes of Health Research; Aerospace Center Hospital; Manitoba Health Research Council; Bill and Melinda Gates Foundation","keywords":"Hydroxychloroquine; Medicine; Pharmacology; Internal medicine; Coronavirus disease 2019 (COVID-19)","score_opus":0.021532386069187212,"score_gpt":0.25029089587023373,"score_spread":0.2287585098010465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059050231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9472317,0.009789408,0.039415795,0.00012525904,0.00010745983,0.00021968497,0.00021484353,0.00035435244,0.0025415057],"genre_scores_gemma":[0.9679363,0.002118402,0.027490135,0.00003690984,0.000019527268,0.00007031973,0.00011792263,0.000024263916,0.0021861969],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998288,0.00003098084,0.00001327934,0.00003886761,0.00006254142,0.000025474688],"domain_scores_gemma":[0.9998241,0.00003280187,0.0000824344,0.000021504236,0.000022651782,0.000016509408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022494442,0.00022745873,0.00016712524,0.00014033793,0.00007120114,0.00029601413,0.00026992324,0.00034359845,0.00045040398],"category_scores_gemma":[0.00024037936,0.00014686771,0.00021526095,0.000069074325,0.00014295134,0.00023180064,0.00015350735,0.0002478217,0.00023561856],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025468657,0.000014642236,0.000051376177,0.000048172216,0.00000264091,0.000047645877,0.00000959841,0.00011451822,0.9962488,0.00005855426,0.000021554244,0.0033571068],"study_design_scores_gemma":[0.000016481976,0.0007585165,0.001197627,0.000008201905,0.0000133781205,0.00026122332,0.000010740696,0.0016974068,0.99213237,0.000012358293,0.0038823122,0.000009521221],"about_ca_topic_score_codex":0.00020151307,"about_ca_topic_score_gemma":0.0003304191,"teacher_disagreement_score":0.00045040398,"about_ca_system_score_codex":0.00013047822,"about_ca_system_score_gemma":0.00013255517,"threshold_uncertainty_score":0.0015067458},"labels":[],"label_agreement":null},{"id":"W2085903398","doi":"10.2147/dddt.s67349","title":"Microencapsulation as a novel delivery method for the potential antidiabetic drug, Probucol","year":2014,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Advanced Drug Delivery Systems","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Curtin Health Innovation Research Institute, Curtin University; Curtin University of Technology","keywords":"Dispersity; Transdermal; Thixotropy; Drug delivery; Materials science; Probucol; Zeta potential; Polymer; Thermal analysis; Chemical engineering; Chromatography; Chemistry; Biomedical engineering; Nanotechnology; Pharmacology; Nanoparticle; Antioxidant; Organic chemistry; Polymer chemistry; Medicine; Thermal; Composite material","score_opus":0.08454579430934943,"score_gpt":0.38115576021509545,"score_spread":0.296609965905746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085903398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8714954,0.020027008,0.104305856,0.00035102674,0.00026309377,0.00024569128,0.00017914028,0.00035730348,0.0027754365],"genre_scores_gemma":[0.93312424,0.0061052693,0.057008307,0.00013060414,0.00006824551,0.00012494394,0.00011460166,0.00004459251,0.0032791963],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983823,0.000017833076,0.000011582026,0.00005816018,0.00005686174,0.000017306877],"domain_scores_gemma":[0.9999013,0.000020868158,0.000034549234,0.000008800544,0.00002331357,0.000011112714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017930334,0.00046836672,0.00026370405,0.00027061818,0.00015043725,0.00022460453,0.0001893056,0.0002860536,0.00047699173],"category_scores_gemma":[0.00018440648,0.00014233275,0.0002732143,0.00011755343,0.0002731148,0.00029897573,0.0002022048,0.0003542352,0.00022107993],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024997902,0.0000148459085,0.000064678745,0.000099031495,0.000008197587,0.00006257941,0.00001642313,0.0001819435,0.99391246,0.00009990316,0.0000350145,0.0054799505],"study_design_scores_gemma":[0.000006202484,0.00016532632,0.00045506755,0.000008635656,0.00001935324,0.00024725083,0.0000056187014,0.00103494,0.9951983,0.000019984416,0.0028330488,0.0000064033097],"about_ca_topic_score_codex":0.0005207041,"about_ca_topic_score_gemma":0.00073114823,"teacher_disagreement_score":0.0005207041,"about_ca_system_score_codex":0.00035635827,"about_ca_system_score_gemma":0.00020820246,"threshold_uncertainty_score":0.00258559},"labels":[],"label_agreement":null},{"id":"W2086247967","doi":"10.2147/dddt.s36984","title":"The biology of PCSK9 from the endoplasmic reticulum to lysosomes: new and emerging therapeutics to control low-density lipoprotein cholesterol","year":2013,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Canadian Institutes of Health Research; Institut de Cardiologie de Montréal; Fondation Institut de Cardiologie de Montréal; Heart and Stroke Foundation of Canada","keywords":"PCSK9; LDL receptor; Kexin; Proprotein convertase; Cholesterol; Lipoprotein; Low-density lipoprotein; Endocrinology; Medicine; Internal medicine; Pharmacology; Biology","score_opus":0.0452173383743127,"score_gpt":0.2978546919823394,"score_spread":0.2526373536080267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086247967","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001988003,0.9982705,0.00015971188,0.00029079334,0.00021895017,0.0000039999795,0.000011326355,0.000008899888,0.0008369682],"genre_scores_gemma":[0.00046696138,0.9986376,0.00016154222,0.00011677537,0.00011365806,0.00000397986,0.00001417646,9.823517e-7,0.0004843654],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99987197,0.000017861832,0.000020281088,0.00001937157,0.000057242192,0.00001328265],"domain_scores_gemma":[0.9998877,0.000039880648,0.000016980513,0.0000044356602,0.000035990488,0.0000150987935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003319682,0.000665775,0.0011511573,0.0018176395,0.0002564875,0.0007041328,0.0005303005,0.0008232606,0.0018941632],"category_scores_gemma":[0.00031273594,0.0002535714,0.00039117195,0.0016529111,0.00037283258,0.0011701927,0.00056989375,0.0015294921,0.0019318829],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000087849105,0.00009513947,0.0001614232,0.013765528,0.000085580505,0.0002948831,0.00006835968,0.00032237152,0.004433412,0.0038251749,0.029451031,0.9474093],"study_design_scores_gemma":[0.000025886,0.00009314682,0.00083080574,0.001760959,0.00007294316,0.0015711228,0.00004843628,0.00011022139,0.0006822535,0.0016474525,0.99313945,0.00001742122],"about_ca_topic_score_codex":0.0006522571,"about_ca_topic_score_gemma":0.0012843283,"teacher_disagreement_score":0.0018941632,"about_ca_system_score_codex":0.0004840751,"about_ca_system_score_gemma":0.00076849724,"threshold_uncertainty_score":0.0063366294},"labels":[],"label_agreement":null},{"id":"W2101968968","doi":"10.2147/dddt.s70299","title":"Differential benefit risk assessment of DOACs in the treatment of venous thromboembolism: focus on dabigatran","year":2015,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Dabigatran; Medicine; Apixaban; Rivaroxaban; Edoxaban; Intensive care medicine; Direct thrombin inhibitor; Dosing; Warfarin; Atrial fibrillation; Pharmacology; Internal medicine","score_opus":0.09982856678948611,"score_gpt":0.3585364966659736,"score_spread":0.2587079298764875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101968968","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17145443,0.54679084,0.067533016,0.055419806,0.0028255202,0.0012647377,0.006833992,0.0003376417,0.14753999],"genre_scores_gemma":[0.8062096,0.10885731,0.043532327,0.013606311,0.010642291,0.00082309626,0.0038163825,0.00023717791,0.012275449],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99409276,0.0034338657,0.0005389048,0.00041280923,0.0013740502,0.00014749181],"domain_scores_gemma":[0.984914,0.0115827145,0.0012328406,0.00040607745,0.0014326886,0.0004317331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0074374704,0.0008143321,0.0014375555,0.0017503701,0.00025279674,0.0025354745,0.00057703286,0.0011606595,0.010673421],"category_scores_gemma":[0.024746964,0.0002431997,0.002186193,0.0009976798,0.0005650147,0.0011146432,0.0011376343,0.0025761337,0.0013090189],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007302504,0.00032895524,0.058394138,0.007992009,0.0064637153,0.0009597547,0.00036235186,0.0039497395,0.0033182073,0.030833578,0.03571499,0.8443801],"study_design_scores_gemma":[0.004624363,0.008758669,0.2201122,0.02129467,0.024514033,0.016658911,0.0010308715,0.026211133,0.010067172,0.15969828,0.5066058,0.00042382398],"about_ca_topic_score_codex":0.00087025046,"about_ca_topic_score_gemma":0.0011040121,"teacher_disagreement_score":0.010673421,"about_ca_system_score_codex":0.0010147643,"about_ca_system_score_gemma":0.0010933903,"threshold_uncertainty_score":0.039333582},"labels":[],"label_agreement":null},{"id":"W2112867551","doi":"10.2147/dddt.s90580","title":"Maraviroc: a review of its use in HIV infection and beyond","year":2015,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":205,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute of Mental Health","keywords":"Maraviroc; CCR5 receptor antagonist; Medicine; Chemokine receptor CCR5; CXCR4; Drug resistance; Chemokine receptor; Entry inhibitor; Pharmacology; Boswellia serrata; Drug; Viral load; Virology; Viral entry; Immunology; Human immunodeficiency virus (HIV); Internal medicine; Virus; Chemokine; Biology; Viral replication; Receptor; Microbiology","score_opus":0.09617880986677699,"score_gpt":0.3299175114230901,"score_spread":0.23373870155631313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112867551","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016397418,0.99806577,0.00010156998,0.0002344438,0.00036071864,0.00000920115,0.000030511994,0.0000070151627,0.001026952],"genre_scores_gemma":[0.00060514436,0.9980605,0.00018063697,0.00028314363,0.0003336155,0.000011683211,0.00004554704,0.0000023468926,0.00047736443],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996983,0.00006892751,0.00006189438,0.000050355015,0.00009425524,0.00002635199],"domain_scores_gemma":[0.9996728,0.00015845358,0.000053390966,0.00001056927,0.000074989344,0.000029860865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062749354,0.0008287457,0.0014232241,0.0020181013,0.00029704403,0.0011846782,0.00077935046,0.0009265044,0.0045279395],"category_scores_gemma":[0.00087906164,0.0002795724,0.00075581676,0.0018810647,0.00035160634,0.0013038035,0.0006108907,0.0016951011,0.0020725923],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013659688,0.00008737324,0.00015992715,0.021100724,0.000091119146,0.00022950623,0.00009006058,0.00032195065,0.0013695194,0.0024068179,0.036210507,0.9377958],"study_design_scores_gemma":[0.000024363395,0.0001796063,0.00056579884,0.0051590763,0.00012331852,0.0013225345,0.00004504637,0.0000855821,0.0002838097,0.0008673646,0.9913224,0.000021159956],"about_ca_topic_score_codex":0.0008783483,"about_ca_topic_score_gemma":0.0013863959,"teacher_disagreement_score":0.0045279395,"about_ca_system_score_codex":0.0004283132,"about_ca_system_score_gemma":0.00093516975,"threshold_uncertainty_score":0.015147448},"labels":[],"label_agreement":null},{"id":"W2116491845","doi":"10.2147/dddt.s90170","title":"Therapeutic designed poly (lactic-co-glycolic acid) cylindrical oseltamivir phosphate-loaded implants impede tumor neovascularization, growth and metastasis in mouse model of human pancreatic carcinoma","year":2015,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"PLGA; Neovascularization; Pancreatic cancer; Metastasis; Cancer research; Irinotecan; Medicine; In vivo; Angiogenesis; Pharmacology; Colorectal cancer; Pathology; Chemistry; In vitro; Cancer; Internal medicine; Biology; Biochemistry","score_opus":0.04500067962431849,"score_gpt":0.28329784147999193,"score_spread":0.23829716185567346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116491845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960592,0.00067196065,0.0022314452,0.0000525789,0.000044958277,0.00008121026,0.00021807839,0.00008048128,0.0005601019],"genre_scores_gemma":[0.99114734,0.0008213593,0.004801247,0.000035342862,0.000016509008,0.00016155308,0.00027599005,0.00002586716,0.002714825],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998468,0.000013483816,0.0000126757295,0.000032344233,0.00004976365,0.000044818884],"domain_scores_gemma":[0.9999101,0.000013418167,0.0000330704,0.000009312558,0.000007281346,0.00002681831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015541715,0.00045528272,0.00033460476,0.00027295444,0.00008217791,0.00029649993,0.00023490883,0.00043255623,0.00070157746],"category_scores_gemma":[0.00009318049,0.00020981306,0.00025909723,0.0001397297,0.00022479735,0.00029525085,0.00011879466,0.0006912164,0.0001701686],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024318058,0.00013931563,0.000055794502,0.000023123015,0.000002805603,0.000025086394,0.000010183139,0.00011694835,0.9983997,0.00005275102,0.000016406182,0.0009146922],"study_design_scores_gemma":[0.000040986044,0.001964132,0.000879951,0.0000047123094,0.0000171703,0.00007853093,0.00001228332,0.001466302,0.9947371,0.000025076784,0.0007689521,0.0000046664345],"about_ca_topic_score_codex":0.00044991504,"about_ca_topic_score_gemma":0.0005820625,"teacher_disagreement_score":0.00070157746,"about_ca_system_score_codex":0.00021086959,"about_ca_system_score_gemma":0.0002977841,"threshold_uncertainty_score":0.0023469925},"labels":[],"label_agreement":null},{"id":"W2126469018","doi":"10.2147/dddt.s65396","title":"Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: a characterization study","year":2014,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Curtin University of Technology","keywords":"Gliclazide; Deoxycholic acid; Thixotropy; Chromatography; Chemistry; Pharmacokinetics; Permeation; Pharmacology; Bile acid; Materials science; Insulin; Biochemistry; Medicine; Membrane","score_opus":0.05547251103098966,"score_gpt":0.2617466584976248,"score_spread":0.20627414746663514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126469018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851376,0.002618444,0.010683047,0.00006269048,0.00007041721,0.00010068597,0.00024815032,0.00006944534,0.0010095336],"genre_scores_gemma":[0.98401374,0.0014175553,0.012619901,0.000034201483,0.000013256619,0.00009160825,0.00019554298,0.00001910625,0.0015951301],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990976,0.000007969051,0.000010946113,0.0000308743,0.000026448513,0.000013972042],"domain_scores_gemma":[0.9999002,0.000019973602,0.000025279936,0.000009974775,0.000025106661,0.000019400963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016759617,0.00030201132,0.00029037613,0.00017173342,0.00010794235,0.00025480616,0.0001749549,0.00029168886,0.00028903328],"category_scores_gemma":[0.00014949974,0.00009571865,0.00023427336,0.00016318345,0.00015964668,0.0001923529,0.00011858098,0.00024052382,0.0001887044],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027679927,0.000014634786,0.00006222528,0.000040689963,0.000004147784,0.000032094,0.000019922201,0.00012767116,0.9982539,0.000030089976,0.00001198937,0.0013748804],"study_design_scores_gemma":[0.000003993426,0.00017572593,0.0008467837,0.0000037798975,0.000012982443,0.00005917849,0.00000864442,0.0009183396,0.9968593,0.000006738923,0.0010990137,0.000005403229],"about_ca_topic_score_codex":0.000833411,"about_ca_topic_score_gemma":0.00091181404,"teacher_disagreement_score":0.000833411,"about_ca_system_score_codex":0.00022259945,"about_ca_system_score_gemma":0.00014437229,"threshold_uncertainty_score":0.0016570687},"labels":[],"label_agreement":null},{"id":"W2156954694","doi":"10.2147/dddt.s89338","title":"A novel small-molecule inhibitor of HIV-1 entry","year":2015,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of California, San Francisco; McGill University","keywords":"Human immunodeficiency virus (HIV); Small molecule; Drug; Drug resistance; Antiretroviral therapy; ANTIRETROVIRAL AGENTS; Pharmacology; Lentivirus; Medicine; Virology; Chemistry; Viral load; Biology; Viral disease; Biochemistry; Microbiology","score_opus":0.0504161142988806,"score_gpt":0.25327954943224573,"score_spread":0.20286343513336513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156954694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9305273,0.030034492,0.0070728622,0.00081045844,0.000358065,0.00052837597,0.0017455448,0.00048783017,0.028435042],"genre_scores_gemma":[0.9335199,0.0240169,0.0118354075,0.00068171945,0.00014728011,0.00022945178,0.0041391538,0.000030238729,0.025400074],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99995136,0.0000041887097,0.0000047083795,0.000010990774,0.00001609749,0.000012710842],"domain_scores_gemma":[0.99997413,0.0000032751223,0.000004929974,0.000001780198,0.000003818416,0.000012160319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009158356,0.00049795816,0.00036158643,0.00020539666,0.00013926045,0.0002265389,0.00043409405,0.00028800202,0.0035598543],"category_scores_gemma":[0.00008028123,0.000104972125,0.00020214813,0.00016907767,0.00014807378,0.00021280453,0.0002735508,0.0005034018,0.0012164812],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001032761,0.00044015175,0.0006188531,0.00078381546,0.000026232754,0.0008708903,0.00006435425,0.0008852681,0.905426,0.0012809513,0.0019425583,0.08662824],"study_design_scores_gemma":[0.005413638,0.023317927,0.013939313,0.00030767827,0.00026258305,0.01304632,0.00009743438,0.006281215,0.79075253,0.0013158427,0.14518428,0.00008120554],"about_ca_topic_score_codex":0.00041137272,"about_ca_topic_score_gemma":0.0009344558,"teacher_disagreement_score":0.0035598543,"about_ca_system_score_codex":0.00021516904,"about_ca_system_score_gemma":0.00029626032,"threshold_uncertainty_score":0.011908889},"labels":[],"label_agreement":null},{"id":"W2165775264","doi":"10.2147/dddt.s88473","title":"Pain relief and improved physical function in knee osteoarthritis patients receiving ongoing hylan G-F 20, a high-molecular-weight hyaluronan, versus other treatment options: data from a large real-world longitudinal cohort in Canada","year":2015,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sanofi (Canada); Lawson Health Research Institute; Western University","funders":"Sanofi; Amgen","keywords":"Medicine; Osteoarthritis; Visual analogue scale; Viscosupplementation; Cohort; Physical therapy; Internal medicine; Intra articular","score_opus":0.03046307116537179,"score_gpt":0.24608155390389141,"score_spread":0.21561848273851963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165775264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968195,0.0005990769,0.000019209916,0.00008507282,0.0000044839135,0.000019150468,0.0021258767,0.0000018552607,0.0003257575],"genre_scores_gemma":[0.99747866,0.0003128167,0.000048328886,0.00009131857,0.000006688179,0.000013772075,0.0018494924,0.0000014568652,0.00019756498],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989982,0.0001331843,0.000087842185,0.0001954647,0.00031305224,0.00027219363],"domain_scores_gemma":[0.9977785,0.00016837228,0.00088335894,0.00009589475,0.0005797241,0.00049411866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007362794,0.0002592319,0.0005790642,0.00050824153,0.0009727942,0.0010520442,0.0008175973,0.0005690091,0.00079955923],"category_scores_gemma":[0.002646673,0.00027011835,0.0007724149,0.0018467148,0.00054018013,0.0003782409,0.00048541004,0.0007038316,0.0001419102],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036421596,0.000043656175,0.9981856,0.000015823616,0.00008500762,0.00003969625,0.00011126942,0.00002848262,0.00011357672,0.0000074526533,0.00022749888,0.0007777175],"study_design_scores_gemma":[0.000035015823,0.00006611959,0.9993449,0.000007806041,0.00003891354,0.000045305154,0.00016852969,0.00008963186,0.00001974274,0.000004007841,0.0001749446,0.0000050782714],"about_ca_topic_score_codex":0.8374884,"about_ca_topic_score_gemma":0.878609,"teacher_disagreement_score":0.16251159,"about_ca_system_score_codex":0.007077364,"about_ca_system_score_gemma":0.005919876,"threshold_uncertainty_score":0.32693726},"labels":[],"label_agreement":null},{"id":"W2299034615","doi":"10.2147/dddt.s98323","title":"Computational and nonglycosylated systems: a simpler approach for development of nanosized PEGylated proteins","year":2016,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Tech University","funders":"","keywords":"Computational biology; Computer science; Bioinformatics; Chemistry; Biology","score_opus":0.036646402415503355,"score_gpt":0.27236581205005983,"score_spread":0.23571940963455648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2299034615","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.48415545,0.0011946333,0.49967834,0.00036543942,0.00013128121,0.00024738943,0.0006045787,0.0012186596,0.01240415],"genre_scores_gemma":[0.7671686,0.0011677764,0.22681957,0.00012241908,0.000016814534,0.0002693658,0.001012658,0.00026197266,0.0031608497],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989724,0.00001892098,0.0000074379664,0.000030769683,0.000035448124,0.000010242353],"domain_scores_gemma":[0.99993074,0.000019753446,0.00001289332,0.000015309357,0.00001473909,0.0000065508943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023017266,0.0003567932,0.00039892146,0.00013739865,0.00015479274,0.00043239899,0.00040767103,0.0003768458,0.0015394966],"category_scores_gemma":[0.0003781567,0.00021446875,0.0003850631,0.0001438984,0.0001812331,0.0005041634,0.00026564585,0.0005771588,0.00047301783],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018607438,0.00019670886,0.0017133313,0.0006059643,0.00008309469,0.00022770671,0.00008644173,0.17984171,0.7672101,0.015091989,0.0008580172,0.03389873],"study_design_scores_gemma":[0.00006245993,0.00058848195,0.0013135328,0.000029034822,0.000068996014,0.0002571434,0.000046586927,0.61278033,0.35800698,0.004021228,0.02278243,0.000042795604],"about_ca_topic_score_codex":0.00062952214,"about_ca_topic_score_gemma":0.0006337237,"teacher_disagreement_score":0.0015394966,"about_ca_system_score_codex":0.00033534245,"about_ca_system_score_gemma":0.00035716756,"threshold_uncertainty_score":0.0051501393},"labels":[],"label_agreement":null},{"id":"W2464934251","doi":"10.2147/dddt.s106802","title":"Clinical implications for substandard, nonproprietary medicines in multiple sclerosis: focus on fingolimod","year":2016,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada)","funders":"Novartis Pharma; World Health Organization","keywords":"Fingolimod; Medicine; Food and drug administration; Marketing authorization; Quality (philosophy); Authorization; Good manufacturing practice; Documentation; Agency (philosophy); Bioequivalence; Pharmacy; Risk analysis (engineering); Intensive care medicine; Business; Family medicine; Multiple sclerosis; Pharmacology; Marketing; Computer security; Bioinformatics; Computer science","score_opus":0.3702865754020696,"score_gpt":0.3829632242045164,"score_spread":0.012676648802446788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2464934251","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005338408,0.6629687,0.0030957123,0.28831285,0.0050987075,0.000071152666,0.00006907379,0.00010825199,0.03493715],"genre_scores_gemma":[0.08976526,0.7104835,0.009071064,0.13457239,0.03393085,0.00013444509,0.00012567553,0.00009272487,0.021824202],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99740833,0.0010449094,0.00025346183,0.00020512576,0.0009501777,0.00013803036],"domain_scores_gemma":[0.99344337,0.004037977,0.0007457101,0.00013765457,0.0012146473,0.00042063167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00396189,0.0005133413,0.0007477322,0.0006668984,0.00083101646,0.0023315516,0.0006617892,0.004427964,0.008755215],"category_scores_gemma":[0.008746761,0.00019184005,0.0009473347,0.00055589917,0.0018451957,0.002948636,0.0015793421,0.0051086303,0.0019340392],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043259395,0.00025053002,0.0036567762,0.0054267566,0.00008110623,0.013170184,0.001141109,0.0004108639,0.006739408,0.030376747,0.17763796,0.760676],"study_design_scores_gemma":[0.000117060714,0.00076109177,0.0044245142,0.00636327,0.0001353212,0.04015516,0.001258538,0.00035227445,0.0018495977,0.017277436,0.92724085,0.00006483265],"about_ca_topic_score_codex":0.00083681085,"about_ca_topic_score_gemma":0.0024715778,"teacher_disagreement_score":0.008755215,"about_ca_system_score_codex":0.0014796702,"about_ca_system_score_gemma":0.0021289457,"threshold_uncertainty_score":0.029289067},"labels":[],"label_agreement":null},{"id":"W2489361700","doi":"10.2147/dddt.s104037","title":"Rational design and synthesis of novel diphenyl ether derivatives as antitubercular agents","year":2016,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Antimicrobial agents and applications","field":"Chemistry","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Indian Council of Medical Research; All India Council for Technical Education; Department of Science and Technology, Ministry of Science and Technology, India","keywords":"Cytotoxicity; Triclosan; Diphenyl ether; Chemistry; Vero cell; Mycobacterium tuberculosis; Ether; In vitro; Minimum inhibitory concentration; IC50; Stereochemistry; Lead compound; Microsome; INHA; Combinatorial chemistry; Reductase; Biochemistry; Enzyme; Organic chemistry; Tuberculosis","score_opus":0.041192303203665445,"score_gpt":0.25406855203717865,"score_spread":0.2128762488335132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2489361700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91770464,0.022534713,0.032468706,0.00058594503,0.00018870088,0.0008188386,0.0015589531,0.00020588399,0.0239336],"genre_scores_gemma":[0.93980706,0.018313615,0.034319844,0.00021115769,0.00003179379,0.0002325463,0.000852841,0.000035194626,0.0061959596],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992275,0.000015605496,0.000009537283,0.000013736046,0.000017343153,0.000021096985],"domain_scores_gemma":[0.99995947,0.000004786954,0.000010631641,0.0000041057447,0.000009080725,0.000011912712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016262845,0.0004339712,0.00038559406,0.00028942619,0.00011720433,0.00031032902,0.00032772298,0.00029269283,0.0019520732],"category_scores_gemma":[0.00014700166,0.00021686927,0.00021840693,0.00029043236,0.00016179275,0.00033959627,0.00026500027,0.00038974464,0.0006732374],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042961902,0.00032597527,0.00033184042,0.00105837,0.000048709906,0.0007952755,0.00009406064,0.0081064785,0.9386576,0.004557829,0.0007087308,0.044885665],"study_design_scores_gemma":[0.00038220733,0.0038634716,0.0011600655,0.00011307977,0.00011610787,0.0008035087,0.00009046147,0.00904435,0.9220312,0.0008252718,0.061519716,0.000050600767],"about_ca_topic_score_codex":0.0003109293,"about_ca_topic_score_gemma":0.00093889976,"teacher_disagreement_score":0.0019520732,"about_ca_system_score_codex":0.00028576466,"about_ca_system_score_gemma":0.00030848978,"threshold_uncertainty_score":0.0065303445},"labels":[],"label_agreement":null},{"id":"W2508827030","doi":"10.2147/dddt.s112181","title":"Pharmacokinetic profile of defibrotide in patients with renal impairment","year":2016,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Quebec Rehabilitation Research Network","funders":"Jazz Pharmaceuticals","keywords":"Defibrotide; Medicine; Hepatic veno-occlusive disease; Pharmacokinetics; Dialysis; Cmax; Dosing; Hemodialysis; Internal medicine; Confidence interval; Gastroenterology; Urology; Surgery; Transplantation; Hematopoietic stem cell transplantation","score_opus":0.014355227916114453,"score_gpt":0.22922254691676197,"score_spread":0.2148673190006475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2508827030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99842876,0.0007355743,0.00019088163,0.000045417124,0.0000062447143,0.000022482634,0.000102890655,0.000008418438,0.0004594105],"genre_scores_gemma":[0.999265,0.00018851893,0.00016703524,0.00008835763,0.000015370942,0.000012836241,0.00013045815,0.0000017150657,0.00013080859],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99968123,0.00009947936,0.000038270908,0.000073520336,0.00007425514,0.000033298635],"domain_scores_gemma":[0.9990287,0.00029111133,0.00033790316,0.00007435386,0.00008399475,0.00018401654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006415864,0.00020459291,0.0007895646,0.00017095085,0.00019168682,0.00037578412,0.000108825385,0.00029660566,0.00053689705],"category_scores_gemma":[0.0018515165,0.0001265869,0.0002819615,0.0002164165,0.00018202003,0.000376572,0.00015530975,0.0004938097,0.000157778],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05300787,0.0023970986,0.8069481,0.0002158253,0.0005990281,0.0010638349,0.00062356226,0.002057724,0.05105991,0.00019840119,0.00080182817,0.0810269],"study_design_scores_gemma":[0.0014188066,0.043134086,0.94182116,0.000026481806,0.00028494204,0.002275415,0.00018670352,0.003013268,0.0049895365,0.0001791395,0.0026323053,0.000038141658],"about_ca_topic_score_codex":0.00041340673,"about_ca_topic_score_gemma":0.0004434608,"teacher_disagreement_score":0.0007895646,"about_ca_system_score_codex":0.00022809047,"about_ca_system_score_gemma":0.0002231258,"threshold_uncertainty_score":0.003393054},"labels":[],"label_agreement":null},{"id":"W2531727627","doi":"10.2147/dddt.s99600","title":"Yellow fever vaccine-associated viscerotropic disease: current perspectives","year":2016,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Mosquito-borne diseases and control","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Yellow fever vaccine; Medicine; Pharmacovigilance; Disease; Yellow fever; Family medicine; Incidence (geometry); Pediatrics; Adverse effect; Virology; Internal medicine","score_opus":0.04583121891987053,"score_gpt":0.32399229414635045,"score_spread":0.2781610752264799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531727627","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018284796,0.99234325,0.00014586568,0.004452523,0.0005109959,0.000018808827,0.000109901775,0.000005872335,0.0005843531],"genre_scores_gemma":[0.03010733,0.9617198,0.0008637188,0.0039098137,0.0028133697,0.00005204774,0.00033074804,0.000006076516,0.00019709469],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9927402,0.0020933044,0.003021934,0.00067372987,0.0012169327,0.00025396238],"domain_scores_gemma":[0.9100198,0.05374052,0.023311261,0.0009635177,0.01095729,0.001007641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012612681,0.0006672604,0.0023962269,0.007945962,0.00047697124,0.0033985951,0.0011975123,0.002248262,0.004692596],"category_scores_gemma":[0.036911048,0.00040591668,0.0016328846,0.0068198773,0.0013550028,0.0050119674,0.0009848338,0.0010317414,0.00075318234],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010162533,0.00015644016,0.03474927,0.37939012,0.0025780313,0.0015724421,0.0010720685,0.00023558698,0.0013538367,0.0040472215,0.026809849,0.5470189],"study_design_scores_gemma":[0.00028581175,0.0009855988,0.06892706,0.591866,0.010618982,0.012985806,0.005175118,0.0005967093,0.0008945205,0.009608545,0.2978825,0.00017340368],"about_ca_topic_score_codex":0.001996857,"about_ca_topic_score_gemma":0.0038027994,"teacher_disagreement_score":0.012612681,"about_ca_system_score_codex":0.0015318765,"about_ca_system_score_gemma":0.004469093,"threshold_uncertainty_score":0.06670308},"labels":[],"label_agreement":null},{"id":"W2548371687","doi":"10.2147/dddt.s119214","title":"Evaluating the cytotoxic effects of the water extracts of four anticancer herbs against human malignant melanoma cells","year":2016,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Flavonoids in Medical Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Saskatchewan; Queen's University","funders":"College of Pharmacy and Nutrition, University of Saskatchewan","keywords":"Cytotoxicity; Herb; Traditional medicine; Cytotoxic T cell; Melanoma; Cancer cell; Cancer; Medicine; Medicinal herbs; Pharmacology; Chemistry; Biology; In vitro; Cancer research; Internal medicine; Biochemistry","score_opus":0.0755976652955106,"score_gpt":0.3469543211764928,"score_spread":0.2713566558809822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548371687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942365,0.0038039715,0.00056290725,0.00005505297,0.000036387482,0.000039409515,0.00019767623,0.000015991958,0.0010521075],"genre_scores_gemma":[0.99363446,0.002329409,0.0018218062,0.000065516695,0.000016744041,0.000037541853,0.00034683064,0.0000054049005,0.0017423796],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999169,0.000016191807,0.000010124055,0.000014163453,0.000030463354,0.000012057082],"domain_scores_gemma":[0.9999404,0.000014037328,0.000012963093,0.0000047460026,0.000019050589,0.000008728136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000110864814,0.00038541178,0.000217671,0.00041049364,0.00019021826,0.0001260331,0.00011536853,0.00021067726,0.00097197376],"category_scores_gemma":[0.00012634427,0.000083867664,0.00029475358,0.00034919148,0.00013242252,0.00017469002,0.00017317205,0.00023734836,0.00013057355],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021870776,0.00010419649,0.00077169936,0.00017468944,0.000015861431,0.00005157505,0.0000349157,0.00008008948,0.99438477,0.000019328974,0.000035818844,0.004108265],"study_design_scores_gemma":[0.000038366845,0.003089905,0.01491302,0.000027241476,0.00012735711,0.00022009367,0.00013193807,0.0005608977,0.9784807,0.000029411103,0.002371038,0.000009947242],"about_ca_topic_score_codex":0.0009246498,"about_ca_topic_score_gemma":0.001774817,"teacher_disagreement_score":0.00097197376,"about_ca_system_score_codex":0.0001035064,"about_ca_system_score_gemma":0.00016812836,"threshold_uncertainty_score":0.0032515526},"labels":[],"label_agreement":null},{"id":"W2558346154","doi":"10.2147/dddt.s117078","title":"Effect of peritoneal dialysis fluid containing osmo-metabolic agents on human endothelial cells","year":2016,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Dialysis and Renal Disease Management","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"Ministero dell’Istruzione, dell’Università e della Ricerca","keywords":"Viability assay; Cell adhesion molecule; Cell adhesion; Biochemistry; Chemistry; Endothelial stem cell; Pharmacology; Biology; Immunology; In vitro; Cell","score_opus":0.02594054227768645,"score_gpt":0.2799810474981427,"score_spread":0.25404050522045624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558346154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940234,0.0037538128,0.0006605441,0.00008056965,0.00007665402,0.000019594992,0.00018655273,0.000017816143,0.0011810849],"genre_scores_gemma":[0.9952041,0.0019479006,0.0015914335,0.00008277231,0.000026345293,0.000032590848,0.00031723757,0.0000047849485,0.0007928996],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99978167,0.00007948058,0.000027308924,0.000034012413,0.00004184041,0.000035756377],"domain_scores_gemma":[0.9998259,0.000060020986,0.000035023157,0.000021953663,0.000038318518,0.000018815932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031188023,0.00024821635,0.00020696937,0.00011944836,0.00015919688,0.0003034449,0.00015710619,0.00022457584,0.0009786297],"category_scores_gemma":[0.0002933692,0.000079019046,0.0002528587,0.00015810283,0.00013296546,0.00018854039,0.0001610154,0.0002879188,0.00014350118],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018955058,0.00031617473,0.001859252,0.00033504283,0.000054016888,0.00025506195,0.00017558277,0.00026422928,0.9852667,0.00014535959,0.00023293261,0.009200126],"study_design_scores_gemma":[0.00005470021,0.0020267616,0.007952521,0.000023163248,0.0000619532,0.0002527096,0.00009226906,0.00074181514,0.98506606,0.00002721155,0.0036927925,0.000007899385],"about_ca_topic_score_codex":0.0006242885,"about_ca_topic_score_gemma":0.0005179807,"teacher_disagreement_score":0.0009786297,"about_ca_system_score_codex":0.00016328214,"about_ca_system_score_gemma":0.00015355229,"threshold_uncertainty_score":0.003273785},"labels":[],"label_agreement":null},{"id":"W2566999893","doi":"10.2147/dddt.s123386","title":"Folic acid-conjugated amphiphilic alternating copolymer as a new active tumor targeting drug delivery platform","year":2016,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Royal Military College of Canada","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Amphiphile; Drug delivery; Chemistry; Biophysics; Conjugated system; Cancer cell; Internalization; Targeted drug delivery; Copolymer; SMA*; Biochemistry; Combinatorial chemistry; Cell; Polymer; Cancer; Organic chemistry; Biology","score_opus":0.022327190536447543,"score_gpt":0.23421429898015578,"score_spread":0.21188710844370823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566999893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95531625,0.010338527,0.02836595,0.00033393418,0.000111205016,0.00013367059,0.00022087389,0.00046085793,0.0047187824],"genre_scores_gemma":[0.97637844,0.002831896,0.016725767,0.00010841671,0.000033996872,0.0000675379,0.00018256044,0.00002068946,0.0036506238],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994636,0.000006340917,0.0000042293063,0.000015915788,0.000014380265,0.000012830363],"domain_scores_gemma":[0.9999696,0.0000026715024,0.000010902199,0.0000021382702,0.000004476285,0.000010212009],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000089241876,0.0003744699,0.00017759757,0.00026031968,0.00012907725,0.00021128054,0.00020529111,0.00042171378,0.0005115572],"category_scores_gemma":[0.000064674365,0.00016416839,0.00015541582,0.00012838189,0.0001399097,0.00030524124,0.00017024389,0.0002714601,0.00030807246],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022516224,0.000010854233,0.000026816515,0.000027373966,0.000002607036,0.000055224737,0.0000059167114,0.00013722548,0.997271,0.00015727548,0.000038977778,0.0022442683],"study_design_scores_gemma":[0.000018273606,0.0002596744,0.0005260816,0.0000052268947,0.00001603682,0.00029487858,0.0000045336365,0.0022819357,0.99023235,0.00004695627,0.0063038054,0.000010174956],"about_ca_topic_score_codex":0.0005446845,"about_ca_topic_score_gemma":0.0005678548,"teacher_disagreement_score":0.0005446845,"about_ca_system_score_codex":0.0003223148,"about_ca_system_score_gemma":0.00016201692,"threshold_uncertainty_score":0.0023385286},"labels":[],"label_agreement":null},{"id":"W2579853360","doi":"10.2147/dddt.s118154","title":"Comparison of the long-term efficacy and safety of generic Tacrobell with original tacrolimus (Prograf) in kidney transplant recipients","year":2017,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Future Earth","funders":"","keywords":"Medicine; Tacrolimus; Hazard ratio; Confidence interval; Internal medicine; Proportional hazards model; Kidney transplant; Observational study; Single Center; Kidney transplantation; Kidney; Transplantation","score_opus":0.04780615045640875,"score_gpt":0.3191769288478833,"score_spread":0.27137077839147455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2579853360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99868816,0.0011141383,0.00006903257,0.000016591992,0.0000058710366,0.0000029336866,0.0000402885,0.0000010967206,0.00006192892],"genre_scores_gemma":[0.9996371,0.00014459231,0.000056525452,0.00002105322,0.000015650081,0.0000024806293,0.00009544353,5.3164234e-7,0.00002668332],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859136,0.0006304096,0.00016519157,0.00016549668,0.00033997442,0.00010749323],"domain_scores_gemma":[0.99592066,0.0010026739,0.0022525466,0.00021605265,0.00021660823,0.00039148485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025136922,0.00013913633,0.00040581202,0.0002902004,0.00013344508,0.0004928471,0.00017559934,0.00027006792,0.00045213028],"category_scores_gemma":[0.00315957,0.00007649399,0.0005686594,0.00034160056,0.00023044695,0.00035241645,0.0002203938,0.0004549406,0.000068907546],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023554815,0.00052050507,0.9468736,0.00021150775,0.001490569,0.00015380503,0.00008560646,0.00030181848,0.003816666,0.00006371379,0.00012221871,0.022805193],"study_design_scores_gemma":[0.0005342459,0.012943038,0.981952,0.000030366118,0.00074097264,0.00058930315,0.000092920396,0.0009858444,0.0015912848,0.00005287113,0.0004742867,0.00001275027],"about_ca_topic_score_codex":0.00026794124,"about_ca_topic_score_gemma":0.00029981692,"teacher_disagreement_score":0.0025136922,"about_ca_system_score_codex":0.00033167587,"about_ca_system_score_gemma":0.00022419779,"threshold_uncertainty_score":0.013293803},"labels":[],"label_agreement":null},{"id":"W2583669122","doi":"10.2147/dddt.s121518","title":"<em>Kelussia odoratissima</em> Mozaff. activates intrinsic pathway of apoptosis in breast cancer cells associated with S phase cell cycle arrest via involvement of p21/p27 in vitro and in vivo","year":2017,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Plant chemical constituents analysis","field":"Agricultural and Biological Sciences","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"","keywords":"Apoptosis; MCF-7; Cell cycle checkpoint; Programmed cell death; MTT assay; Cell cycle; In vivo; Chemistry; Cancer research; Cell growth; Annexin; Cytotoxicity; Cancer cell; Cancer; In vitro; Biology; Biochemistry","score_opus":0.01629617305963993,"score_gpt":0.2128400323415158,"score_spread":0.19654385928187587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583669122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827382,0.0059127663,0.0022982708,0.00032585286,0.000056551344,0.000042521948,0.00054759823,0.0001698607,0.007908482],"genre_scores_gemma":[0.9909046,0.0021612002,0.0018700204,0.00016973577,0.000024890947,0.000022355336,0.0004559997,0.000016032289,0.0043751555],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999966,0.000003958643,0.0000030585938,0.0000063827597,0.000010811739,0.0000096933],"domain_scores_gemma":[0.9999678,0.000003768066,0.000011852434,0.000002646901,0.000008020247,0.0000060325146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000054724896,0.00033736537,0.00021973622,0.00040193423,0.00022517104,0.00011396241,0.00011571514,0.00019510312,0.002103576],"category_scores_gemma":[0.000045795034,0.00007252335,0.0002362216,0.00022409906,0.00014361918,0.00016974483,0.00015535197,0.0003147985,0.00043947328],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043626543,0.00013285228,0.0012314748,0.00044341548,0.000021915936,0.0003166961,0.0000337034,0.00014483221,0.9757976,0.00018212188,0.00026727226,0.020991959],"study_design_scores_gemma":[0.00016045469,0.002292622,0.09617336,0.00012818622,0.00018199522,0.004228262,0.00019320742,0.0012695085,0.8653637,0.00062605983,0.029353937,0.00002882484],"about_ca_topic_score_codex":0.0009415092,"about_ca_topic_score_gemma":0.0016620845,"teacher_disagreement_score":0.002103576,"about_ca_system_score_codex":0.00018857149,"about_ca_system_score_gemma":0.00017746266,"threshold_uncertainty_score":0.007037163},"labels":[],"label_agreement":null},{"id":"W2593956993","doi":"10.2147/dddt.s97635","title":"Eteplirsen in the treatment of Duchenne muscular dystrophy","year":2017,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":488,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Muscular Dystrophy Canada; University of Alberta","funders":"Canadian Institutes of Health Research; Alberta Innovates; Muscular Dystrophy Canada; Children's Health Research Institute; Women and Children's Health Research Institute; Ministry of Advanced Education, Government of Alberta; Alberta Innovates - Health Solutions","keywords":"Exon skipping; Duchenne muscular dystrophy; Medicine; Muscular dystrophy; Dystrophin; Exon; Bioinformatics; Genetics; Internal medicine; Biology; Gene; Alternative splicing","score_opus":0.10158412888656976,"score_gpt":0.33786707257114035,"score_spread":0.2362829436845706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593956993","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032425267,0.997821,0.00013520138,0.00018002617,0.00016786733,0.0000055331097,0.000017515064,0.000009386517,0.0013392305],"genre_scores_gemma":[0.0018704701,0.99637765,0.00021094196,0.00020940222,0.000133127,0.000009271148,0.000037086753,0.0000019627646,0.0011499947],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9999039,0.0000149235975,0.00001614637,0.00002007039,0.00003571433,0.0000092356595],"domain_scores_gemma":[0.9999021,0.000043564247,0.000017504974,0.000002625264,0.00002303653,0.000011189717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003024075,0.00048236165,0.00061996805,0.0015511519,0.00016676086,0.00046930832,0.0004683649,0.00060943066,0.002515715],"category_scores_gemma":[0.00031909498,0.00013568124,0.00027201764,0.0010391987,0.00022628049,0.00065747596,0.00035066353,0.0012782734,0.0014317981],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000108197695,0.0000730088,0.00012737198,0.008048397,0.00006065487,0.00025316238,0.000042487205,0.0002744662,0.0026871504,0.0021900677,0.015274251,0.9708609],"study_design_scores_gemma":[0.00003710943,0.00020158882,0.00071467226,0.0020953936,0.000104134044,0.002470582,0.000038259448,0.000099400946,0.0013471367,0.0007873189,0.99208903,0.000015222506],"about_ca_topic_score_codex":0.00043057802,"about_ca_topic_score_gemma":0.0009462103,"teacher_disagreement_score":0.002515715,"about_ca_system_score_codex":0.0003287428,"about_ca_system_score_gemma":0.0004265391,"threshold_uncertainty_score":0.008415878},"labels":[],"label_agreement":null},{"id":"W2606323667","doi":"10.2147/dddt.s117277","title":"Riociguat: a soluble guanylate cyclase stimulator for the treatment of pulmonary hypertension","year":2017,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Bayer Fund; Bayer","keywords":"Riociguat; Guanylate cyclase; Pulmonary hypertension; GUCY1A3; Medicine; GUCY2D; GUCY1B3; Chronic thromboembolic pulmonary hypertension; Internal medicine; Cardiology; Guanylate cyclase 2C; Receptor","score_opus":0.26077551548955813,"score_gpt":0.3896840185365592,"score_spread":0.12890850304700108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606323667","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017049349,0.9925513,0.00056965975,0.00060565065,0.00041570817,0.000040659077,0.0001412191,0.000060029735,0.003910789],"genre_scores_gemma":[0.010687197,0.983421,0.0009715814,0.0009909723,0.00052117655,0.00006875002,0.00038218815,0.000010034126,0.0029470793],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998863,0.00001899104,0.000016829496,0.000022078324,0.000041465373,0.000014371957],"domain_scores_gemma":[0.99994254,0.000019141065,0.000013939492,0.0000017878131,0.000013775569,0.000008724875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020145487,0.00041429186,0.0005763878,0.00093774655,0.0001819154,0.00042479025,0.00054650457,0.00055139966,0.0028777665],"category_scores_gemma":[0.00022610452,0.000104512386,0.0004558344,0.00060604216,0.0001791897,0.00042128447,0.00023453799,0.0009818344,0.0015846194],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003759524,0.00016497029,0.00034221358,0.0126874205,0.00014554469,0.0008393045,0.00009835544,0.0003380593,0.017617662,0.0016502513,0.037728045,0.92801213],"study_design_scores_gemma":[0.00023466277,0.00073978247,0.0031982402,0.0014274123,0.00030082744,0.0046529854,0.00004709504,0.00025843718,0.005257924,0.0008768515,0.9829699,0.000035799632],"about_ca_topic_score_codex":0.00052338693,"about_ca_topic_score_gemma":0.0010757452,"teacher_disagreement_score":0.0028777665,"about_ca_system_score_codex":0.00027884223,"about_ca_system_score_gemma":0.00040231855,"threshold_uncertainty_score":0.009627104},"labels":[],"label_agreement":null},{"id":"W2606957323","doi":"10.2147/dddt.s131213","title":"Justification of disintegration testing beyond current FDA criteria using in vitro and in silico models","year":2017,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Drug Solubulity and Delivery Systems","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"University of Alberta","keywords":"Dissolution; Dissolution testing; Materials science; Diffusion; Chemistry; Biochemical engineering; Computer science; Thermodynamics; Physics; Engineering","score_opus":0.3897675016050524,"score_gpt":0.4523156752787801,"score_spread":0.06254817367372767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606957323","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14252183,0.017333096,0.7887509,0.009559243,0.0015494394,0.0018795785,0.0023639922,0.0017708085,0.034271117],"genre_scores_gemma":[0.626534,0.010565987,0.34866002,0.0031521292,0.00028649147,0.0011652866,0.0020979533,0.00049389433,0.0070442287],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9801384,0.0067961374,0.0017188705,0.0015905884,0.009315977,0.00043992564],"domain_scores_gemma":[0.9668706,0.017737111,0.00351924,0.0048960773,0.0066268374,0.00035014105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01856071,0.0013506558,0.0014352683,0.0013506261,0.00074812025,0.002804516,0.0030936615,0.0023281733,0.0022945146],"category_scores_gemma":[0.029502956,0.00075519865,0.0016320632,0.0006640485,0.0019351958,0.0017814119,0.0016364822,0.0026823364,0.0013001461],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022469927,0.0015214821,0.011730813,0.0059859497,0.0004031215,0.0015426531,0.00088375056,0.060296953,0.63020283,0.07567411,0.01230064,0.19721068],"study_design_scores_gemma":[0.0003261236,0.005485251,0.006618979,0.0017952853,0.00047593148,0.0017897524,0.00038466608,0.23579633,0.57317686,0.02281304,0.15102558,0.00031231318],"about_ca_topic_score_codex":0.002311536,"about_ca_topic_score_gemma":0.0024594117,"teacher_disagreement_score":0.01856071,"about_ca_system_score_codex":0.0014329378,"about_ca_system_score_gemma":0.0024433485,"threshold_uncertainty_score":0.09815955},"labels":[],"label_agreement":null},{"id":"W2616264501","doi":"10.2147/dddt.s130909","title":"Ten years of clinical experience with biosimilar human growth hormone: a review of safety data","year":2017,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children’s Health Research Institute","funders":"","keywords":"Biosimilar; Medicine; Adverse effect; Patient safety; Clinical trial; Safety profile; Pharmacology; Intensive care medicine; Internal medicine; Health care","score_opus":0.2994236157995498,"score_gpt":0.437390202776585,"score_spread":0.13796658697703523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2616264501","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00091314624,0.9977822,0.00018127316,0.000518044,0.000102069775,0.000013373481,0.00006149795,0.000005116993,0.00042347296],"genre_scores_gemma":[0.0085964715,0.9894701,0.00039830428,0.00095745665,0.00018735931,0.000026236301,0.00018251105,0.000008360999,0.00017320618],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9950588,0.001188801,0.0016235553,0.0005215489,0.001503677,0.0001037263],"domain_scores_gemma":[0.97411615,0.015234847,0.0051918104,0.00046658167,0.004532152,0.0004584768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009332703,0.00083387335,0.0020312248,0.005468463,0.00038493538,0.001882004,0.0012751337,0.0012303484,0.0020199951],"category_scores_gemma":[0.015614482,0.0004623494,0.0017619603,0.00637854,0.0011866032,0.003157896,0.0009751154,0.0017837612,0.00061846577],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005694065,0.00010373896,0.0037148793,0.09876585,0.0013402248,0.0005350056,0.0006235163,0.00046374826,0.001697316,0.0016443013,0.016117789,0.87442416],"study_design_scores_gemma":[0.00021242828,0.0019631104,0.021279633,0.18487513,0.0061242515,0.010760364,0.001557523,0.00040790255,0.003259249,0.0024277074,0.7669528,0.00017981953],"about_ca_topic_score_codex":0.0009734459,"about_ca_topic_score_gemma":0.001396397,"teacher_disagreement_score":0.009332703,"about_ca_system_score_codex":0.0015754836,"about_ca_system_score_gemma":0.003044668,"threshold_uncertainty_score":0.04935664},"labels":[],"label_agreement":null},{"id":"W2721615787","doi":"10.2147/dddt.s102500","title":"Intranasal agomelatine solid lipid nanoparticles to enhance brain delivery: formulation, optimization and in vivo pharmacokinetics","year":2017,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Advancements in Transdermal Drug Delivery","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Bioavailability; Solid lipid nanoparticle; Pharmacokinetics; Pharmacology; Nasal administration; Drug delivery; In vivo; Chemistry; First pass effect; Zeta potential; Agomelatine; Chromatography; Drug; Nanoparticle; Materials science; Medicine; Nanotechnology; Antidepressant; Internal medicine; Organic chemistry","score_opus":0.07019639001687886,"score_gpt":0.4005162602364778,"score_spread":0.33031987021959897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2721615787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817276,0.002707377,0.0128867375,0.00012916235,0.00004840273,0.00012752722,0.00014888971,0.00013849397,0.002085719],"genre_scores_gemma":[0.9800063,0.0017317828,0.014826956,0.000057010046,0.000011846651,0.00009637071,0.0001698633,0.00003387592,0.0030660832],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992514,0.000012742794,0.0000059939275,0.00002031153,0.00002599034,0.0000098314895],"domain_scores_gemma":[0.99995697,0.0000065774398,0.000014696947,0.0000038304297,0.000012039813,0.00000589833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016806072,0.00029419686,0.00020259927,0.00015001296,0.00008556016,0.00019034307,0.00018221955,0.00025972715,0.00040461647],"category_scores_gemma":[0.00013130008,0.00012650872,0.00022424696,0.000079925194,0.00012934893,0.00017383165,0.00011710511,0.00030207296,0.0002220466],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000093016766,0.000053134223,0.00006791682,0.000058889887,0.000006524035,0.000024849725,0.000010074698,0.00020229649,0.99579585,0.0000439741,0.000040843057,0.0036025506],"study_design_scores_gemma":[0.000022878938,0.00082668255,0.0009045811,0.000005602823,0.000024106557,0.00011524573,0.000008495755,0.0022253732,0.99418384,0.000021363214,0.0016556381,0.000006305025],"about_ca_topic_score_codex":0.0009578551,"about_ca_topic_score_gemma":0.0015142325,"teacher_disagreement_score":0.0009578551,"about_ca_system_score_codex":0.00028902554,"about_ca_system_score_gemma":0.0002117454,"threshold_uncertainty_score":0.0020970106},"labels":[],"label_agreement":null},{"id":"W2741339609","doi":"10.2147/dddt.s137934","title":"Combinatorial and sequential delivery of gemcitabine and oseltamivir phosphate from implantable poly(D,L-lactic-co-glycolic acid) cylinders disables human pancreatic cancer cell survival","year":2017,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Glycolic acid; Gemcitabine; PLGA; Lactic acid; Pancreatic cancer; Pharmacology; Chemistry; Medicine; Cancer; Biology; Internal medicine; Biochemistry; Bacteria","score_opus":0.05728142097212312,"score_gpt":0.332939632993578,"score_spread":0.27565821202145485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741339609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966264,0.00059434446,0.002090484,0.000014812113,0.000019564282,0.000028249242,0.000065804656,0.000046837704,0.0005135481],"genre_scores_gemma":[0.9955512,0.00036960788,0.0029372778,0.000011864347,0.000004556424,0.000025592673,0.00007985689,0.0000105629315,0.0010094742],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991024,0.000007908894,0.000008386423,0.000022549173,0.000028480912,0.000022407412],"domain_scores_gemma":[0.9999093,0.000011409408,0.000041664567,0.000007960114,0.000009884893,0.000019769492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007767161,0.0003454909,0.00013393268,0.00015982855,0.000063978136,0.00024336159,0.00012009971,0.00019605418,0.0002892411],"category_scores_gemma":[0.000113655835,0.00014261885,0.00017534153,0.000084666804,0.000109991255,0.00020554122,0.00014918332,0.0001914001,0.000105424544],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010495566,0.000021833863,0.00011520574,0.00002355442,0.000004174348,0.000026188942,0.0000063961966,0.00023860921,0.9973947,0.00003328663,0.000015294692,0.0020158926],"study_design_scores_gemma":[0.00001049887,0.0004913695,0.0009773951,0.0000025746187,0.000017307122,0.00006614249,0.0000072632893,0.0018325442,0.99573874,0.000007195009,0.0008443968,0.000004638665],"about_ca_topic_score_codex":0.00042723806,"about_ca_topic_score_gemma":0.00071624026,"teacher_disagreement_score":0.00042723806,"about_ca_system_score_codex":0.00024418786,"about_ca_system_score_gemma":0.00022667565,"threshold_uncertainty_score":0.0017716885},"labels":[],"label_agreement":null},{"id":"W2741826338","doi":"10.2147/dddt.s136240","title":"Antibiotic susceptibility, heteroresistance, and updated treatment strategies in <em>Helicobacter pylori</em> infection","year":2017,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Metronidazole; Clarithromycin; Helicobacter pylori; Amoxicillin; Antibiotics; Antibiotic resistance; Medicine; Drug resistance; Tetracycline; Internal medicine; Microbiology; Biology","score_opus":0.06558470192644412,"score_gpt":0.3174042359082693,"score_spread":0.2518195339818252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741826338","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00061003474,0.9967796,0.00023962218,0.0013515776,0.00031933739,0.000007211988,0.000033417775,0.000008464184,0.00065071275],"genre_scores_gemma":[0.007130369,0.98971176,0.00068605837,0.0011716689,0.000804252,0.000018994886,0.00011280709,0.000005200997,0.00035890692],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986563,0.00040450357,0.00036889454,0.00016424624,0.00033230585,0.00007378277],"domain_scores_gemma":[0.9980621,0.0010389476,0.00035385173,0.00003865452,0.00043331552,0.00007313936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015550472,0.00062294165,0.0012636334,0.0022560444,0.00029752016,0.0012255505,0.00060065486,0.0012131579,0.0021833458],"category_scores_gemma":[0.004176592,0.00021388958,0.0010075968,0.0015430812,0.000584463,0.0014865672,0.00070578855,0.0012484007,0.00046911938],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021335189,0.0000901921,0.0048517515,0.044034,0.0004475565,0.00097609626,0.00043832356,0.0004264808,0.0010076949,0.0037291858,0.03681821,0.90696704],"study_design_scores_gemma":[0.00006150032,0.0003865181,0.01635223,0.0435258,0.0021675737,0.009598845,0.00078265707,0.00065755437,0.0013384781,0.0039688894,0.9210538,0.00010616843],"about_ca_topic_score_codex":0.0020798915,"about_ca_topic_score_gemma":0.002953753,"teacher_disagreement_score":0.0022560444,"about_ca_system_score_codex":0.0008730973,"about_ca_system_score_gemma":0.0017681171,"threshold_uncertainty_score":0.008223951},"labels":[],"label_agreement":null},{"id":"W2743191900","doi":"10.2147/dddt.s133944","title":"Modeling the human Na<sub>v</sub>1.5 sodium channel: structural and mechanistic insights of ion permeation and drug blockade","year":2017,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Ion channel regulation and function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Natural Sciences and Engineering Research Council of Canada; University of Toronto; Western Canada Research Grid","keywords":"Molecular dynamics; Sodium channel; Chemistry; Permeation; Ion channel; Lipid bilayer; Homology modeling; Biophysics; Ion; Membrane; Sodium; Computational chemistry; Biochemistry; Biology; Receptor","score_opus":0.023354775554868402,"score_gpt":0.23845133398224572,"score_spread":0.21509655842737732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2743191900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9485725,0.0003019085,0.045517772,0.00026162065,0.000023797838,0.000049087357,0.0005868158,0.00023319428,0.0044533378],"genre_scores_gemma":[0.9834192,0.0002506377,0.014483543,0.00004070217,0.0000052119694,0.00006698997,0.00039266315,0.00003198258,0.0013091635],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.999967,0.000007178267,0.0000014658201,0.000007321074,0.000007928888,0.000009091156],"domain_scores_gemma":[0.99995065,0.000019258003,0.000007744034,0.000005004241,0.0000091746215,0.0000082023025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010948019,0.0003466326,0.00032561956,0.00014715157,0.00029229908,0.00031589254,0.0005443816,0.00071057864,0.0012891305],"category_scores_gemma":[0.00022869326,0.00017245674,0.00047877757,0.00015667519,0.00031897848,0.00029088542,0.00024409012,0.00036544696,0.00018979449],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007402149,0.00004472852,0.0015289277,0.000054003292,0.00003173766,0.00019386131,0.000054880456,0.98114014,0.013166431,0.0018882925,0.00016930394,0.0016536192],"study_design_scores_gemma":[0.000012466975,0.000036562575,0.00037761783,0.0000043906416,0.000008779864,0.000029056608,0.00001799116,0.9969013,0.0017843818,0.000443829,0.00037871004,0.000004972887],"about_ca_topic_score_codex":0.013635866,"about_ca_topic_score_gemma":0.008219471,"teacher_disagreement_score":0.013635866,"about_ca_system_score_codex":0.0007282239,"about_ca_system_score_gemma":0.001450329,"threshold_uncertainty_score":0.02711302},"labels":[],"label_agreement":null},{"id":"W2752934452","doi":"10.2147/dddt.s133943","title":"Recent developments in the clinical pharmacology of rolapitant: subanalyses in specific populations","year":2017,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Nausea and vomiting management","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"William Osler Health System","funders":"","keywords":"Aprepitant; NK1 receptor antagonist; Chemotherapy-induced nausea and vomiting; Medicine; CYP3A4; Pharmacology; Internal medicine; Oncology; Vomiting; Substance P; Cytochrome P450; Receptor; Antiemetic","score_opus":0.5975365174808033,"score_gpt":0.5173394257454302,"score_spread":0.08019709173537304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752934452","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18378693,0.7936757,0.009306934,0.0013623197,0.000381712,0.0007532292,0.002900799,0.00014150645,0.007690891],"genre_scores_gemma":[0.6514195,0.32418552,0.008186643,0.005884534,0.0018833606,0.0011640632,0.005162338,0.00018677322,0.0019272493],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.994826,0.0020638024,0.0012342852,0.0007638233,0.00092455593,0.00018751904],"domain_scores_gemma":[0.9843225,0.008434295,0.0042264177,0.0009482123,0.001807096,0.00026154163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0075811576,0.00053724076,0.0016067437,0.0014045654,0.00017512547,0.0009747499,0.00037073245,0.00039871677,0.0016848921],"category_scores_gemma":[0.013103907,0.00025293996,0.003379282,0.0030020885,0.00032424816,0.0008198926,0.00052332383,0.0009051692,0.00040198062],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012528989,0.0004323204,0.22525896,0.015908003,0.03267166,0.00038146303,0.00032783824,0.0008232603,0.005755942,0.00053717085,0.0058293114,0.69954515],"study_design_scores_gemma":[0.0021679637,0.0073317382,0.794642,0.0026690145,0.081169866,0.0030806467,0.00038151318,0.0010610042,0.0072403834,0.0011008541,0.09905158,0.00010353829],"about_ca_topic_score_codex":0.00067037414,"about_ca_topic_score_gemma":0.0012205336,"teacher_disagreement_score":0.0075811576,"about_ca_system_score_codex":0.00059250917,"about_ca_system_score_gemma":0.000856935,"threshold_uncertainty_score":0.04009348},"labels":[],"label_agreement":null},{"id":"W2770164160","doi":"10.2147/dddt.s149214","title":"In silico-based identification of human α-enolase inhibitors to block cancer cell growth metabolically","year":2017,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Chang Gung Medical Foundation; National Science Council","keywords":"Cancer cell; Enolase; In silico; Glycolysis; Cancer; Cancer research; Biochemistry; Chemistry; Biology; Docking (animal); Pharmacology; Metabolism; Medicine; Immunology; Genetics","score_opus":0.02402148462264244,"score_gpt":0.2862611366473175,"score_spread":0.2622396520246751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770164160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8791703,0.013678051,0.08071098,0.00090063206,0.00015381198,0.00061230274,0.0045800987,0.002350096,0.017843693],"genre_scores_gemma":[0.9482875,0.005699154,0.036809135,0.00022944057,0.000022061746,0.00024295863,0.0057834648,0.00010654704,0.0028197581],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99982387,0.000045588626,0.000010536777,0.00003573225,0.000053797787,0.000030624215],"domain_scores_gemma":[0.9998461,0.00006685451,0.000030577386,0.00000766793,0.000030208614,0.000018623788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042261847,0.0012333321,0.0014656117,0.00094404374,0.00032639253,0.00089283846,0.0007362251,0.0004960187,0.0025234325],"category_scores_gemma":[0.0007937869,0.00031288358,0.0011916562,0.0007531744,0.00018964434,0.00037483653,0.00035111108,0.0004453309,0.00050878467],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013197697,0.0009939894,0.012537182,0.0013763171,0.00059560756,0.0009387328,0.000044982724,0.8661211,0.05626292,0.003877561,0.0042473013,0.05168451],"study_design_scores_gemma":[0.0002656384,0.0010367322,0.0018267693,0.00006158706,0.00046096876,0.0002766096,0.000057605954,0.960316,0.0278741,0.0012844166,0.006505979,0.000033645316],"about_ca_topic_score_codex":0.0030521092,"about_ca_topic_score_gemma":0.0043343883,"teacher_disagreement_score":0.0030521092,"about_ca_system_score_codex":0.00065547327,"about_ca_system_score_gemma":0.001103023,"threshold_uncertainty_score":0.008441687},"labels":[],"label_agreement":null},{"id":"W2772982640","doi":"10.2147/dddt.s142580","title":"EUREKA study – the evaluation of real-life use of a biophotonic system in chronic wound management: an interim analysis","year":2017,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Laser Applications in Dentistry and Medicine","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Klox Technologies (Canada)","funders":"","keywords":"Medicine; Context (archaeology); Quality of life (healthcare); Venous leg ulcer; Wound healing; Interim analysis; Prospective cohort study; Adverse effect; Internal medicine; Surgery; Clinical trial; Nursing","score_opus":0.17963371830400557,"score_gpt":0.39320295221716556,"score_spread":0.21356923391316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2772982640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98492694,0.0037108392,0.0022242516,0.00014291033,0.000119875804,0.0032198785,0.0027607693,0.00003322158,0.0028613133],"genre_scores_gemma":[0.97991127,0.0011528917,0.0047027864,0.0004009769,0.0003103004,0.006336763,0.0037339816,0.000046266534,0.0034047947],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99390703,0.0041739917,0.00044184696,0.0003984304,0.00070643856,0.00037230918],"domain_scores_gemma":[0.992292,0.0030397882,0.0023122435,0.0012014149,0.00066725473,0.00048729492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012697272,0.0009223195,0.0017360813,0.00053211034,0.00029478647,0.0009823027,0.00062322646,0.0008414107,0.003967211],"category_scores_gemma":[0.0050663855,0.000281815,0.0021674342,0.0006238799,0.0007110843,0.00067062466,0.0005372986,0.0011543493,0.00064704695],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8927584,0.010287405,0.039427437,0.0009805069,0.0029589254,0.00014553648,0.00014445749,0.0007728312,0.010728558,0.00023066417,0.00093548984,0.04062972],"study_design_scores_gemma":[0.14086786,0.6304461,0.19393712,0.00019007616,0.006162236,0.0003390487,0.00017880675,0.001935971,0.015452952,0.000313672,0.010096158,0.00007998471],"about_ca_topic_score_codex":0.00020603079,"about_ca_topic_score_gemma":0.00019600558,"teacher_disagreement_score":0.012697272,"about_ca_system_score_codex":0.00045145562,"about_ca_system_score_gemma":0.00079783465,"threshold_uncertainty_score":0.067150354},"labels":[],"label_agreement":null},{"id":"W2780401732","doi":"10.2147/dddt.s144602","title":"Intra-articular collagenase injection increases range of motion in a rat knee flexion contracture model","year":2017,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Dupuytren's Contracture and Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"Canadian Institutes of Health Research; University of Ottawa","keywords":"Collagenase; Contracture; Capsule; Range of motion; Muscle contracture; Microbial collagenase; Medicine; Knee Joint; Joint capsule; Chemistry; Extracellular matrix; Anatomy; Pathology; Surgery; Biology; Enzyme; Biochemistry","score_opus":0.027909627960670442,"score_gpt":0.26865058979467915,"score_spread":0.2407409618340087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2780401732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937622,0.0027997764,0.0018790644,0.00010736914,0.000072483635,0.0000575906,0.0001885304,0.00013579127,0.00099722],"genre_scores_gemma":[0.9892173,0.002297619,0.0029954885,0.00006324074,0.000034828394,0.00013599078,0.00048493466,0.000020802698,0.0047498685],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99962795,0.000042944932,0.0000409289,0.00007096538,0.000113312424,0.000103883496],"domain_scores_gemma":[0.99948466,0.000044942924,0.00023664576,0.000040259158,0.00004766807,0.00014580255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037522317,0.000983158,0.0005107657,0.0008011421,0.00016429587,0.00030472834,0.0003018435,0.00046873628,0.0016078049],"category_scores_gemma":[0.0001783463,0.00032879235,0.0005502971,0.0003494156,0.0003699693,0.00030290236,0.00019802082,0.0009914346,0.00044015414],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006995344,0.00043103824,0.00033786893,0.00007265278,0.0000129138625,0.00008368115,0.000022072934,0.00006448046,0.99693644,0.000029190507,0.000037774244,0.0012722446],"study_design_scores_gemma":[0.00017075095,0.011240058,0.0071609076,0.00002853788,0.00008281424,0.00043147866,0.000087419394,0.0010664021,0.97885865,0.000033991106,0.0008246353,0.000014373893],"about_ca_topic_score_codex":0.0008636539,"about_ca_topic_score_gemma":0.0015515375,"teacher_disagreement_score":0.0016078049,"about_ca_system_score_codex":0.00028639144,"about_ca_system_score_gemma":0.0003553182,"threshold_uncertainty_score":0.0053786635},"labels":[],"label_agreement":null},{"id":"W2790600717","doi":"10.2147/dddt.s156724","title":"Intra-articular platelet-rich plasma versus hyaluronic acid in the treatment of knee osteoarthritis: a meta-analysis","year":2018,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Periodontal Regeneration and Treatments","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Natural Science Foundation of China","keywords":"WOMAC; Osteoarthritis; Medicine; Platelet-rich plasma; Hyaluronic acid; Cochrane Library; Confidence interval; Meta-analysis; Randomized controlled trial; Internal medicine; Visual analogue scale; Physical therapy; Platelet; Pathology","score_opus":0.14823570821055748,"score_gpt":0.33608691061642887,"score_spread":0.1878512024058714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790600717","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022327922,0.97491634,0.00075607316,0.00027705767,0.0003838318,0.00038305146,0.0005070604,0.00004978867,0.00039888962],"genre_scores_gemma":[0.49368945,0.49756208,0.0029209072,0.0015795555,0.0007030021,0.0015642215,0.0009926293,0.00006182753,0.0009263809],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9933703,0.003775654,0.0012930899,0.0007203839,0.0005627841,0.0002778265],"domain_scores_gemma":[0.99150544,0.005751569,0.0015399976,0.0003378841,0.0006092014,0.00025589077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009913426,0.0029633117,0.02252773,0.0037274028,0.0006639077,0.0030818896,0.0020238159,0.0030615022,0.0043091234],"category_scores_gemma":[0.014733057,0.0014159455,0.044584636,0.004620654,0.0006810299,0.001337287,0.0011638331,0.0025356575,0.00036756293],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020880954,0.00009411765,0.0022368967,0.11291716,0.8563106,0.00009596919,0.000043003784,0.00054900406,0.00033402257,0.00008845532,0.00032458158,0.006125199],"study_design_scores_gemma":[0.0038756542,0.00061802915,0.0019302694,0.0039034386,0.9887916,0.00003721465,0.000023518756,0.0001914911,0.00008752156,0.00007904946,0.0004478295,0.0000144243],"about_ca_topic_score_codex":0.006014162,"about_ca_topic_score_gemma":0.010187871,"teacher_disagreement_score":0.02252773,"about_ca_system_score_codex":0.0018374431,"about_ca_system_score_gemma":0.0016040731,"threshold_uncertainty_score":0.05242783},"labels":[],"label_agreement":null},{"id":"W2794378246","doi":"10.2147/dddt.s130809","title":"Rucaparib: a novel PARP inhibitor for <em>BRCA</em> advanced ovarian cancer","year":2018,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"PARP inhibitor; Ovarian cancer; Cancer research; Medicine; Poly ADP ribose polymerase; Chemistry; Pharmacology; Cancer; Internal medicine; Biochemistry; DNA; Polymerase","score_opus":0.11202327551983936,"score_gpt":0.3535853993551428,"score_spread":0.24156212383530345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794378246","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72011137,0.20196971,0.014158374,0.002846227,0.0013243565,0.0012875422,0.0055559534,0.00329602,0.049450476],"genre_scores_gemma":[0.9356578,0.027711235,0.006185785,0.0018009758,0.00030093393,0.00051688525,0.0089576505,0.000088386456,0.018780353],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999925,0.000012687184,0.0000061684204,0.000018448038,0.000018838069,0.000018824834],"domain_scores_gemma":[0.9999491,0.0000043189902,0.000009087587,0.000004620975,0.0000088538145,0.000024121047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014289247,0.00052145135,0.0005418001,0.00041183003,0.00018926065,0.00038019792,0.00065954454,0.00056711916,0.0049437806],"category_scores_gemma":[0.000119157696,0.00013692689,0.00029454826,0.00045073603,0.00020704516,0.0002674433,0.000236828,0.001254634,0.0017393726],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008052686,0.003288453,0.0027731245,0.0020630423,0.00028946073,0.0023510258,0.000100149686,0.002602656,0.34937567,0.0020130745,0.044243153,0.5828476],"study_design_scores_gemma":[0.016921692,0.03378657,0.029660225,0.00038632812,0.00069734233,0.025222493,0.00008206494,0.014485911,0.4339208,0.00089389266,0.44376692,0.00017578153],"about_ca_topic_score_codex":0.0006002886,"about_ca_topic_score_gemma":0.00085234735,"teacher_disagreement_score":0.0049437806,"about_ca_system_score_codex":0.00039580077,"about_ca_system_score_gemma":0.00034520237,"threshold_uncertainty_score":0.01653862},"labels":[],"label_agreement":null},{"id":"W2800001750","doi":"10.2147/dddt.s163476","title":"Identification of novel drug targets in bovine respiratory disease: an essential step in applying biotechnologic techniques to develop more effective therapeutic treatments","year":2018,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Microbial infections and disease research","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"Mitacs; King Saud University","keywords":"Bovine respiratory disease; Druggability; Drug resistance; Antimicrobial; Medicine; Antibiotic resistance; Disease; Drug; Biology; Biotechnology; Antibiotics; Pharmacology; Microbiology; Immunology; Gene; Internal medicine; Genetics","score_opus":0.026797771367215267,"score_gpt":0.30955541747535614,"score_spread":0.28275764610814086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800001750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3825982,0.2302328,0.33682927,0.021417523,0.0013415877,0.0012878173,0.0032207887,0.0012593389,0.021812636],"genre_scores_gemma":[0.51199037,0.11006958,0.3592186,0.004259959,0.0004673786,0.00063277764,0.0031257207,0.00020945206,0.010026119],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99959403,0.00009608591,0.000039934304,0.000061012583,0.00015271784,0.00005621793],"domain_scores_gemma":[0.9995059,0.00015768174,0.000106904554,0.00007143772,0.00011058287,0.000047502945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009849834,0.0006395406,0.0009486538,0.000752896,0.000328029,0.0012782813,0.00054506,0.0011653862,0.003707031],"category_scores_gemma":[0.00061343855,0.00032328884,0.0007467029,0.00045963787,0.00059284724,0.0011689067,0.0004962743,0.0022069435,0.001485607],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015482878,0.00028144152,0.0011264394,0.00091240334,0.00003213644,0.00020970902,0.00006556333,0.0010456473,0.9303494,0.0032551491,0.0012023682,0.061364867],"study_design_scores_gemma":[0.000100445395,0.0025113458,0.0050373822,0.0004339839,0.00022472892,0.0018395972,0.000281911,0.0046413797,0.8237285,0.004909428,0.15622781,0.00006340874],"about_ca_topic_score_codex":0.000312741,"about_ca_topic_score_gemma":0.0006910451,"teacher_disagreement_score":0.003707031,"about_ca_system_score_codex":0.0008019548,"about_ca_system_score_gemma":0.00091554184,"threshold_uncertainty_score":0.012401223},"labels":[],"label_agreement":null},{"id":"W2807347319","doi":"10.2147/dddt.s166893","title":"Chloroquine and hydroxychloroquine are associated with reduced cardiovascular risk: a systematic review and meta-analysis","year":2018,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Drug-Induced Ocular Toxicity","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Key Research and Development Program of China; National Natural Science Foundation of China","keywords":"Medicine; Hydroxychloroquine; Relative risk; Internal medicine; Meta-analysis; Odds ratio; Hazard ratio; Confidence interval; Randomized controlled trial; Chloroquine; Disease; Immunology; Malaria","score_opus":0.10031656046798645,"score_gpt":0.2998698002566381,"score_spread":0.19955323978865167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807347319","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0044366987,0.9941963,0.00034753146,0.00016413078,0.00010738183,0.00022586931,0.00032733823,0.000017026185,0.00017766513],"genre_scores_gemma":[0.15068302,0.84383434,0.0021730685,0.00087584986,0.00030769684,0.0010144342,0.00078893115,0.00002850474,0.0002940714],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9916831,0.003893035,0.0022909686,0.00087080384,0.000982256,0.00027979238],"domain_scores_gemma":[0.98242074,0.01247951,0.0029960338,0.0004370242,0.0014182214,0.00024840632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01178421,0.002724485,0.0183245,0.006542742,0.0006655967,0.0029298281,0.0023576487,0.0023826996,0.0036112557],"category_scores_gemma":[0.026207926,0.0015186634,0.040455874,0.0071552275,0.00073572004,0.0014669012,0.001399451,0.0017544341,0.00024775648],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021081807,0.00003939834,0.0045879716,0.37346113,0.60669017,0.00013403926,0.00007849775,0.00049591484,0.00020232338,0.0001052006,0.00059766794,0.011499479],"study_design_scores_gemma":[0.0005195102,0.00017094337,0.003950247,0.020226963,0.9733757,0.000101546364,0.000034557288,0.00017683674,0.00009078604,0.00013147507,0.0012002378,0.000021176143],"about_ca_topic_score_codex":0.0066816164,"about_ca_topic_score_gemma":0.014410225,"teacher_disagreement_score":0.0183245,"about_ca_system_score_codex":0.0026068029,"about_ca_system_score_gemma":0.0031140253,"threshold_uncertainty_score":0.062321603},"labels":[],"label_agreement":null},{"id":"W2886448521","doi":"10.2147/dddt.s171269","title":"Preclinical safety evaluation of hepatic arterial infusion of oncolytic poxvirus","year":2018,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nexen (Canada)","funders":"National Research Foundation of Korea; Ministry of Science, ICT and Future Planning; National Research Foundation","keywords":"Oncolytic virus; Medicine; Cirrhosis; Vaccinia; Hepatocellular carcinoma; Liver cancer; Cancer; Pathology; Internal medicine; Biology; Gene","score_opus":0.07173052238067792,"score_gpt":0.35809555017354733,"score_spread":0.28636502779286943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886448521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832882,0.0022422664,0.010399071,0.00017677339,0.00014032648,0.0006909839,0.00053862756,0.00014488908,0.0023789513],"genre_scores_gemma":[0.98866767,0.00247379,0.0051553957,0.000084523934,0.000070603666,0.00055937254,0.0007775204,0.0000316862,0.0021794382],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99963224,0.00011108394,0.000032789692,0.000055394572,0.000096653894,0.00007187367],"domain_scores_gemma":[0.9994123,0.00012258653,0.00018564198,0.000082352046,0.000104152095,0.00009298317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001006623,0.00063699426,0.00045044118,0.0004300218,0.00021931948,0.00045951217,0.0004443001,0.0004905431,0.0016998977],"category_scores_gemma":[0.0007057129,0.0001947862,0.00036984624,0.0002055428,0.0005829931,0.00046378575,0.00017044596,0.001116964,0.00031991405],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045333835,0.0033894817,0.0012969095,0.0002688056,0.00006152954,0.00014699834,0.00013233996,0.00163009,0.97265685,0.00042854768,0.00046843034,0.014986647],"study_design_scores_gemma":[0.00036086704,0.07559328,0.003543048,0.00004633538,0.00018141416,0.0003413702,0.00008144531,0.004631208,0.91019094,0.0001583882,0.004853115,0.000018637851],"about_ca_topic_score_codex":0.0005996624,"about_ca_topic_score_gemma":0.0005221325,"teacher_disagreement_score":0.0016998977,"about_ca_system_score_codex":0.00042781472,"about_ca_system_score_gemma":0.00054752047,"threshold_uncertainty_score":0.0056867003},"labels":[],"label_agreement":null},{"id":"W2886610362","doi":"10.2147/dddt.s147276","title":"Current research for a vaccine against Lassa hemorrhagic fever virus","year":2018,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada; University of Manitoba","funders":"","keywords":"Lassa virus; Lassa fever; Arenavirus; Case fatality rate; Virology; Viral hemorrhagic fever; Medicine; Outbreak; Transmission (telecommunications); Immunology; Clinical trial; Ebola virus; Immune system; Virus; Environmental health; Population","score_opus":0.31617845031761993,"score_gpt":0.47198514887017323,"score_spread":0.1558066985525533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886610362","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012059532,0.9978531,0.000121038574,0.00039024773,0.00024979998,0.000007767918,0.000025327741,0.000008175174,0.0012240019],"genre_scores_gemma":[0.00069365144,0.99779713,0.0002594439,0.0002767184,0.00012189814,0.000011050131,0.000039343064,0.000001909192,0.00079890963],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974924,0.000047291367,0.000042551863,0.000039183604,0.00009510938,0.000026668098],"domain_scores_gemma":[0.9996779,0.0001549167,0.000044327695,0.000012065172,0.00008626443,0.00002453594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006541475,0.0006794222,0.0010051423,0.0021387108,0.00028262867,0.00097550417,0.0007032617,0.0013520573,0.0061270683],"category_scores_gemma":[0.00095273805,0.00030138314,0.0006772746,0.001600933,0.00035025974,0.0017456358,0.0005823889,0.0021157225,0.0026712574],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007022484,0.00009181057,0.0001360411,0.035782177,0.00009450065,0.00017781081,0.00010637282,0.00035319923,0.003925488,0.006579795,0.045310892,0.90737164],"study_design_scores_gemma":[0.000011267483,0.000055052256,0.00030365033,0.0042008017,0.0000717615,0.00043564296,0.000036897472,0.000034800087,0.00044929623,0.0012188738,0.99317366,0.000008238814],"about_ca_topic_score_codex":0.0010489258,"about_ca_topic_score_gemma":0.0013642787,"teacher_disagreement_score":0.0061270683,"about_ca_system_score_codex":0.00054650614,"about_ca_system_score_gemma":0.0012474295,"threshold_uncertainty_score":0.020497084},"labels":[],"label_agreement":null},{"id":"W2890299984","doi":"10.2147/dddt.s172068","title":"Efficacy and safety of a fixed-dose combination of nimesulide/pantoprazole compared to naproxen/esomeprazole for pain relief in patients with osteoarticular diseases and dyspeptic symptoms","year":2018,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nimesulide; Medicine; Esomeprazole; Nausea; Pantoprazole; Internal medicine; Adverse effect; Visual analogue scale; Gastroenterology; Anesthesia","score_opus":0.010983453292885966,"score_gpt":0.23002410831797548,"score_spread":0.21904065502508951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890299984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99083626,0.007099284,0.00021050689,0.00019577306,0.00013624737,0.00055383507,0.00018647475,0.000027154734,0.00075448776],"genre_scores_gemma":[0.9963605,0.0015757689,0.00074183824,0.00021521465,0.0001850144,0.00028514542,0.00018523437,0.0000051837083,0.00044606737],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9987902,0.00056498055,0.00013858564,0.00017718982,0.00026285916,0.00006616644],"domain_scores_gemma":[0.99855167,0.0004627341,0.00048357717,0.00009931911,0.0001231178,0.0002796021],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012550069,0.00063846813,0.002599856,0.00041286266,0.00028899993,0.00050564355,0.00079414103,0.0010431599,0.0029616542],"category_scores_gemma":[0.0025291257,0.0004511332,0.0013533848,0.00031955316,0.00050463143,0.0005231208,0.00024410198,0.0011761546,0.00045452276],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.863757,0.010169743,0.0050507863,0.001226122,0.0023364788,0.00008793753,0.00007648485,0.00042170705,0.010349268,0.000040686045,0.00043713392,0.1060467],"study_design_scores_gemma":[0.409307,0.5504593,0.033227738,0.00009860182,0.0022305392,0.00029864354,0.000057883983,0.0010679401,0.002147896,0.000048806083,0.0010167053,0.000038955826],"about_ca_topic_score_codex":0.00059143605,"about_ca_topic_score_gemma":0.0020703883,"teacher_disagreement_score":0.0029616542,"about_ca_system_score_codex":0.0006665873,"about_ca_system_score_gemma":0.0006338043,"threshold_uncertainty_score":0.009907782},"labels":[],"label_agreement":null},{"id":"W2890671849","doi":"10.2147/dddt.s168878","title":"Alpha lipoic acid combined with epalrestat: a therapeutic option for patients with diabetic peripheral neuropathy","year":2018,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Biochemical Acid Research Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Guangzhou University; National Natural Science Foundation of China","keywords":"Peripheral neuropathy; Medicine; Peripheral; Diabetic neuropathy; Lipoic acid; Alpha-Lipoic Acid; Diabetes mellitus; Pharmacology; Surgery; Internal medicine; Endocrinology; Chemistry; Biochemistry","score_opus":0.029194135093338743,"score_gpt":0.2734795362707481,"score_spread":0.24428540117740938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890671849","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005450335,0.99370366,0.000104606355,0.00021620088,0.00008483246,0.000069120346,0.000044290584,0.000004380609,0.0003225872],"genre_scores_gemma":[0.08752831,0.9097095,0.0010673291,0.00081035245,0.0002536776,0.00029896598,0.000118883814,0.0000035630112,0.00020945545],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99877733,0.0005173297,0.00036787224,0.00011591609,0.0001720582,0.00004950562],"domain_scores_gemma":[0.9979546,0.001223345,0.0005991605,0.000028372291,0.00013345054,0.00006107364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025912048,0.00061488815,0.003859884,0.002355259,0.00033273146,0.0010063258,0.00071335473,0.0013330659,0.0029396496],"category_scores_gemma":[0.0040153186,0.0003714674,0.0040168217,0.0017749995,0.00040883702,0.001007774,0.000475039,0.0011068465,0.00017141244],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011936133,0.00046886125,0.0026230558,0.6333577,0.017034564,0.0003815419,0.00018446641,0.00030489155,0.0019629917,0.0005840175,0.0024266613,0.32873514],"study_design_scores_gemma":[0.038463462,0.018010866,0.03117233,0.5571551,0.2655258,0.003994135,0.0011349897,0.0013313341,0.0035031915,0.0026357549,0.07687346,0.00019967667],"about_ca_topic_score_codex":0.0013499426,"about_ca_topic_score_gemma":0.0030961803,"teacher_disagreement_score":0.003859884,"about_ca_system_score_codex":0.0006399305,"about_ca_system_score_gemma":0.0016122113,"threshold_uncertainty_score":0.0137037635},"labels":[],"label_agreement":null},{"id":"W2891834094","doi":"10.2147/dddt.s174928","title":"The effect of food and liquid pH on the integrity of enteric-coated beads from cysteamine bitartrate delayed-release capsules","year":2018,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Biomedical Research and Pathophysiology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Horizon Pharma; American Pharmacists Association","keywords":"Cysteamine; Enteric coated; Chemistry; Pharmacology; Chromatography; Medicine; Biochemistry","score_opus":0.027843459954816623,"score_gpt":0.27507944021318476,"score_spread":0.24723598025836813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891834094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973346,0.0011422565,0.00048301424,0.000028350338,0.00002876292,0.000026350477,0.00027538757,0.000019968707,0.0006612681],"genre_scores_gemma":[0.99636036,0.0005418558,0.0012902383,0.00004518265,0.000008746143,0.00002926091,0.00057587307,0.00002145978,0.001127031],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994752,0.00010441813,0.000067999856,0.000097465876,0.00015866842,0.00009622524],"domain_scores_gemma":[0.99897826,0.0002527751,0.000376572,0.00007099356,0.00022227516,0.000099261815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004973609,0.0004395552,0.00033029975,0.00019610485,0.00021533978,0.00047758993,0.00026152472,0.00033097147,0.0019604492],"category_scores_gemma":[0.0010544584,0.00022242549,0.00041794416,0.00021537901,0.00031566012,0.00044549035,0.00036236044,0.00050335214,0.0003727974],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004514099,0.0002080824,0.0033197005,0.00024967364,0.0000763042,0.00016069443,0.00015509065,0.00023352067,0.9842532,0.000029471943,0.00009597836,0.006704151],"study_design_scores_gemma":[0.000031442,0.0038161902,0.024771156,0.000028865514,0.00009347504,0.00016242357,0.000098544006,0.00074084924,0.9692063,0.000012067746,0.0010200959,0.00001858368],"about_ca_topic_score_codex":0.001263152,"about_ca_topic_score_gemma":0.0011745391,"teacher_disagreement_score":0.0019604492,"about_ca_system_score_codex":0.00030831044,"about_ca_system_score_gemma":0.00023175645,"threshold_uncertainty_score":0.0065583587},"labels":[],"label_agreement":null},{"id":"W2891907584","doi":"10.2147/dddt.s172538","title":"Macrocyclic lactones inhibit nasopharyngeal carcinoma cells proliferation through PAK1 inhibition and reduce in vivo tumor growth","year":2018,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Parasitic Diseases Research and Treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Institut National de la Santé et de la Recherche Médicale","keywords":"Nasopharyngeal carcinoma; In vivo; Cytotoxic T cell; Medicine; Cancer research; Cancer; Pharmacology; Cytotoxicity; In vitro; Immunology; Biology; Radiation therapy; Internal medicine; Biochemistry","score_opus":0.03305226841364001,"score_gpt":0.29481395273461763,"score_spread":0.26176168432097763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891907584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985047,0.00884711,0.0014749116,0.00014130585,0.000041202708,0.00007667887,0.00066143036,0.00014811523,0.0035622944],"genre_scores_gemma":[0.9917783,0.004069584,0.001073371,0.0000663739,0.000009152512,0.000049016482,0.00041752114,0.00001023918,0.0025264884],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999972,0.00000474275,0.0000023799287,0.00000523338,0.0000067535925,0.000008863801],"domain_scores_gemma":[0.9999651,0.0000049748965,0.000013381078,0.0000030459576,0.000004411197,0.000009196338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000043807628,0.00034324452,0.00017395618,0.00017501414,0.000075735436,0.00010783773,0.00012924674,0.00012999376,0.0019533064],"category_scores_gemma":[0.000066628716,0.00005867681,0.00016903173,0.0001097576,0.00012397626,0.00010963292,0.0001044056,0.00029992615,0.00031105443],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004952293,0.00014105617,0.0003932683,0.00018586717,0.00001210246,0.000054774035,0.000014117937,0.0002838729,0.98862094,0.0000580045,0.0001789765,0.00956174],"study_design_scores_gemma":[0.00007867104,0.00416546,0.0058913236,0.000017803824,0.000028830578,0.0001832846,0.000021971793,0.00052511494,0.98458374,0.000030405312,0.004467719,0.0000056899885],"about_ca_topic_score_codex":0.00048442432,"about_ca_topic_score_gemma":0.0011925794,"teacher_disagreement_score":0.0019533064,"about_ca_system_score_codex":0.00015279907,"about_ca_system_score_gemma":0.00016030276,"threshold_uncertainty_score":0.006534457},"labels":[],"label_agreement":null},{"id":"W2894830330","doi":"10.2147/dddt.s167382","title":"Synthesis and anticancer activity of dimeric podophyllotoxin derivatives","year":2018,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Plant-derived Lignans Synthesis and Bioactivity","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lakehead University","funders":"Institute of Botany, Chinese Academy of Sciences; National Key Research and Development Program of China; Kunming Institute of Botany, Chinese Academy of Sciences; State Key Laboratory of Phytochemistry and Plant Resources in West China; Chinese Academy of Sciences","keywords":"Podophyllotoxin; Etoposide; Chemistry; Triazole; Cytotoxicity; MTT assay; Click chemistry; Combinatorial chemistry; Stereochemistry; Cell growth; In vitro; Biochemistry; Biology; Chemotherapy; Organic chemistry","score_opus":0.022126889974903283,"score_gpt":0.23917903709522956,"score_spread":0.21705214712032628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2894830330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846502,0.0029407085,0.008681169,0.00013134583,0.000045301305,0.000086654734,0.0004047832,0.000057274297,0.0030025532],"genre_scores_gemma":[0.99048096,0.0017907338,0.0047081746,0.00005106938,0.000009239804,0.000037273825,0.0005246716,0.000012798687,0.002385097],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999528,0.0000068596246,0.000006119887,0.000011932052,0.000010112077,0.000012215257],"domain_scores_gemma":[0.99994075,0.000004116422,0.000021841573,0.0000080768905,0.0000099169865,0.000015328327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008656508,0.00024903443,0.00016704907,0.00014189558,0.00009821331,0.00014705311,0.00016934842,0.00016568674,0.000973286],"category_scores_gemma":[0.000109955916,0.000083590756,0.00014763701,0.00020789143,0.00008380938,0.00018956588,0.0001393032,0.00038970768,0.00020541683],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008618106,0.00007250678,0.00019766946,0.00008399414,0.000008943445,0.00008839702,0.000024560943,0.00043627003,0.994709,0.00016054146,0.00008335758,0.004048601],"study_design_scores_gemma":[0.000051186642,0.0009782194,0.0015100103,0.00001220273,0.000036295864,0.00031101462,0.000021259566,0.0009516017,0.9890905,0.00007480221,0.0069554374,0.0000075142434],"about_ca_topic_score_codex":0.000143676,"about_ca_topic_score_gemma":0.00024579422,"teacher_disagreement_score":0.000973286,"about_ca_system_score_codex":0.00020517193,"about_ca_system_score_gemma":0.00014177643,"threshold_uncertainty_score":0.0032559633},"labels":[],"label_agreement":null},{"id":"W2897528830","doi":"10.2147/dddt.s172487","title":"Antioxidative stress effects of vitamins C, E, and B<sub>12</sub>, and their combination can protect the liver against acetaminophen-induced hepatotoxicity in rats","year":2018,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"College of Pharmacy and Nutrition, University of Saskatchewan; University of Petra","keywords":"Acetaminophen; Oxidative stress; Pharmacology; Vitamin E; In vivo; Antioxidant; Chemistry; Hepatocyte; Glutathione; Vitamin C; Lipid peroxidation; Superoxide dismutase; Hepatoprotection; Liver injury; Biochemistry; In vitro; Enzyme; Medicine; Biology","score_opus":0.06731345294423799,"score_gpt":0.31041097095283504,"score_spread":0.24309751800859705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897528830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99502003,0.002975626,0.0010998972,0.000097216674,0.000031239117,0.000025874342,0.00010782549,0.000046706144,0.0005955425],"genre_scores_gemma":[0.9930026,0.002073707,0.0020474154,0.0000684263,0.000018622746,0.000047333368,0.00021930395,0.000012936583,0.0025096547],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999039,0.000018263774,0.000016132628,0.000015589196,0.000022699285,0.00002352801],"domain_scores_gemma":[0.99982834,0.0000149651105,0.00006149614,0.000020465222,0.000025468507,0.000049177957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015010167,0.00054033543,0.00038304797,0.00056861626,0.0001672791,0.00019046306,0.0002145663,0.0003059419,0.0010222732],"category_scores_gemma":[0.00015797114,0.00017768482,0.00026873048,0.00021378745,0.00029075347,0.00026332316,0.00019257642,0.0004932057,0.00016889833],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066384496,0.00063698424,0.0009442196,0.00021466536,0.000074688825,0.000098032804,0.000042555475,0.00016292161,0.98320454,0.000090944544,0.000095295254,0.007796635],"study_design_scores_gemma":[0.00018373688,0.00780185,0.0056049707,0.000028938566,0.00021578012,0.0002151185,0.00007409778,0.00041446378,0.9829047,0.000085653795,0.0024561556,0.000014523401],"about_ca_topic_score_codex":0.00075275893,"about_ca_topic_score_gemma":0.0011977553,"teacher_disagreement_score":0.0010222732,"about_ca_system_score_codex":0.00013663238,"about_ca_system_score_gemma":0.0002995795,"threshold_uncertainty_score":0.003419876},"labels":[],"label_agreement":null},{"id":"W2900391822","doi":"10.2147/dddt.s138765","title":"CTL019 (tisagenlecleucel): CAR-T therapy for relapsed and refractory B-cell acute lymphoblastic leukemia","year":2018,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Cytokine release syndrome; Chimeric antigen receptor; Context (archaeology); Medicine; Oncology; Internal medicine; Immunotherapy; Cancer; Biology","score_opus":0.06862769789823206,"score_gpt":0.32885039219268575,"score_spread":0.26022269429445366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900391822","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021794873,0.9982305,0.00011583375,0.00016896405,0.00013579894,0.000005981772,0.000017096187,0.0000101332025,0.0010978362],"genre_scores_gemma":[0.0013642724,0.9972721,0.0001690154,0.00021583556,0.00010441616,0.000009082476,0.000037192647,0.0000018283779,0.00082632684],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998771,0.000019959545,0.000021392483,0.000023409297,0.000047583755,0.00001064643],"domain_scores_gemma":[0.99988484,0.000049080656,0.000023635735,0.0000034338027,0.000025933265,0.000013088567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030466268,0.0005444229,0.00074117666,0.002014415,0.00022156084,0.00048816905,0.0005689201,0.00062226696,0.0025653495],"category_scores_gemma":[0.00036663606,0.00015828568,0.00032311564,0.0015560373,0.00027922905,0.0007257316,0.00044985025,0.0014205012,0.0017590224],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000657866,0.000060720864,0.00008092352,0.009007316,0.00005142875,0.00014042185,0.000038138063,0.00024563028,0.0015123185,0.0019173605,0.021499433,0.9653806],"study_design_scores_gemma":[0.00002645664,0.00012568162,0.00052635244,0.0019902599,0.00007740385,0.0018696191,0.000031736105,0.00007751118,0.00067216,0.00073637825,0.99385494,0.000011460638],"about_ca_topic_score_codex":0.0006869108,"about_ca_topic_score_gemma":0.0012229,"teacher_disagreement_score":0.0025653495,"about_ca_system_score_codex":0.0003449367,"about_ca_system_score_gemma":0.0005334413,"threshold_uncertainty_score":0.008581936},"labels":[],"label_agreement":null},{"id":"W2902197007","doi":"10.2147/dddt.s186614","title":"Synthesis of small peptide compounds, molecular docking, and inhibitory activity evaluation against phosphatases PTP1B and SHP2","year":2018,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Natural Sciences and Engineering Research Council of Canada; Allard Foundation","keywords":"Allosteric regulation; Biochemistry; Phosphatase; Docking (animal); Peptide; Chemistry; Enzyme; Protein tyrosine phosphatase; Active site; Tripeptide; Binding site; IC50; In vitro","score_opus":0.024099581247320437,"score_gpt":0.24976968129948887,"score_spread":0.22567010005216842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902197007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9350138,0.010984535,0.033521563,0.00038665137,0.00015969836,0.00065752235,0.00435869,0.0005737187,0.014343904],"genre_scores_gemma":[0.93280065,0.008631401,0.0513158,0.00012486,0.000027711374,0.0006808308,0.0030257546,0.00010282582,0.0032901845],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999093,0.000012094672,0.000006413968,0.000021803406,0.0000321697,0.000018224639],"domain_scores_gemma":[0.99992585,0.00001875439,0.000017803608,0.0000065893773,0.000017193854,0.00001393187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015053712,0.00063345255,0.00078918354,0.00034786176,0.00024407265,0.00041376986,0.0004535135,0.0003172655,0.0037280347],"category_scores_gemma":[0.00035289518,0.00023540523,0.0005058807,0.0006113324,0.00014460707,0.0003240578,0.00025697163,0.0006393123,0.0007563002],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013060186,0.0013869415,0.0014591499,0.0038858082,0.0002410228,0.001541751,0.00011487139,0.30495214,0.60656184,0.004409238,0.0035302357,0.07061098],"study_design_scores_gemma":[0.0012925193,0.007906126,0.0019980841,0.0001389079,0.0003549318,0.0007443555,0.00012186044,0.27004135,0.6860576,0.0015800464,0.029650766,0.000113354625],"about_ca_topic_score_codex":0.0007600011,"about_ca_topic_score_gemma":0.0013606747,"teacher_disagreement_score":0.0037280347,"about_ca_system_score_codex":0.0003060624,"about_ca_system_score_gemma":0.00040950323,"threshold_uncertainty_score":0.012471497},"labels":[],"label_agreement":null},{"id":"W2917800338","doi":"10.2147/dddt.s180836","title":"<p>siRNA-based breast cancer therapy by suppressing 17β-hydroxysteroid dehydrogenase type 1 in an optimized xenograft cell and molecular biology model in vivo</p>","year":2019,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Shanghai Institute Of Planned Parenthood Research; Shanghai Municipal Health and Family Planning Commission; Science and Technology Commission of Shanghai Municipality","keywords":"In vivo; Gene knockdown; Gene silencing; Estrone; Chemistry; Cancer research; Cell growth; Small interfering RNA; Breast cancer; Pharmacology; Cancer; Biology; Apoptosis; Medicine; Internal medicine; Biochemistry; Hormone; RNA; Gene","score_opus":0.010325199561902046,"score_gpt":0.24328675180174203,"score_spread":0.23296155223984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917800338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95458746,0.002946385,0.03498989,0.0003996281,0.0001616851,0.000269373,0.0008776672,0.0006274008,0.0051404564],"genre_scores_gemma":[0.95373666,0.0027913188,0.030283133,0.00013888249,0.000020665573,0.0004104116,0.0011658286,0.00008763846,0.011365422],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999858,0.000018134762,0.000013108164,0.000036725054,0.000051000574,0.000022917582],"domain_scores_gemma":[0.99995196,0.0000067899127,0.000015063331,0.0000066783423,0.000008896244,0.000010619361],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019919338,0.00037877995,0.00031878572,0.00023552804,0.00014201754,0.00017485916,0.00027344466,0.00031796528,0.00088345405],"category_scores_gemma":[0.00006029789,0.00015187697,0.00028272436,0.0001570087,0.00023848873,0.00021722338,0.00010556186,0.00041906766,0.00037312132],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007123637,0.000042849748,0.00005512768,0.000050361326,0.0000040042123,0.000034077577,0.000012751918,0.00014363117,0.9976815,0.00013765482,0.00012355087,0.0016430953],"study_design_scores_gemma":[0.000017930777,0.00029105454,0.00034052136,0.0000030127374,0.000013997744,0.000104947045,0.00000638511,0.0011687102,0.99531174,0.000018673474,0.0027193674,0.000003694911],"about_ca_topic_score_codex":0.0013141212,"about_ca_topic_score_gemma":0.0018195509,"teacher_disagreement_score":0.0013141212,"about_ca_system_score_codex":0.0003270566,"about_ca_system_score_gemma":0.00040266616,"threshold_uncertainty_score":0.0029554963},"labels":[],"label_agreement":null},{"id":"W2937366373","doi":"10.2147/dddt.s196119","title":"<p>Beneficial effects of resveratrol and exercise training on cardiac and aortic function and structure in the 3xTg mouse model of Alzheimer’s disease</p>","year":2019,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Adipose Tissue and Metabolism","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Midwestern University; Diabetes Action Research and Education Foundation","keywords":"Resveratrol; Disease; Medicine; Cardiac function curve; Cardiology; Neuroscience; Internal medicine; Pharmacology; Physical medicine and rehabilitation; Psychology; Heart failure","score_opus":0.025725236446243693,"score_gpt":0.24283950326570813,"score_spread":0.21711426681946444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2937366373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945186,0.0007528193,0.0014008741,0.00040756474,0.00009595362,0.00007331629,0.0014581367,0.0002910762,0.0010017972],"genre_scores_gemma":[0.9820296,0.0016028485,0.004880737,0.00037172833,0.00006016993,0.00028200637,0.0021589077,0.00015906077,0.00845494],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997832,0.000030902942,0.00003111785,0.000053500444,0.00004719273,0.000054094347],"domain_scores_gemma":[0.9996958,0.000016618778,0.00012515778,0.000030260322,0.000027189097,0.00010501117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037006364,0.0011297727,0.00077766494,0.000961429,0.00039497134,0.00050094933,0.00041510462,0.0009700314,0.0023533583],"category_scores_gemma":[0.000112324684,0.00038743953,0.00086077437,0.00031938686,0.0007660343,0.0004931126,0.00028658565,0.0015225767,0.00051065034],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023208356,0.000569523,0.00039342028,0.000126899,0.000036202175,0.00021524845,0.000048464837,0.000097644035,0.9931982,0.0001739518,0.00025407106,0.0025654873],"study_design_scores_gemma":[0.0012383161,0.012593141,0.046335123,0.0001270371,0.00051372906,0.0015319634,0.00030355345,0.003346618,0.9249934,0.0006601628,0.008273525,0.0000834811],"about_ca_topic_score_codex":0.00095823064,"about_ca_topic_score_gemma":0.0015973952,"teacher_disagreement_score":0.0023533583,"about_ca_system_score_codex":0.00038796366,"about_ca_system_score_gemma":0.00028833552,"threshold_uncertainty_score":0.00787282},"labels":[],"label_agreement":null},{"id":"W2975456987","doi":"10.2147/dddt.s217211","title":"<p>Hydrogels For Peptide Hormones Delivery: Therapeutic And Tissue Engineering Applications</p>","year":2019,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Hydrogels: synthesis, properties, applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Kerman University of Medical Sciences","keywords":"Self-healing hydrogels; Peptide; Hormone; Tissue engineering; Chemistry; Biomedical engineering; Internal medicine; Medicine; Biochemistry; Organic chemistry","score_opus":0.03921277430519101,"score_gpt":0.2653786315775983,"score_spread":0.22616585727240726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2975456987","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016092629,0.9836295,0.0023532636,0.0003610256,0.00042514855,0.00002573123,0.00010989337,0.00005825388,0.011427899],"genre_scores_gemma":[0.00708768,0.980409,0.0020243006,0.00023233303,0.00014289154,0.000035349352,0.00012610941,0.000013016125,0.009929424],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999161,0.000008909476,0.0000071974578,0.000014991338,0.000041835465,0.000010992967],"domain_scores_gemma":[0.9999405,0.000019859719,0.000012937086,0.0000027657989,0.000016246206,0.00000767573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022591143,0.0005871802,0.0004102777,0.0012195668,0.00019175721,0.0005816205,0.00032691946,0.0005536014,0.0044095586],"category_scores_gemma":[0.00016398597,0.00017709029,0.00027832534,0.001140116,0.00022803133,0.0007963462,0.00038821893,0.0008463544,0.0029046324],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046255278,0.000094647985,0.000099112614,0.012110196,0.000040944353,0.00028059192,0.000060262868,0.0005464946,0.045002516,0.00794214,0.024009766,0.90976715],"study_design_scores_gemma":[0.0000071102836,0.00008287082,0.00039011633,0.00096705894,0.000029937211,0.00084058766,0.000029268045,0.00026692645,0.015368978,0.0013416869,0.9806604,0.000015135225],"about_ca_topic_score_codex":0.00048681794,"about_ca_topic_score_gemma":0.0009122721,"teacher_disagreement_score":0.0044095586,"about_ca_system_score_codex":0.00032216517,"about_ca_system_score_gemma":0.0004367805,"threshold_uncertainty_score":0.014751434},"labels":[],"label_agreement":null},{"id":"W2980521005","doi":"10.2147/dddt.s205820","title":"<p>Clinical And Bacteriological Impact Of Clarithromycin In Streptococcal Pharyngitis: Findings From A Meta-Analysis Of Clinical Trials</p>","year":2019,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Streptococcal Infections and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Pharyngitis; Medicine; Clarithromycin; Meta-analysis; Clinical trial; Internal medicine; Microbiology; Biology","score_opus":0.4968928949834816,"score_gpt":0.5101473942419875,"score_spread":0.013254499258505914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980521005","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011940016,0.99799794,0.00009422478,0.00020387014,0.00007867694,0.000055570305,0.00017187277,0.0000069317257,0.00019691541],"genre_scores_gemma":[0.04946994,0.94807184,0.00095924904,0.0004983245,0.00022898141,0.00018571194,0.00032962728,0.000012279476,0.00024405115],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99572337,0.0021382163,0.00095295056,0.00042707587,0.00060146477,0.00015695699],"domain_scores_gemma":[0.98639375,0.010534749,0.0018592234,0.0002539069,0.00077606394,0.00018230018],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00878086,0.0017467495,0.008320129,0.0041964054,0.00037705354,0.0024202436,0.0010245397,0.0014698732,0.005495826],"category_scores_gemma":[0.02114168,0.0007641631,0.017071318,0.004443401,0.00045564497,0.0010259247,0.0009332844,0.0012401225,0.00031380967],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034456404,0.000043648597,0.0047885864,0.6321016,0.2709564,0.00020207424,0.00009197127,0.00051417155,0.0005451917,0.00043636304,0.0037607034,0.08311363],"study_design_scores_gemma":[0.001522217,0.00049323286,0.012088489,0.0950226,0.874373,0.00031053388,0.00008111265,0.0003250262,0.00053618255,0.0006965978,0.014500716,0.0000503096],"about_ca_topic_score_codex":0.0054250597,"about_ca_topic_score_gemma":0.010880799,"teacher_disagreement_score":0.99167985,"about_ca_system_score_codex":0.0018907008,"about_ca_system_score_gemma":0.003402383,"threshold_uncertainty_score":0.046438217},"labels":[],"label_agreement":null},{"id":"W2981860386","doi":"10.2147/dddt.s207856","title":"<p>Cardio- Renal Outcomes With Long- Term Agalsidase Alfa Enzyme Replacement Therapy: A 10- Year Fabry Outcome Survey (FOS) Analysis</p>","year":2019,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Swedish Orphan Biovitrum; JCR Pharmaceuticals; Amicus Therapeutics; Alexion Pharmaceuticals; Ultragenyx Pharmaceutical; Sanofi; Idorsia Pharmaceuticals; Shire Human Genetic Therapies; GlaxoSmithKline","keywords":"Medicine; Renal function; Internal medicine; Cohort; Urology; Left ventricular hypertrophy; Fabry disease; Cardiology; Endocrinology; Blood pressure","score_opus":0.043324552126888585,"score_gpt":0.29557840456518314,"score_spread":0.25225385243829457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981860386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99072874,0.000772551,0.0008985668,0.00036008147,0.000018413599,0.00009110149,0.006228866,0.000019972187,0.00088160514],"genre_scores_gemma":[0.9945714,0.00019885667,0.00044548046,0.0001385409,0.000025813124,0.0000924974,0.004073538,0.0000058149717,0.0004479926],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992692,0.0003491309,0.00007356674,0.00009990965,0.00012299755,0.000085093656],"domain_scores_gemma":[0.9979722,0.0003125533,0.0011933635,0.00009074609,0.00019280089,0.00023832537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025671232,0.00028151076,0.00026326292,0.0005911542,0.0001412324,0.00057274144,0.00025064993,0.00024448187,0.0009135794],"category_scores_gemma":[0.0023713682,0.00010652116,0.0009039492,0.00081074226,0.00020629674,0.00052229746,0.0004811851,0.00043223434,0.00019768917],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025295196,0.00008197035,0.97991794,0.00009373654,0.0009307944,0.00006478529,0.000053591415,0.00042071426,0.00026702444,0.000080380145,0.0021756988,0.0133837825],"study_design_scores_gemma":[0.0002390888,0.00090848317,0.9946879,0.000035124158,0.0006545506,0.00015028821,0.00008693826,0.0012042903,0.00031010783,0.000096436575,0.0016184957,0.000008301497],"about_ca_topic_score_codex":0.0041034296,"about_ca_topic_score_gemma":0.004834787,"teacher_disagreement_score":0.0041034296,"about_ca_system_score_codex":0.00059026974,"about_ca_system_score_gemma":0.0006013136,"threshold_uncertainty_score":0.013576448},"labels":[],"label_agreement":null},{"id":"W2981956000","doi":"10.2147/dddt.s215895","title":"<p>Glucoside Derivatives Of Podophyllotoxin: Synthesis, Physicochemical Properties, And Cytotoxicity</p>","year":2019,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Plant-derived Lignans Synthesis and Bioactivity","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lakehead University","funders":"National Natural Science Foundation of China","keywords":"Podophyllotoxin; Etoposide; Cytotoxicity; Chemistry; Stereochemistry; Cell culture; Glucoside; Acetylation; In vitro; Pharmacology; Biochemistry; Biology; Chemotherapy; Medicine","score_opus":0.020595839385275348,"score_gpt":0.20405058636577636,"score_spread":0.18345474698050102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981956000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9679013,0.003947481,0.015814452,0.0002679361,0.000051382194,0.00016284859,0.0011758575,0.00018811825,0.010490639],"genre_scores_gemma":[0.9791303,0.002819021,0.012340661,0.000109599656,0.000017773187,0.00008256425,0.0011934744,0.000059055717,0.0042475984],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999461,0.00000884761,0.0000070133747,0.000009557483,0.00001859633,0.000009790162],"domain_scores_gemma":[0.9999262,0.000007290649,0.00002663413,0.000011368405,0.000012622462,0.000015911672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010589557,0.00027573275,0.00011210275,0.00015497571,0.00010027147,0.0001486945,0.00015103315,0.00014797274,0.0012185937],"category_scores_gemma":[0.00012171306,0.00007572785,0.00014287149,0.00028713976,0.00014145464,0.00025424678,0.00013297751,0.00035726227,0.00049111736],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008380514,0.000048182832,0.00027582908,0.00009597262,0.0000051327766,0.0001628699,0.000015417263,0.00036626653,0.9870123,0.00026437803,0.00013031269,0.011539496],"study_design_scores_gemma":[0.000018027733,0.0007318967,0.0021789316,0.000010913192,0.000014855818,0.00036862984,0.00001179155,0.00059190905,0.990229,0.00010479128,0.0057326066,0.000006555504],"about_ca_topic_score_codex":0.00028984153,"about_ca_topic_score_gemma":0.00031789287,"teacher_disagreement_score":0.0012185937,"about_ca_system_score_codex":0.00015094,"about_ca_system_score_gemma":0.00016598355,"threshold_uncertainty_score":0.0040766},"labels":[],"label_agreement":null},{"id":"W3001770977","doi":"10.2147/dddt.s231293","title":"<p>Effect of Fimasartan versus Valsartan and Olmesartan on Office and Ambulatory Blood Pressure in Korean Patients with Mild-to-Moderate Essential Hypertension: A Randomized, Double-Blind, Active Control, Three-Parallel Group, Forced Titration, Multicenter, Phase IV Study (Fimasartan Achieving Systolic Blood Pressure Target (FAST) Study)</p>","year":2020,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital","funders":"","keywords":"Olmesartan; Valsartan; Medicine; Ambulatory blood pressure; Blood pressure; Placebo; Clinical endpoint; Ambulatory; Essential hypertension; Internal medicine; Diastole; Randomized controlled trial","score_opus":0.026727821750584642,"score_gpt":0.2597212978676969,"score_spread":0.23299347611711224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3001770977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981499,0.0007466544,0.00017836774,0.00010077855,0.00008954833,0.0002845805,0.00016186664,0.000026014735,0.00026231163],"genre_scores_gemma":[0.9960211,0.0007994812,0.00101309,0.00039880179,0.0002106265,0.00046468753,0.00035083081,0.000012148781,0.00072921993],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99957484,0.0001943643,0.000046305253,0.00007717877,0.000042627005,0.00006454736],"domain_scores_gemma":[0.9993253,0.00009537264,0.00014031268,0.00005354994,0.00003547772,0.00034998494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011767381,0.0012491453,0.0027484153,0.00033936487,0.00036609906,0.0004967023,0.0005639728,0.0007047303,0.0019581488],"category_scores_gemma":[0.000715501,0.0006671062,0.001431186,0.00029094671,0.0008809734,0.00079961907,0.00028413814,0.0015711063,0.00033085284],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95913935,0.011482886,0.0022932198,0.00028921815,0.0008044959,0.000051269788,0.000048105347,0.00016967124,0.010454859,0.000042856595,0.000299913,0.014924195],"study_design_scores_gemma":[0.6960909,0.28334492,0.016391369,0.00001822433,0.0009006795,0.0000863157,0.00004091638,0.0005610312,0.0021329648,0.00006360006,0.00033754454,0.00003158759],"about_ca_topic_score_codex":0.00078049913,"about_ca_topic_score_gemma":0.0020716141,"teacher_disagreement_score":0.0027484153,"about_ca_system_score_codex":0.00048320353,"about_ca_system_score_gemma":0.0010779168,"threshold_uncertainty_score":0.0065507293},"labels":[],"label_agreement":null},{"id":"W3004841311","doi":"10.2147/dddt.s232325","title":"<p>Potential Use of Microbial Surfactant in Microemulsion Drug Delivery System: A Systematic Review</p>","year":2020,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Advancements in Transdermal Drug Delivery","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Kerman University of Medical Sciences","keywords":"Microemulsion; Pulmonary surfactant; Bioavailability; Lipopeptide; Drug; Chemistry; Pharmacology; Medicine; Biology; Biochemistry; Bacteria","score_opus":0.11281858157409172,"score_gpt":0.36106915020987007,"score_spread":0.24825056863577835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004841311","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017862729,0.9943705,0.00031739837,0.0008035748,0.00023700327,0.0011493177,0.000723965,0.000024152278,0.0005877361],"genre_scores_gemma":[0.018270722,0.97527134,0.0010929214,0.0015234392,0.00020917694,0.0024332153,0.0005480807,0.000012539932,0.0006385818],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9961945,0.0010276489,0.0013518215,0.00032065183,0.00090289186,0.00020253522],"domain_scores_gemma":[0.985595,0.008047636,0.0037365782,0.00022091746,0.0021516255,0.00024820043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0062041907,0.001389026,0.0056059863,0.009562086,0.00060905266,0.0024342742,0.0018393472,0.0022126755,0.009461868],"category_scores_gemma":[0.020390786,0.000746774,0.005571875,0.0092155505,0.0008164323,0.0026719563,0.0013639475,0.0007832081,0.0006924325],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012900178,0.000015280024,0.0004566243,0.9693187,0.00225871,0.00010420972,0.00008308909,0.000048055088,0.00022742443,0.00016742348,0.001778147,0.025413264],"study_design_scores_gemma":[0.00029000177,0.00030853986,0.0038021354,0.9290751,0.03367328,0.00048132022,0.0002877834,0.00017124094,0.00055041094,0.0004896089,0.03083131,0.00003937186],"about_ca_topic_score_codex":0.0045188596,"about_ca_topic_score_gemma":0.0115421275,"teacher_disagreement_score":0.009562086,"about_ca_system_score_codex":0.0038464519,"about_ca_system_score_gemma":0.011486229,"threshold_uncertainty_score":0.032811284},"labels":[],"label_agreement":null},{"id":"W3014583199","doi":"10.2147/dddt.s217010","title":"<p>The Efficacy of N-Butylphthalide and Dexamethasone Combined with Hyperbaric Oxygen on Delayed Encephalopathy After Acute Carbon Monoxide Poisoning</p>","year":2020,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Heme Oxygenase-1 and Carbon Monoxide","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hyperbaric oxygen; Carbon monoxide poisoning; Dexamethasone; Medicine; Anesthesia; Carbon monoxide; Encephalopathy; Oxygen; Pharmacology; Chemistry; Internal medicine; Poison control; Emergency medicine; Organic chemistry","score_opus":0.011834477130791134,"score_gpt":0.21070002678204897,"score_spread":0.19886554965125783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014583199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99746346,0.0020038676,0.000042650012,0.00006186596,0.000037855967,0.00007319455,0.00002598755,0.0000045054194,0.00028668935],"genre_scores_gemma":[0.9984068,0.0009794203,0.00015677344,0.00007083235,0.000080183076,0.000058146143,0.000055898283,9.2146445e-7,0.00019089272],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998661,0.00005112658,0.000020862766,0.000018179084,0.000018813207,0.000024874298],"domain_scores_gemma":[0.99978226,0.00003657551,0.00005648365,0.000012830729,0.000017072736,0.00009475302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002896832,0.00034465795,0.0008009021,0.00024939963,0.0002251311,0.00021470219,0.00026529303,0.00029395492,0.000770614],"category_scores_gemma":[0.0003373964,0.00010568191,0.00051050604,0.00018610596,0.0003253223,0.00025042685,0.00021016767,0.00050913444,0.00012751053],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5377717,0.055534102,0.046622593,0.002447136,0.0016301721,0.0016032717,0.00040957748,0.0009402398,0.083898365,0.00014509368,0.0010377476,0.26796004],"study_design_scores_gemma":[0.06519914,0.78857064,0.1221781,0.00016672589,0.0015235092,0.0012056443,0.00024051154,0.0011944182,0.017238125,0.000077536664,0.0023628152,0.000042869946],"about_ca_topic_score_codex":0.0006665127,"about_ca_topic_score_gemma":0.0011419685,"teacher_disagreement_score":0.0008009021,"about_ca_system_score_codex":0.00024176469,"about_ca_system_score_gemma":0.00043597393,"threshold_uncertainty_score":0.00257802},"labels":[],"label_agreement":null},{"id":"W3026086046","doi":"10.2147/dddt.s242514","title":"<p>A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer</p>","year":2020,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of British Columbia; Queen's University","funders":"Natural Sciences and Engineering Research Council of Canada; Queen's University; Russian Foundation for Basic Research","keywords":"Triple-negative breast cancer; Cancer research; Viability assay; Breast cancer; Apoptosis; Cancer; Medicine; Biology; Chemistry; Internal medicine; Biochemistry","score_opus":0.013722722877537168,"score_gpt":0.2355998324564319,"score_spread":0.22187710957889473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026086046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909314,0.0032058442,0.0013654684,0.00027254754,0.00010485571,0.000049291328,0.00049594825,0.0001596698,0.0034148644],"genre_scores_gemma":[0.9930702,0.001532283,0.002081449,0.00008819416,0.000013077887,0.00005230367,0.00048446,0.000016909136,0.002661177],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992204,0.000009077546,0.000007671591,0.0000147668625,0.000028931034,0.000017564402],"domain_scores_gemma":[0.999964,0.000006169944,0.000007859955,0.0000032804594,0.000006597294,0.000012094873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010255996,0.0002118401,0.00029397508,0.00016985444,0.00014267612,0.00027685097,0.00016282797,0.00022747066,0.0013617034],"category_scores_gemma":[0.00006722372,0.000100406665,0.0002109126,0.00012657531,0.00014269205,0.00020505616,0.00011909863,0.00036322355,0.0002773844],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036599752,0.00008840743,0.00040379912,0.00011911393,0.000013771656,0.00009553709,0.000021351612,0.00016921706,0.9911283,0.00013050031,0.00068738085,0.0067764493],"study_design_scores_gemma":[0.000051123494,0.0011482878,0.003335773,0.000012745563,0.000040306826,0.00030481693,0.000041673804,0.001722412,0.98831034,0.000044191616,0.004980066,0.000008268227],"about_ca_topic_score_codex":0.0010756042,"about_ca_topic_score_gemma":0.0013955907,"teacher_disagreement_score":0.0013617034,"about_ca_system_score_codex":0.00024570565,"about_ca_system_score_gemma":0.00023991826,"threshold_uncertainty_score":0.0045553446},"labels":[],"label_agreement":null},{"id":"W3045514455","doi":"10.2147/dddt.s262141","title":"<p>The Climate is Changing for Metered-Dose Inhalers and Action is Needed</p>","year":2020,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Inhalation and Respiratory Drug Delivery","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Action (physics); Pharmacology; Computer science; Medicine; Physics","score_opus":0.07847897795096846,"score_gpt":0.28249766652401775,"score_spread":0.20401868857304928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045514455","genre_codex":"other","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021668682,0.0039550913,0.0027007158,0.0938399,0.01761027,0.00029107847,0.0042215753,0.0030467852,0.87216777],"genre_scores_gemma":[0.014210686,0.0037839427,0.002845978,0.022767633,0.002367296,0.000118364456,0.0022393528,0.0016255671,0.95004106],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998464,0.00019936061,0.000068216315,0.0001976604,0.00085796247,0.00021292314],"domain_scores_gemma":[0.9950112,0.0005234162,0.00036278064,0.0004086585,0.0025218376,0.0011721418],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011994181,0.00067331374,0.00055067486,0.0006888522,0.0013971692,0.0049791243,0.00093258306,0.0028156063,0.48650408],"category_scores_gemma":[0.0044497442,0.00036965797,0.0006996368,0.0008381132,0.0014830416,0.0037043425,0.0019635463,0.0030446127,0.33597177],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003694835,0.000023595449,0.00028194668,0.00012173059,0.000003931067,0.00007701976,0.000037411384,0.000038397862,0.00050040655,0.0025285112,0.91292614,0.083423935],"study_design_scores_gemma":[0.000006299482,0.000019856929,0.0006555359,0.00004506124,0.0000015888702,0.00006192967,0.00005871223,0.00005813356,0.00028260026,0.0006886757,0.99811566,0.000006092307],"about_ca_topic_score_codex":0.011283243,"about_ca_topic_score_gemma":0.014137313,"teacher_disagreement_score":0.48650408,"about_ca_system_score_codex":0.0018567814,"about_ca_system_score_gemma":0.0037997859,"threshold_uncertainty_score":0.73243964},"labels":[],"label_agreement":null},{"id":"W3048993600","doi":"10.2147/dddt.s247584","title":"<p>Cannabis Extract CT-921 Has a High Efficacy–Adverse Effect Profile in a Neuropathic Pain Model</p>","year":2020,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Neuropathic pain; Analgesic; Adverse effect; Anesthesia; Allodynia; Clinical trial; Cannabis; Pharmacology; Internal medicine; Hyperalgesia; Nociception; Receptor","score_opus":0.032586292228379214,"score_gpt":0.26012517400838764,"score_spread":0.22753888178000842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048993600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98023236,0.004220496,0.003313244,0.00071441353,0.00012000415,0.0002891547,0.0015455588,0.00026710756,0.009297581],"genre_scores_gemma":[0.9735334,0.0028854946,0.008378679,0.0002976975,0.000050843366,0.00022513022,0.0014608814,0.00009691073,0.01307107],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983037,0.00002495224,0.000014997029,0.000030675394,0.00006983049,0.000029170536],"domain_scores_gemma":[0.9997731,0.000035282115,0.00006182981,0.000031402058,0.00005216716,0.000046174457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020848335,0.0005753343,0.0004335127,0.00043968175,0.00026527935,0.00031166116,0.00028541096,0.00045736827,0.0055991355],"category_scores_gemma":[0.00023704125,0.00016253434,0.00032862186,0.00027160355,0.0004918175,0.00039578963,0.00019635013,0.0009085697,0.0009348691],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011960369,0.0001960309,0.00020722217,0.00018384779,0.000014737132,0.00012458189,0.000016304633,0.000078433266,0.99055016,0.00012978705,0.00028534082,0.0070175035],"study_design_scores_gemma":[0.00025651563,0.007606942,0.009173655,0.00006572097,0.00008371096,0.001168453,0.000060988263,0.0006751742,0.9726548,0.00012065764,0.008111808,0.000021488957],"about_ca_topic_score_codex":0.001645998,"about_ca_topic_score_gemma":0.0027829742,"teacher_disagreement_score":0.0055991355,"about_ca_system_score_codex":0.00025887424,"about_ca_system_score_gemma":0.00045539837,"threshold_uncertainty_score":0.018730998},"labels":[],"label_agreement":null},{"id":"W3092098441","doi":"10.2147/dddt.s264122","title":"<p>Novel Molecular Mechanism of Aspirin and Celecoxib Targeting Mammalian Neuraminidase-1 Impedes Epidermal Growth Factor Receptor Signaling Axis and Induces Apoptosis in Pancreatic Cancer Cells</p>","year":2020,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Cancer research; Epidermal growth factor receptor; Apoptosis; Pancreatic cancer; Mechanism (biology); Signal transduction; Epidermal growth factor; Growth factor receptor; Chemistry; Receptor; Medicine; Pharmacology; Internal medicine; Cancer; Cell biology; Biology; Biochemistry","score_opus":0.022504205350056743,"score_gpt":0.23305503989233625,"score_spread":0.21055083454227952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092098441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91513944,0.030656002,0.016649626,0.003556433,0.0011774936,0.0005062393,0.0018128816,0.0010011306,0.029500857],"genre_scores_gemma":[0.96270204,0.010213038,0.0061576203,0.00054154434,0.00009838685,0.00026234065,0.0011737866,0.00003607,0.018815279],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998987,0.000012319157,0.000011284132,0.000018314871,0.000033489145,0.000025871052],"domain_scores_gemma":[0.9999665,0.0000025340933,0.000011968468,0.0000045741094,0.0000054701554,0.0000089589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012840306,0.00039331248,0.00033992328,0.0001868328,0.00022274573,0.0003558058,0.00031530458,0.0003923923,0.0026781848],"category_scores_gemma":[0.00007028081,0.00015336733,0.00039807736,0.0001593129,0.000280459,0.00030036023,0.00018182523,0.00078464655,0.0008178404],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007231851,0.00025301927,0.00043509222,0.00052088476,0.00004794921,0.00070791866,0.000027651253,0.00025736357,0.9750793,0.0017416789,0.0024256739,0.017780252],"study_design_scores_gemma":[0.00023981194,0.0013326177,0.005353171,0.00002847404,0.000087480425,0.0015915759,0.000041567924,0.0027306823,0.9614446,0.00045931374,0.026676387,0.000014340863],"about_ca_topic_score_codex":0.0005846092,"about_ca_topic_score_gemma":0.0007885348,"teacher_disagreement_score":0.0026781848,"about_ca_system_score_codex":0.0003654581,"about_ca_system_score_gemma":0.00037595883,"threshold_uncertainty_score":0.008959413},"labels":[],"label_agreement":null},{"id":"W3101238129","doi":"10.2147/dddt.s259547","title":"<p>Synthesis and Cytotoxic Property of Annonaceous Acetogenin Glycoconjugates</p>","year":2020,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Traditional and Medicinal Uses of Annonaceae","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lakehead University","funders":"South China Sea Institute of Oceanology, Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Oceanology, Chinese Academy of Sciences; National Natural Science Foundation of China","keywords":"Acetogenin; HeLa; Chemistry; Galactose; Cytotoxicity; MTT assay; Glycoconjugate; Glycosyl; Cell culture; Biochemistry; Stereochemistry; In vitro; Annonaceae; Biology","score_opus":0.02503340349993544,"score_gpt":0.21646052997890053,"score_spread":0.1914271264789651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3101238129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827571,0.00068611646,0.011563108,0.00010732032,0.000029366924,0.00006623627,0.00039654708,0.00010614144,0.0042880955],"genre_scores_gemma":[0.9889016,0.00068172405,0.007388321,0.000060348837,0.0000070422197,0.00003753153,0.0005568996,0.000028439565,0.0023381393],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999546,0.000006616418,0.0000042915412,0.000009306117,0.000013098172,0.000012071159],"domain_scores_gemma":[0.999954,0.0000042535603,0.0000149699335,0.0000057728653,0.000010370971,0.000010595327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007906676,0.00033107185,0.0000891336,0.00011729086,0.00008993017,0.00010223325,0.00012024328,0.00013275351,0.0007504334],"category_scores_gemma":[0.00009431131,0.00005637168,0.000175337,0.00019882811,0.00012278729,0.00015060016,0.00013085137,0.00024473187,0.00023764843],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008259813,0.000024368204,0.00013747589,0.00003954645,0.000004160341,0.00008092796,0.000013256284,0.00022682396,0.99443865,0.0001631592,0.00007013771,0.004718938],"study_design_scores_gemma":[0.000007002596,0.00031216492,0.0010216555,0.0000032383582,0.000009899458,0.00010494527,0.0000067692426,0.00054747734,0.99580574,0.000031222313,0.0021463828,0.0000035220667],"about_ca_topic_score_codex":0.00045700738,"about_ca_topic_score_gemma":0.00038920424,"teacher_disagreement_score":0.0007504334,"about_ca_system_score_codex":0.00017148732,"about_ca_system_score_gemma":0.00012595285,"threshold_uncertainty_score":0.0025104284},"labels":[],"label_agreement":null},{"id":"W3110799083","doi":"10.2147/dddt.s289753","title":"<p>Super Activated Platelet Lysate, a Novel Autologous Platelet Lysate, Regulates the Expression of Inflammasome and Cytokine in the Experimental Periodontitis in Rats</p>","year":2020,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Oral microbiology and periodontitis research","field":"Dentistry","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Natural Science Foundation of China","keywords":"Ligature; Periodontitis; Saline; Medicine; Cytokine; Inflammasome; Dental alveolus; Inflammation; Chemokine; Andrology; Pathology; Internal medicine; Immunology; Dentistry","score_opus":0.031028049467704464,"score_gpt":0.25970447835321425,"score_spread":0.2286764288855098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110799083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98625356,0.004490449,0.006478147,0.00048677778,0.00012175839,0.00015367253,0.00048715947,0.00023852712,0.0012899181],"genre_scores_gemma":[0.9835792,0.003754405,0.007107947,0.00029397308,0.00007651798,0.00038167989,0.00075945864,0.000039907976,0.0040068394],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99977595,0.000032388267,0.000031049683,0.000041624182,0.000073091185,0.00004589296],"domain_scores_gemma":[0.99984443,0.000011553524,0.000079960766,0.000013036069,0.000014749194,0.000036234618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029663762,0.0006686281,0.0005565457,0.00039155362,0.00017814692,0.0003448073,0.00020500357,0.0004932426,0.0012591021],"category_scores_gemma":[0.00016060354,0.00022449406,0.00052844133,0.00021998274,0.00054791494,0.00049177435,0.00021650587,0.0010416746,0.00044039526],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013515729,0.000269761,0.00027000628,0.00020206401,0.000014535531,0.0001974348,0.000023744096,0.000071285125,0.99349964,0.00010746429,0.00014795674,0.0038444554],"study_design_scores_gemma":[0.00027237393,0.0070412634,0.0061279526,0.000035155437,0.000080614234,0.0010809553,0.00009989669,0.0010908857,0.98087746,0.00015566699,0.0031217525,0.00001620116],"about_ca_topic_score_codex":0.00028204857,"about_ca_topic_score_gemma":0.00036915034,"teacher_disagreement_score":0.0012591021,"about_ca_system_score_codex":0.00019115825,"about_ca_system_score_gemma":0.00034721472,"threshold_uncertainty_score":0.0042120814},"labels":[],"label_agreement":null},{"id":"W3164945230","doi":"10.2147/dddt.s299591","title":"A Review of Romiplostim Mechanism of Action and Clinical Applicability","year":2021,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; Amgen","keywords":"Romiplostim; Thrombopoietin; Medicine; Eltrombopag; Aplastic anemia; Megakaryocyte; Thrombopoietin receptor; Platelet; Internal medicine; Immunology; Oncology; Haematopoiesis; Bone marrow; Stem cell; Immune thrombocytopenia","score_opus":0.16127100110894912,"score_gpt":0.40991094415966867,"score_spread":0.24863994305071954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164945230","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00052602,0.9964945,0.00030644372,0.00041948975,0.00029336676,0.000019006313,0.000094434574,0.00002071412,0.0018259683],"genre_scores_gemma":[0.0023655142,0.99471384,0.00050477585,0.0005420846,0.00042348364,0.00003025794,0.0001922535,0.000005915463,0.0012218844],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998016,0.000033507233,0.000052445503,0.0000335616,0.00005904259,0.00001997205],"domain_scores_gemma":[0.99970144,0.0001281308,0.000064528576,0.00000855347,0.00006925976,0.000028082175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054700696,0.0006953756,0.0010708577,0.002117073,0.00022833659,0.0009238568,0.0007844873,0.00085450767,0.0051996927],"category_scores_gemma":[0.00089410733,0.00026164344,0.00089446345,0.0015584981,0.00023622363,0.0013459584,0.00042067986,0.0015683874,0.0021678528],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004237556,0.00016410845,0.00040889758,0.02595196,0.00019226629,0.00054350984,0.00008006242,0.0005028387,0.004583217,0.0026136434,0.042886525,0.9216492],"study_design_scores_gemma":[0.000074295254,0.0004966954,0.001105304,0.0034345326,0.00036705253,0.0028979974,0.000041692037,0.00019580727,0.001675401,0.00084003375,0.9888399,0.000031138672],"about_ca_topic_score_codex":0.000718826,"about_ca_topic_score_gemma":0.0008967731,"teacher_disagreement_score":0.0051996927,"about_ca_system_score_codex":0.00052216585,"about_ca_system_score_gemma":0.0009492718,"threshold_uncertainty_score":0.017394722},"labels":[],"label_agreement":null},{"id":"W3177211387","doi":"10.2147/dddt.s304708","title":"Network Pharmacology Analysis of the Mechanisms of Compound Herba Sarcandrae (Fufang Zhongjiefeng) Aerosol in Chronic Pharyngitis Treatment","year":2021,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Natural Science Foundation of China","keywords":"KEGG; Signal transduction; Computational biology; Pharmacology; Receptor; G protein-coupled receptor; Biology; Chemistry; Gene; Gene expression; Gene ontology; Biochemistry","score_opus":0.03019942623124172,"score_gpt":0.2810780049760161,"score_spread":0.25087857874477437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3177211387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9000048,0.027629782,0.052989163,0.0013784287,0.000113361195,0.0004152952,0.0072176433,0.0007970691,0.009454415],"genre_scores_gemma":[0.97818464,0.008126792,0.0082721235,0.00015781699,0.000042635205,0.00024139884,0.0035837328,0.000020635054,0.0013702392],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9997639,0.00005188368,0.000017610362,0.00006621307,0.00006290115,0.000037453152],"domain_scores_gemma":[0.9997781,0.000052634725,0.00008366038,0.000011490457,0.00004719456,0.000026909374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033578408,0.00049713644,0.0006945596,0.0013682449,0.00036412617,0.00064538745,0.00029559646,0.0002870248,0.0017748069],"category_scores_gemma":[0.00048460395,0.00016239878,0.00090914214,0.0012021117,0.00020421248,0.00064026116,0.00044985564,0.00032673313,0.0001545622],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039650123,0.0010294119,0.20149107,0.007399389,0.0029565194,0.0030094986,0.0006485912,0.079114385,0.3367488,0.011469997,0.010117991,0.3420492],"study_design_scores_gemma":[0.00031055228,0.0024710202,0.50489265,0.0004175426,0.0047987713,0.002581549,0.0007295231,0.34922582,0.07819923,0.018847773,0.037363816,0.0001617614],"about_ca_topic_score_codex":0.0022401593,"about_ca_topic_score_gemma":0.0017367797,"teacher_disagreement_score":0.0022401593,"about_ca_system_score_codex":0.0007214273,"about_ca_system_score_gemma":0.00073316926,"threshold_uncertainty_score":0.005937338},"labels":[],"label_agreement":null},{"id":"W3179565049","doi":"10.2147/dddt.s281602","title":"Profile of Ipragliflozin, an Oral SGLT-2 Inhibitor for the Treatment of Type 2 Diabetes: The Evidence to Date","year":2021,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Medicine; Type 2 diabetes; Adverse effect; Hypoglycemia; Renal glucose reabsorption; Intensive care medicine; Diabetes mellitus; Diabetes management; Pharmacology; Internal medicine; Endocrinology","score_opus":0.15371710382983725,"score_gpt":0.36263580421117464,"score_spread":0.2089187003813374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3179565049","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038288592,0.99886024,0.00004127314,0.00025715664,0.00005001571,0.000017093613,0.00011362303,0.0000023934958,0.00027524732],"genre_scores_gemma":[0.007000399,0.99179614,0.0002718782,0.00053185166,0.00011592449,0.000037596754,0.00016542319,0.0000028275279,0.00007792695],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99677014,0.0007269101,0.0012243076,0.00030653464,0.00089047087,0.000081657134],"domain_scores_gemma":[0.98450875,0.009204663,0.0045462428,0.00014447013,0.0013850292,0.00021086157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004594322,0.00094146084,0.0052840076,0.0042458973,0.00030744483,0.0024683117,0.0013889611,0.001962914,0.0054141716],"category_scores_gemma":[0.015652264,0.0005623585,0.0048972126,0.0047564665,0.00047382174,0.0016811698,0.0006939063,0.0015974492,0.0006533568],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001708051,0.00008071786,0.0015331706,0.66208476,0.0088621015,0.0002601747,0.00009848206,0.0002387708,0.0008776933,0.000513682,0.0044500586,0.3192924],"study_design_scores_gemma":[0.0015693071,0.0024693257,0.016034646,0.6759417,0.13692105,0.0024582988,0.00041252782,0.00037889287,0.0018882415,0.0018875503,0.15994088,0.00009764426],"about_ca_topic_score_codex":0.0014972193,"about_ca_topic_score_gemma":0.002946104,"teacher_disagreement_score":0.0054141716,"about_ca_system_score_codex":0.0011863811,"about_ca_system_score_gemma":0.0024792994,"threshold_uncertainty_score":0.024297416},"labels":[],"label_agreement":null},{"id":"W4212951396","doi":"10.2147/dddt.s330947","title":"Network Pharmacology and Molecular Docking Study of the Chinese Miao Medicine Sidaxue in the Treatment of Rheumatoid Arthritis","year":2022,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Science and Technology Program of Guizhou Province; Guizhou University; Guizhou Medical University; National Natural Science Foundation of China","keywords":"Rheumatoid arthritis; Systems pharmacology; Signal transduction; Traditional Chinese medicine; Arthritis; Molecular Pharmacology; Animal model","score_opus":0.019271023358547457,"score_gpt":0.28233306037643263,"score_spread":0.26306203701788516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212951396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92019045,0.015930349,0.044243302,0.0008902784,0.00011235808,0.00022194411,0.002472774,0.0009060965,0.0150324935],"genre_scores_gemma":[0.9786468,0.0058351043,0.01208843,0.00009784096,0.00001930222,0.00012050032,0.0017274239,0.000032069052,0.0014325408],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99991536,0.00002188067,0.0000035988721,0.000018667988,0.000025382627,0.000015107666],"domain_scores_gemma":[0.99995244,0.000012770052,0.000014687087,0.0000032998628,0.000008481496,0.000008378767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013248113,0.00071846816,0.00074281683,0.0006440526,0.00025622302,0.00042241465,0.00037152958,0.00024933164,0.0026545476],"category_scores_gemma":[0.00024429453,0.00016071767,0.00088108255,0.0007397555,0.00013380325,0.00039399564,0.00029400116,0.0002850031,0.00023518066],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025306202,0.0009961133,0.039543577,0.004259897,0.0019255644,0.0015417344,0.00015726441,0.58976865,0.16942129,0.0121012535,0.007408284,0.17034578],"study_design_scores_gemma":[0.00026674036,0.0011094252,0.019517154,0.00006688502,0.000851301,0.00045220405,0.00009071282,0.93738693,0.02348119,0.004192061,0.01252535,0.000060094728],"about_ca_topic_score_codex":0.0025285808,"about_ca_topic_score_gemma":0.002342779,"teacher_disagreement_score":0.0026545476,"about_ca_system_score_codex":0.00046319552,"about_ca_system_score_gemma":0.00062032026,"threshold_uncertainty_score":0.008880377},"labels":[],"label_agreement":null},{"id":"W4378232952","doi":"10.2147/dddt.s368584","title":"Profile of Luspatercept in the Treatment of Anemia in Adults with Non-Transfusion-Dependent β-Thalassemia (NTDT): Design, Development and Potential Place in Therapy","year":2023,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Thalassemia; Medicine; Anemia; Transfusion therapy; Intensive care medicine; Blood transfusion; Pediatrics; Surgery; Internal medicine","score_opus":0.02885699474887819,"score_gpt":0.27027301678548066,"score_spread":0.24141602203660248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378232952","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025741517,0.99868745,0.00007265743,0.0001531086,0.000071662274,0.000010665156,0.000026305643,0.000005363877,0.00071529136],"genre_scores_gemma":[0.0013914496,0.997575,0.00019253216,0.00025020927,0.00005497254,0.000012313464,0.00004864787,0.0000015895944,0.00047329903],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998165,0.00003955887,0.000034453027,0.000027240294,0.0000652844,0.000016999267],"domain_scores_gemma":[0.9997136,0.00013531695,0.00006463357,0.0000055648557,0.000058199763,0.000022803835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007870875,0.0006111705,0.0015105422,0.0017232979,0.00017335576,0.00091455487,0.00085346244,0.0008153395,0.0035287717],"category_scores_gemma":[0.0006696264,0.00025309893,0.0008443065,0.0014604575,0.00024062062,0.0007770316,0.0003234081,0.001473348,0.001238716],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003340873,0.000100704565,0.0001592101,0.032122824,0.00030448654,0.00021822438,0.000055384688,0.0004257921,0.0022325788,0.001796852,0.016405458,0.9458444],"study_design_scores_gemma":[0.00033855397,0.000811579,0.0016968228,0.013279939,0.0009429333,0.0026239168,0.00006862698,0.00032865012,0.00149095,0.0015791523,0.9767993,0.00003958559],"about_ca_topic_score_codex":0.0008661593,"about_ca_topic_score_gemma":0.002429336,"teacher_disagreement_score":0.0035287717,"about_ca_system_score_codex":0.00044339552,"about_ca_system_score_gemma":0.00074519904,"threshold_uncertainty_score":0.011804938},"labels":[],"label_agreement":null},{"id":"W4380629765","doi":"10.2147/dddt.s407905","title":"Effects of Different Injection Rates of Propofol on Postoperative Cognition in Elderly Patients Undergoing Laparoscopic Inguinal Hernia Repair","year":2023,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Anesthesia and Sedative Agents","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Natural Science Foundation of China","keywords":"Propofol; Medicine; Anesthesia; Remifentanil; Bispectral index; Inguinal hernia; Incidence (geometry); Hernia; Surgery","score_opus":0.024818633385021473,"score_gpt":0.2707158124073964,"score_spread":0.24589717902237493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380629765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99922884,0.00056390825,0.000038697828,0.00002019305,0.000009908254,0.000004656762,0.000019055376,0.0000010580402,0.00011360601],"genre_scores_gemma":[0.9995889,0.00023235948,0.00005923553,0.00003481859,0.000013915466,0.000005621134,0.000031004227,4.17457e-7,0.00003373935],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99969375,0.000076506025,0.00005214228,0.00004145834,0.000078469915,0.000057707162],"domain_scores_gemma":[0.99898285,0.00019463303,0.00049576024,0.000044531957,0.00008360364,0.0001986017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033258685,0.00020919702,0.00039230238,0.00020025735,0.00018965485,0.00029919902,0.00009123898,0.00020935445,0.00039512123],"category_scores_gemma":[0.0018222843,0.000077662495,0.00047907705,0.00019383058,0.00016719887,0.00020925327,0.00018966352,0.0003725757,0.00006271235],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006378214,0.00044873217,0.9727773,0.00011658261,0.00032404572,0.0005546701,0.0002559804,0.00010838708,0.0022657602,0.000019636633,0.00010408306,0.01664659],"study_design_scores_gemma":[0.00006147246,0.0035555724,0.9948266,0.000014663673,0.0001620922,0.00048526918,0.00024653628,0.00014365395,0.0003043417,0.000018561883,0.00017282949,0.0000084613885],"about_ca_topic_score_codex":0.0005625753,"about_ca_topic_score_gemma":0.0009777737,"teacher_disagreement_score":0.0005625753,"about_ca_system_score_codex":0.0001614391,"about_ca_system_score_gemma":0.0002392396,"threshold_uncertainty_score":0.0017589331},"labels":[],"label_agreement":null},{"id":"W4400694331","doi":"10.2147/dddt.s388410","title":"Evaluating the Therapeutic Potential of Ublituximab in the Treatment of MS: Design, Development and Place in Therapy","year":2024,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"University of Toronto","keywords":"Medicine; Medical physics","score_opus":0.33816580930928175,"score_gpt":0.43977076543208676,"score_spread":0.10160495612280501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400694331","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023440763,0.9987392,0.00009034702,0.00016659188,0.00006460235,0.000006887803,0.00001792954,0.0000046909004,0.00067530386],"genre_scores_gemma":[0.0009838031,0.99825436,0.00019878856,0.00014230685,0.000040987532,0.00000902642,0.000024413977,0.0000013734636,0.0003449407],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997719,0.00005086242,0.000041633186,0.00003262212,0.00008051768,0.000022442355],"domain_scores_gemma":[0.99961925,0.00021215364,0.000057946498,0.000008442361,0.00008149384,0.000020767542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007949614,0.00054848625,0.0012712113,0.0020083245,0.00019398976,0.0010598535,0.0006028245,0.0009609895,0.0030916592],"category_scores_gemma":[0.0008581905,0.00023891956,0.0007561716,0.0016344103,0.00027140212,0.0010553312,0.00045974288,0.0012184591,0.0011847448],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015080957,0.000095950854,0.00016758866,0.03955765,0.00019102682,0.00017353492,0.00008024506,0.0004276664,0.0033882505,0.0029519198,0.010302511,0.9425129],"study_design_scores_gemma":[0.00006033509,0.00041577787,0.0008295169,0.011885376,0.0005525537,0.0012053142,0.00008138648,0.00017974016,0.0017731625,0.0016271137,0.9813623,0.000027351787],"about_ca_topic_score_codex":0.0007959301,"about_ca_topic_score_gemma":0.0016351218,"teacher_disagreement_score":0.0030916592,"about_ca_system_score_codex":0.00049078156,"about_ca_system_score_gemma":0.001187811,"threshold_uncertainty_score":0.010342658},"labels":[],"label_agreement":null},{"id":"W4405194730","doi":"10.2147/dddt.s491223","title":"Effect of Remimazolam vs Midazolam on Early Postoperative Cognitive Recovery in Elderly Patients Undergoing Dental Extraction: A Prospective Randomized Controlled Study","year":2024,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Intensive Care Unit Cognitive Disorders","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Chinese Stomatological Association","keywords":"Midazolam; Medicine; Anesthesia; Prospective cohort study; Randomized controlled trial; Dental extraction; Extraction (chemistry); Surgery; Sedation","score_opus":0.008821822727912045,"score_gpt":0.272765986510034,"score_spread":0.26394416378212193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405194730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9733516,0.016544582,0.00079623336,0.0003557232,0.0007586424,0.0070340163,0.0005069314,0.000059436825,0.0005927626],"genre_scores_gemma":[0.9759069,0.008546088,0.0026737025,0.0008705166,0.0010725033,0.009520919,0.00039742995,0.000013572265,0.0009982435],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99784017,0.0011445775,0.00033595285,0.00029944323,0.00021151082,0.00016842893],"domain_scores_gemma":[0.99728835,0.0009397043,0.00090662425,0.00019198608,0.00023165629,0.00044166463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034057333,0.001214823,0.0052481587,0.00062560866,0.00054907525,0.0011856756,0.0010851822,0.0019914545,0.004164587],"category_scores_gemma":[0.0040952866,0.0007855574,0.0032991075,0.0006847878,0.0010660294,0.000915694,0.00047930432,0.0017520247,0.0004581205],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9818746,0.006786829,0.0006060658,0.0014298067,0.0016531188,0.00003371298,0.000030373425,0.00006692744,0.00110339,0.000026799264,0.000107808184,0.006280632],"study_design_scores_gemma":[0.8813035,0.11397226,0.0021320921,0.00009642241,0.0017711573,0.000023610475,0.00002722501,0.00018011364,0.00023075871,0.000031879354,0.00021493842,0.000016083342],"about_ca_topic_score_codex":0.0008571804,"about_ca_topic_score_gemma":0.0021437907,"teacher_disagreement_score":0.0052481587,"about_ca_system_score_codex":0.0006685895,"about_ca_system_score_gemma":0.0016826174,"threshold_uncertainty_score":0.01801145},"labels":[],"label_agreement":null},{"id":"W4406808042","doi":"10.2147/dddt.s504485","title":"Tanshinone I Ameliorates Psoriasis-Like Dermatitis by Suppressing Inflammation and Regulating Keratinocyte Differentiation","year":2025,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"National Natural Science Foundation of China","keywords":"Psoriasis; Keratinocyte; Inflammation; Medicine; Dermatology; Immunology; Biology; Cell culture; Genetics","score_opus":0.014999870614813655,"score_gpt":0.22261221925640662,"score_spread":0.20761234864159298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406808042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97343826,0.016181381,0.0034949936,0.00020299744,0.00025275032,0.00016124116,0.00054391864,0.000338822,0.005385647],"genre_scores_gemma":[0.98571855,0.00908079,0.0017575698,0.0001647776,0.00004617718,0.000063274805,0.0004648109,0.000028295815,0.0026757666],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994826,0.000008083409,0.0000044882263,0.000008763518,0.000015123198,0.000015237],"domain_scores_gemma":[0.9999584,0.000004428872,0.000011754815,0.0000037370464,0.000008301601,0.000013334314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000087110784,0.0003622672,0.00028647148,0.00024236843,0.00008782542,0.00017776294,0.00013559201,0.00011764549,0.0015530038],"category_scores_gemma":[0.00006945836,0.000095008436,0.0003003608,0.00012685008,0.00018311568,0.00016434115,0.000111275236,0.0006596288,0.00026041898],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006811634,0.00025367094,0.0003655766,0.0004393507,0.000026405147,0.00006567714,0.000017573222,0.00012775692,0.9845628,0.000090725865,0.0002444096,0.01312483],"study_design_scores_gemma":[0.0006381465,0.008044161,0.019885495,0.00011619017,0.0002634439,0.00074471324,0.00015068222,0.0014907898,0.9499053,0.0003650489,0.018373715,0.00002233018],"about_ca_topic_score_codex":0.00025675027,"about_ca_topic_score_gemma":0.00061613007,"teacher_disagreement_score":0.0015530038,"about_ca_system_score_codex":0.000105780215,"about_ca_system_score_gemma":0.0002086512,"threshold_uncertainty_score":0.0051953197},"labels":[],"label_agreement":null},{"id":"W4409964874","doi":"10.2147/dddt.s505751","title":"Bibliometric Analysis of Non-Vitamin K Antagonist Oral Anticoagulants (NOACS) in the Prevention of Venous Thrombosis and Pulmonary Embolism","year":2025,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Natural Science Foundation of Hunan Province; Central South University; National Natural Science Foundation of China","keywords":"Vitamin K antagonist; Medicine; Pulmonary embolism; Venous thrombosis; Vitamin k; Venous thromboembolism; Thrombosis; Intensive care medicine; Internal medicine; Warfarin; Atrial fibrillation","score_opus":0.07940201947080826,"score_gpt":0.36455686739936366,"score_spread":0.2851548479285554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409964874","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39074296,0.4411843,0.004930241,0.006123041,0.00057776645,0.0013678739,0.12621036,0.0006624864,0.028200906],"genre_scores_gemma":[0.8368698,0.12506829,0.004791129,0.00032614783,0.00053275115,0.0010713994,0.029961461,0.00007730771,0.0013016907],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.981199,0.0038914755,0.00549037,0.0017327764,0.007114573,0.0005717952],"domain_scores_gemma":[0.91124576,0.057688814,0.016758941,0.0018149393,0.011485767,0.0010057081],"candidate_categories":["bibliometrics"],"consensus_categories":[],"category_scores_codex":[0.009817207,0.0009294235,0.0036032074,0.15295455,0.001027921,0.003595886,0.0011620412,0.0008863718,0.004915919],"category_scores_gemma":[0.07321989,0.00036295716,0.0046883533,0.20393555,0.0007540007,0.002648738,0.0020059692,0.00054939877,0.00073756353],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066943147,0.0001675463,0.5692345,0.13878192,0.015964238,0.001149583,0.0026099528,0.0048762336,0.0012725658,0.004572073,0.024260705,0.23644128],"study_design_scores_gemma":[0.0002032792,0.00035793878,0.8571498,0.0267578,0.02707388,0.0030247786,0.0036782073,0.0083131725,0.0014598583,0.0075559267,0.064189985,0.00023532835],"about_ca_topic_score_codex":0.0073276986,"about_ca_topic_score_gemma":0.007184459,"teacher_disagreement_score":0.8470454,"about_ca_system_score_codex":0.002714211,"about_ca_system_score_gemma":0.005958323,"threshold_uncertainty_score":0.051918983},"labels":[],"label_agreement":null},{"id":"W4410484671","doi":"10.2147/dddt.s513461","title":"Exploring the Potential of Pyridine Carboxylic Acid Isomers to Discover New Enzyme Inhibitors","year":2025,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Click Chemistry and Applications","field":"Chemistry","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lakehead University","funders":"","keywords":"Enzyme; Carboxylic acid; Pyridine; Chemistry; Stereochemistry; Biochemistry; Combinatorial chemistry; Computational biology; Organic chemistry; Biology","score_opus":0.08459063998253667,"score_gpt":0.28777176377069424,"score_spread":0.20318112378815756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410484671","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038526563,0.97999406,0.0022074154,0.00045580664,0.0004043213,0.000031968942,0.00008860686,0.0000616137,0.012903509],"genre_scores_gemma":[0.019733276,0.9731784,0.0014177434,0.00037864962,0.00021737405,0.000032209013,0.000098729004,0.000006731683,0.004936813],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998845,0.000015344896,0.000008433753,0.000023074337,0.000048322894,0.000020355925],"domain_scores_gemma":[0.9999484,0.00001983315,0.0000084441745,0.0000025284564,0.0000139935455,0.0000068546174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027276817,0.0005497736,0.0005964132,0.0014136571,0.00021681118,0.00060627214,0.00038464705,0.0005538231,0.0032895585],"category_scores_gemma":[0.00027011376,0.00022124355,0.00037318625,0.0011297124,0.00026234286,0.00087833486,0.0004566381,0.0011690926,0.001429403],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011544988,0.00025422807,0.0002666972,0.016278882,0.000088252134,0.0008028662,0.00015638924,0.0022040952,0.05040413,0.028753994,0.018745746,0.8819292],"study_design_scores_gemma":[0.00003237068,0.00041496044,0.0007494368,0.0009822872,0.00007523769,0.0014461114,0.0000631108,0.0007980499,0.016014026,0.003331045,0.97606444,0.000029005245],"about_ca_topic_score_codex":0.0004568508,"about_ca_topic_score_gemma":0.0011026809,"teacher_disagreement_score":0.0032895585,"about_ca_system_score_codex":0.00037899252,"about_ca_system_score_gemma":0.00038767804,"threshold_uncertainty_score":0.011004627},"labels":[],"label_agreement":null},{"id":"W4411842837","doi":"10.2147/dddt.s502910","title":"Dose-Dependent Effects of Remimazolam on Early Perioperative Neurocognitive Disorders in Elderly Colorectal Cancer Patients Undergoing Laparoscopic Surgery","year":2025,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Intensive Care Unit Cognitive Disorders","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Neurocognitive; Perioperative; Colorectal cancer; Laparoscopic surgery; Cancer; Laparoscopy; Surgery; Anesthesia; Internal medicine; Psychiatry; Cognition","score_opus":0.010462917643419197,"score_gpt":0.25213552543579215,"score_spread":0.24167260779237296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411842837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990386,0.00077407784,0.000027923745,0.000013338359,0.000008076888,0.000018757075,0.000021445476,0.0000016429062,0.000096156604],"genre_scores_gemma":[0.99912614,0.00049207505,0.00013622003,0.000038564027,0.000020655918,0.000030406594,0.000042622174,6.1278075e-7,0.00011271431],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99987364,0.000046225716,0.000017264823,0.000016316071,0.000024683288,0.00002184896],"domain_scores_gemma":[0.9996649,0.00006689392,0.00012707718,0.000024351046,0.000035066976,0.00008177643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028080898,0.0002134475,0.0004827425,0.00010270207,0.00011989557,0.00013972838,0.000119288205,0.0001688943,0.00063141313],"category_scores_gemma":[0.0007674357,0.000079038866,0.00031132143,0.00009487137,0.00011633237,0.00014339367,0.000121695666,0.00029296003,0.00010429307],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3252091,0.017703282,0.2501119,0.0012644387,0.0015446354,0.0009077096,0.0006719445,0.00085575465,0.16690068,0.00005373682,0.00066294736,0.23411392],"study_design_scores_gemma":[0.0057451185,0.3033569,0.6740667,0.000058596324,0.00066447014,0.0006929411,0.00032162166,0.0006231841,0.012896468,0.0000359091,0.0015112105,0.00002680776],"about_ca_topic_score_codex":0.00028465196,"about_ca_topic_score_gemma":0.00072312437,"teacher_disagreement_score":0.00063141313,"about_ca_system_score_codex":0.00008087281,"about_ca_system_score_gemma":0.0001826555,"threshold_uncertainty_score":0.002112329},"labels":[],"label_agreement":null},{"id":"W4413848559","doi":"10.2147/dddt.s536225","title":"Effect of Ciprofol on Postoperative Cognitive Function in Patients Undergoing Cardiac Surgery with Cardiopulmonary Bypass: A Prospective, Randomized, Controlled Trial","year":2025,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Intensive Care Unit Cognitive Disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Guizhou Medical University; National Natural Science Foundation of China","keywords":"Cardiopulmonary bypass; Medicine; Randomized controlled trial; Cardiac surgery; Prospective cohort study; Anesthesia; Surgery","score_opus":0.007259522619073475,"score_gpt":0.23633310202954144,"score_spread":0.22907357941046796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413848559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97118104,0.023152271,0.0004345484,0.0006416356,0.0005547896,0.002744756,0.00041561693,0.000036243477,0.00083914143],"genre_scores_gemma":[0.9859818,0.008372859,0.0009734677,0.00070171576,0.0006042894,0.002561849,0.00035445424,0.0000056380027,0.00044396028],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998664,0.0007222006,0.00017441988,0.00021111009,0.000111082445,0.00011722176],"domain_scores_gemma":[0.9977483,0.0007718177,0.0007643674,0.00012608293,0.00017027388,0.00041915965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017351832,0.0010559437,0.0033231052,0.00040445564,0.0004959492,0.0010477299,0.00074727455,0.0016502088,0.003156277],"category_scores_gemma":[0.004135523,0.00052886864,0.002168767,0.00056607905,0.00082273595,0.0006722423,0.00033407024,0.0017332656,0.0003285019],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.981402,0.0029914598,0.0019608915,0.0018634401,0.00219841,0.000048393827,0.00002341369,0.00011528788,0.0006340768,0.00004570637,0.00022005041,0.008496849],"study_design_scores_gemma":[0.93727946,0.054701604,0.004570159,0.00014597301,0.002406928,0.00004724249,0.000021270782,0.0002577286,0.00019708245,0.00005177935,0.00030553737,0.000015173499],"about_ca_topic_score_codex":0.0011403131,"about_ca_topic_score_gemma":0.001752863,"teacher_disagreement_score":0.0033231052,"about_ca_system_score_codex":0.000545954,"about_ca_system_score_gemma":0.0015617232,"threshold_uncertainty_score":0.010558784},"labels":[],"label_agreement":null},{"id":"W4416192077","doi":"10.2147/dddt.s553693","title":"The Impact of Intranasal Esketamine on Emergence Agitation in Children Undergoing Adenotonsillectomy: A Randomized Controlled Study","year":2025,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Anesthesia and Sedative Agents","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nasal administration; Randomized controlled trial; Incidence (geometry); Ketamine; Adverse effect; Clinical trial","score_opus":0.016158718525234282,"score_gpt":0.30339033410370186,"score_spread":0.2872316155784676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416192077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99010605,0.00487621,0.00033275562,0.00017270584,0.00034595025,0.0035052274,0.00026272135,0.000027831713,0.0003706004],"genre_scores_gemma":[0.9841738,0.004804445,0.0019086155,0.00045297894,0.0006857099,0.0069466513,0.00032263287,0.000009147241,0.0006960541],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9986463,0.0006303156,0.00021036195,0.00019466026,0.00018429678,0.00013404332],"domain_scores_gemma":[0.9979219,0.0007004476,0.0005742897,0.00014392455,0.00016800956,0.00049139763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019583213,0.00088244665,0.003558324,0.00046590695,0.00050962897,0.00072025193,0.00087756774,0.001491714,0.0035309824],"category_scores_gemma":[0.0025478,0.0005366655,0.0018835956,0.00056739006,0.0011668636,0.00072826137,0.00034204192,0.0017496553,0.00029103996],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9561587,0.02289003,0.0016930384,0.0014241306,0.0011056201,0.000062283725,0.000060313363,0.0000985008,0.0020074404,0.00004514463,0.00016487946,0.014289856],"study_design_scores_gemma":[0.75775164,0.23368487,0.0062707337,0.00008700216,0.0009927165,0.000039164268,0.000049060585,0.00022536019,0.00050975085,0.000035377412,0.00033821457,0.000016031956],"about_ca_topic_score_codex":0.0010315115,"about_ca_topic_score_gemma":0.0021866506,"teacher_disagreement_score":0.003558324,"about_ca_system_score_codex":0.0006212824,"about_ca_system_score_gemma":0.0017054789,"threshold_uncertainty_score":0.011812329},"labels":[],"label_agreement":null}]}